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Abstract 
The combination of physiology and genetics affords opportunities to perform 
experiments with greater precision, and with less risk of artefact, than 
heretofore possible. This is illustrated here by demonstrating the selective 
manipulation of the second messengers cyclic GMP (cGMP), cyclic AMP 
(cAMP) and calcium (Ca") in the renal (Malpighian) tubule of the genetic 
model organism, Drosophila melanogaster. Pharmacological intervention 
typically involves bathing a whole tissue in a drug, or the use of agents with 
broad specificities that might confound interpretation. However, ectopic 
expression of receptors in a cell renders it sensitive to the putative ligand, and 
-provided that the necessary internal machinery is present- gives it the 
potential to respond in defined ways. In the case of Drosophila, it is possible to 
target such transgenes with great precision, using the GAL4/UAS 'binary' 
enhancer trap system, allowing the targetting of defined cells in an organotypic 
context. 
The importance of the second messengers cGMP, cAMP and Ca" in control of 
fluid transport makes the MalPighian tubule an ideal testbed for such 
technology. The actions of known hormones can be compared with the results 
obtained by manipulating levels of the second messenger through which these 
are thought to act. 
Flies were constructed or obtained transgenic for the rat atrial natriuretic 
peptide receptor, GC-A, the Drosophila 5HT7D,,, receptor, and the Drosophila 
5HTIAD,,, receptor, under control of the UAS or heat-shock promoter. Tubules 
dissected from such flies were then demonstrated to show diuresis induced by 
application of rANP or 5HT, whereas controls showed no response. Second 
messenger measurements showed that the rat GC-A receptor acted to raise 
cGMP levels, the 5HT7D,. receptor to raise cAMP levels, and the 5HTIADro 
receptor to raise intracellular calcium. In addition, modulation of both cell- 
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specific cyclic nucleotide phosphodiesterase activity and cell-specific cyclic 
nucleotide-dependent kinase activity of tubules with elevated cyclic nucleotide 
levels was observed, implicating these enzymes as key regulators /effectors of 
signalling in tubules. Cross-talk between cGMP, cAMP and Ca", was also 
assessed and shown to be variable, depending on the particular cell type in 
which the signal was generated. This reveals further complexity in the control 
of tubules and suggests a distinct role for cyclic nuleotide-gated channels in 
principal cells. 
This study has validated ectopic transgene expression as a generic technology 
with potential beyond Malpighian tubules: in principle, such transgenes can be 
expressed specifically in any population of cells that can be delineated by a 
GAL4 driver line. 
4 
Abbreviations 
AEBSF 4-(2-an-dnoethyl) benzenesulphonyl fluoride hydrochloride 
ANP atrial natriuretic peptide 
ATP adenosine triphosphate 
ATPase adenosine triphosphatase 
BDGP Berkeley Drosophila Genome Project 
bp base pairs 
BSA bovine serum albumin 
Ca 2+ Calcium ions 
CAP2b 
cardioacceleratory peptide 2b 
cAK cAMP-dependent kinase 
cAMP Y-5' cyclic adenosine monophosphate 
cDNA complementary DNA 
cGK cGMP-dependent kinase 
cGMP Y-5' cyclic guanosine monophosphate 
cNMP Y-5' cyclic (nucleotide) monophosphate 
CNG cyclic nucleotide gated channel 
CNS central nervous system 
cpm counts per minute 
dATP 2' deoxyadenosine triphosphate 
dCTP 2' deoxycytosine triphosphate 
dGTP 2'deoxyguanosine triphosphate 
dNTP 2' deoxy(nucleotide) triphosphate 
DNA deoxyribonucleic acid 
EDTA ethylenediamine tetra acetic acid (disodium salt) 
ER endoplasn-dc reticulum 




GC-A guanylate cyclase receptor A 
GDP guanosine diphosphate 
GFP green fluorescent protein 
GPCR G protein-coupled receptor 
GTP guanosine triphosphate 
GTPase guanosine triphosphatase 
h hour 
IBMX 3-isobutyl-l-methylxanthine 
I. D. inner diameter 















NO nitric oxide 
NOS nitric oxide synthase 
O. D. outer diameter 
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Ore R Oregon R 
PBS phospate buffered saline 
PCR polymerase chain reaction 
PDE phosphodiesterase 
PKC protein kinase C 
PLC phospholipase C 
pmol picomoles 
PMSF phenylmethylsulphonylfluoride 
PtdIns(4,5)P2phosphatidyl inositol bisphosphate 
RIA radioimmunoassay 
RNA ribonucleic acid 
RNase ribonuclease 
rpm revolutions per min 
RT-PCR reverse transcriptase polymerase chain reaction 
sec second 
SIDS sodium dodecYl sulphate 
sGC soluble guanylate cyclase 
Tris 2-amino-2-(hydroxymethyl)-1,3-propanedioI 
u unit 
UAS upstream activating sequence 
UV ultraviolet light 





0C degrees Celsius 
5HT 5-hydroxytryptamine (serotonin) 
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1.1 Drosophila melanogaster as a model organism 
In biology, an extremely useful way to elucidate gene, cell and tissue function is 
to take a transgenic approach. However, the more biornedically relevant the 
chosen model, the more difficult it becomes to manipulate genetically. 
Therefore, a balance has to be met whereby analogy to higher organisms can be 
drawn, yet genetic manipulation can be achieved easily and effectively. 
Drosophila melanogaster lends itself as an excellent model organism with an 
intermediate level of genomic complexity, yet a sophisticated genetic 
technology as a result of a century of analysis. This has led to a comprehensive 
bed of literature, biological techniques and genetic information being freely 
available to the Drosophila community. Furthermore, Drosophila have a short 
generation time and are easy to culture in hundreds/ thousands of distinct 
genetic lines, cheaply, and in a limited space. The completion of the Drosophila 
genome project means that the entire euchromatic genome has been sequenced, 
and the task of disrupting every gene is well underway. This has been made 
possible by P element mutagenesis, discussed in section 1.2. 
1.2 P elements 
1.2.1 P element structure 
The manipulation of P elements revolutionised Drosophila genetics. They are 
used as tools in a vast array of genetic, developmental and cell biological 
studies. The P element is a 2.9kb autonomous transposable element found in 
natural populations of Drosophila melanogaster, with the ability to hop from one 
chromsomal location to another throughout the genome. They were first 
identified as the cause of a syndrome called P-M hybrid dysgenesis in progeny 
of certain crosses of Drosophila strains. This brings about a number of 
disadvantageous traits, such as male recombination, the generation of 
mutations, chromsomal aberrations and sterility. P-M dysgenesis occurs when 
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males of a paternally contributing (P) strain are mated with females of a 
maternally contributing (M) strain, but not when the reciprocal cross is 
performed. P strains contain multiple P elements dispersed all over the major 
chromsome arms, whereas M strains lack P elements. The P elements are 
repressed in the P strains, regulated by the P cytotype, but when placed in the 
cytoplasmic background of the M cytotype which lack repressor they become 
derepressed, and thus transpose at high rates (Engels and Preston, 1979). 
Transposition is made possible by the P element encoding a trans-acting 87kD 
transposase from four long open reading frames (Rio et al, 1986). P elements 
also contain 5' and 3' perfect 31 bp terminal inverted repeats and an 11 bp 
subterminal inverted repeat needed in cis for efficient transposition (O'Hare 
and Rubin 1983; Mullins et al, 1989). P element transposition is genetically 
regulated, with activity of the transposase restricted to the germline as the 
result of differential splicing (Laski et al, 1986). In the major P element RNA 
transcript, found in somatic cells, the first three open reading frames are joined 
by the removal of two introns. However, the removal of a third intron, 
containing an in frame stop codon, is necessary for transposase production. 
This intron is only removed in the gern-dine (Figure 1.1). Importantly, however, 
P elements with internal deletions that remove or disrupt the transposase gene 
are still capable of transposition when supplied with an exogenous source of 
transposase (Robertson et al, 1988). 
The sites of P element integration in the genome are highly variable, but there is 
a strong preference for euchromatin (the non-repetitive regions of chromsomes) 
and the 5' untranslated regions of genes (Spradling et al, 1995). 
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Full length P element 
AUG UI AA Germline mRNA 
v-------- AAAA encoding transposase 
(87 kDa) 
AUG UI GA Somatic mRNA 
AAAA encoding a 66 kDa V- 
protein 
Internally deleted P element 
A2-3 
AUG UAA Somatic and germline 
AAAA mRNA encoding 
transposase (87 kDa) 
Figure 1.1: Structure of P elements 
The full length 2.9 kb P element has four long ORFs separated by introns. The P element 
contains perfect 31 bp terminal inverted repeats (arrowheads). Germline transcripts, spliced 
as shown, provide functional transposase. Somatic transcripts, which retain the intron 
between exons 2 and 3, encode a prematurely truncated and thus non-functional 
transposase. Internally deleted P elements do not provide functional transposase and are 
thus non-autonomous, but they retain cis-acting determinants that allow their mobilisation 
in the presence of exogenous transposase. A2-3 elements, from which the third intron has 
been removed by in vitro manipulation produce transposase in both germline and somatic 
tissues. 
lAdapted from Sentry and Kaiser, 19921. 
23 
1.2.2 Germline transformation 
Germline transformation of Drosophila M strains with engineered non- 
autonomous P elements containing a gene of interest (Spradling and Rubin, 
1982; Rubin and Spradling, 1982), has allowed almost random insertion of any 
gene into the Drosophila genome, and created great scope for the study of gene 
function. Engineered elements carrying a marker gene such as white, enable flies 
with insertions to be recognised when strains lacking the marker gene are used 
for transformation. Exogenous transposase can be supplied in a number of 
ways to these non-autonomous elements. The P element vector can be 
coinjected with purified protein (Kaufman and Rio, 1991), or with a separate 
vector containing the transposase gene that has the third intron removed 
(named A2-3 helper plasmids) (Figure 1.2). Similarly, the P element construct 
can be injected into embryos of a transgenic strain with constitutively active 
transposase, such as P[ry' A2-31 (99B) flies (Laski et al, 1986; Robertson et al, 
1988) and then the transposase element can be removed by outcrossing to avoid 
further transposition. P element constucts are injected into the posterior end of 
embryos at the transition between syncitium and cellular blastoderm. The DNA 
injected into the region of pole cell formation can become internalised and 
transpose into germline chromsomes. This is not frequent on a per cell basis, 
but nonetheless provides acceptable transformation efficiencies. Newly 
integrated P element constructs in the germ cells are stably inherited by the 
progeny of transformed individuals, and fly lines can then often be bred to 
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w"18 female (white) 
44 
w"18 embryo 
w"m male (white-) 
x 




AIIT Transformed individual 
(white, ) 
rq 
w"18 adult (7ohile) 
-P 
It, * Pt 
Red eyed phenotype %, elected and bred interse 
Figure 1.2. Germline transformation of Drosophila 
Embryos from the strain w"Is were coinjected with a non-autonomous P element vector 
(containing the gene of choice and the miniiiihile marker gene), and A2-3 helper plasmid, which 
encodes an 87 kD transposase. Surviving adults were crossed with 71? 1118 and progeny were 
screened for insertion of the P element, indicated by expression of the marker gene miniuPhite 
producing a red eye phenotype. Transformed individuals were backcrossed with w1118 and 
bred inter se, to establish independent transgenic lines. 
[Adapted from Guo, 19%1. 
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There are several methods to manipulate gene expression using modified P 
elements. For example, a gene can be fused to transcriptional regulatory 
sequences from a defined promoter (Zuker et al, 1988; Parkhurst et al, 1990; 
Parkhurst and Ish Horowicz, 1991). This technique allows tissue- or cell-specific 
transcription, but is limited by the availability of cloned and characterised 
promoters that can drive the desired pattern of expression. Another method is 
to drive expression of the desired gene from a heat-shock promoter. This 
method has the advantage of allowing the gene to be expressed at a specific 
point in development, simply by heat-shocking the transgenic animal (Struhl, 
1985; Schneuwly et al, 1987; Ish-Horowicz and Pinchin, 1987; Ish-Horowicz et al, 
1989; Gonzalez-Reyes and Morata, 1990). However, there are a number of 
disadvantages reported for this method of overexpression; ubiquitous 
expression of the gene after heat-shock may be harmful to the animal, 
expression is notoriously "leaky" and heat-shock itself may induce effects. The 
GAL4/UAS binary system for ectopic gene expression was therefore 
developed, that makes use of a technique called enhancer trapping, described 
below. 
1.2.3 Enhancers 
An important technique utilising P element transformation is enhancer 
trapping (O'Kane and Gehring, 1987; Bellen et al, 1989; Bier et al, 1989; Sentry 
and Kaiser, 1992; Finnegan, 1992; Brand and Perrimon, 1993). Enhancers are 
regulatory sequences that stimulate transcription from the promoters with 
which they are associated. There are two general classes of cellular enhancers, 
namely inducible enhancers and temporal and tissue-specific enhancers. They 
are a major mechanism for regulating gene expression in eukaryotes. Once 
activated by binding of a specific protein, they act as sites for the assembly of 
transcription initiation complexes. Enhancers differ from other regulatory 
sequences in several ways. Firstly, they may be upstream or downstream of the 
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gene(s) and several kb away from the gene(s) that they control. Secondly, they 
can act in either orientation and so can simultaneously influence expression of 
two genes, one on each side of the enhancer sequence. Thirdly, they can be on 
the opposite strand of DNA as the regulated gene (although they must be on 
the same DNA molecule), and lastly, they are not gene specific, but tissue 
specific and will preferentially enhance transcription from the nearest promoter 
(Smith-Keary, 1991). 
1.2.4 First generation enhancer traps 
Enhancer trap vectors were designed containing modified P elements with the 
transposase gene deleted, into which a reporter gene cloned downstream of a 
minimal promoter region (insufficient in itself to induce transcription) could be 
inserted. This P element could be introduced into the genome by germline 
transformation with an exogenous source of transposase, as described earlier. 
The reporter gene would then fall under the regulation of the nearest enhancer 
to the P element in the genome. Initial enhancer traps used the lacZ gene, which 
encodes P-galactosidase from Escherichia coli, as the reporter gene (O'Kane and 
Gehring, 1987) (Figure 1.3A). These Pj1acZj lines expressed lacZ in a manner 
reflecting that of the endogenous gene that the enhancer controls. Enhancer 
activity was then visualised by staining for P-galactosidase activity with the 
chromgenic substrate X-gal. This Pj1acZj fusion was an efficient tool for the 
isolation and characterisation of genes and their enhancers, simply by 
providing knowledge of their pattern of expression (rather than screening for 
phenotypes caused by mutations), and also for the generation of a wide variety 
of cell type-specific markers. For example, Perrimon et al (1991) generated flies 
containing 1acZ fused to either the weak promoter of the P element transposase 
gene, or to partial promoters from the even -skipped, fushi-turazu, or engrailed 
genes. These lines were used to follow specific cell lineages in development and 
also to analyse the phenotype of several developmental mutants. Similarly, 
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Gonczy et al (1992) used marker lines to label early stages of male but not 
female germ cell differentiation, which is useful in the analysis of germline sex- 
determination. 
1.2.5 Second generation enhancer traps 
A second generation enhancer trap was developed by Brand and Perrimon 
(1993), named PIGAL41 using the yeast transcription factor GAL4 as a reporter 
instead of P-galactosidase. GAL4 is functional in Drosophila, but does not 
activate transcription of any endogenous genes (Fischer et al, 1988). It can 
therefore be used to direct expression of other transgenes placed under the 
control of the GAL4-dependent promoter UASG (Upstream Activating Sequence 
for galactose). Constructs containing the UASG sites upstream of the hsp7O 
promoter, which lacks its upstream regulatory sequence, may be used to 
generate flies that contain a gene of choice that will remain silent until crossed 
with a GAL4-expressing fly (Brand and Perrimon, 1993). This binary system, in 
which expression of the gene under control of UASG requires the presence of 
GAL4, means that these lines can be maintained as separate transgenic stocks 
(Figure 1.3B). This system has the benefit of allowing the experimenter to study 
phenotypic consequences of misexpression (which could include lethality) in 
the progeny of a simple cross, rather than trying to maintain (over extended 
periods of time) lines that could potentially be very sick. Furthermore, with a 
large number of PIGAL41 lines available, virtually any expression pattern of the 












Tissue-specific expression of GAL4 
Figure 1.3: Enhancer trap gene expression 
CAL4 
5x UAS 
Trancriptional activation of UAS:: Gene X 
A: A first generation enhancer trap element inserted within a Drosaphila gene. The pattern 
and timing of expression of the reporter, Im-Z, is dependent upon the specific genomic 
context in which it is integrated. whitel is a marker that confers red eye colour in a white- 
genetic background, and thus allows flies containing new insertions to be recognised. The 
ampicillin resistance determinant (anq, R) and E. coh origin of replication (ori) to facilitate 
plasmid rescue of flanking sequences. 
ITaken from Sentry et al, 19941. 
B: A GAL4 enhancer trap element. The pattern and timing of GAIA expression is similarly 
context dependent, and can be used to drive expression of a secondary reporter gene linked 
to the GAI-4-responsive promoter, UAS.. This binary system separates the target gene from 
the driver in two distinct transgenic lines. 
lAdapted from Brand and Perrimon, 19931. 
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1.3 The Drosophila melanogaster Malpighian tubule 
1.3.1 Malpighian tubule morphology 
The Malpighian tubule is the insect equivalent to the vertebrate renal system. It 
secretes a primary urine, and can selectively reabsorb solutes. These processes 
need to be tightly controlled, and this is achieved through neurohormone 
recognition by receptors on the tubule plasma membrane. The morphology and 
development of Malpighian tubules have been reviewed (Wessing and 
Eichelberg, 1978; Skaer, 1993) and describe a tissue of simple morphology. 
Tubules are blind-ended epithelia only one cell thick, and each fly has four 
tubules arranged as two pairs, anterior and posterior, connected to the gut by a 
short ureter. Classically, anterior tubules were described as consisting of three 
distinct segments, an initial segment (which has large luminal concretion 
bodies), and a main segment joined by a small transitional segment (Wessing 
and Eichelberg, 1978). The posterior tubules were thought to consist solely of a 
main segment (Figure 1.4A). Two tubule cell types were reported: principal 
(type I) and secondary, or stellate (type 11). However, using the enhancer trap 
technique described in section 1.2.5, a surprising amount of complexity for this 
simple epithelium was uncovered (S6zen et al, 1997), described in section 1.3.2. 
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Initial seginclu 
A: The classical morphology of the Malpighian hIbUIVS, illU. Strating Main, initial and 
transitional segments of the anterior tubule(s) and One long Main SOgInCnt of the posterior 
tubule(s). Both anterior and posterior pairs of tubules are attached as pairs to the gut by a 
common ureter. 
ITaken from Wessing and Eichelberg, 19781. 
B: SUrrunary of tUbule regional architecture, as reve, flvd by PJGAIA) enhancer trap fines. The 
different SUbregions of the WbUle are indicated and the numbers of princilml md stellate cells 
in each region are shown. 
[Taken from Sozen ct al, 19971. 
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1.3.2 Malpighian tubule enhancer traps 
A panel of over 700 PIGAL41 enhancer trap lines were analysed (Sbzen et al, 
1997) of which approximately 10% revealed interesting expression patterns in 
Malpighian tubules of the progeny of crosses with UASG:: IacZ. This analysis 
revealed that posterior tubules did in fact have small initial and transitional 
segments, which had been overlooked in other studies. Also, the main segment 
could be further subdivided in both anterior and posterior tubules. The lower 
third of the tubule and the ureter were also shown to be genetically separable 
from the main segment, which could itself be resolved into three subregions: a 
lower tubule and an upper and lower ureter. Furthermore, these newly 
identified genetic domains were organised in number to single-cell precision 
(Figure 1.413). This enhancer trap analysis also revealed further cell subtypes: 
principal cells comprise at least two distinct subpopulations, bar-shaped cells 
are found in the initial and transitional segments of the anterior tubules, and 
"tiny" neuroendocrine cells were revealed in the lower tubule and ureter. These 
tiny cells are speculated to secrete hormones involved in the control of fluid 
secretion and reabsorption by tubules. This study gave important insight into 
how the organism views its tubule structure, rather than how the experimentor 
had previously viewed it. Furthermore, PIGAL4) lines that revealed interesting 
patterns of expression were established ýs homozygous stocks and can now be 
used to drive expression of any reporter under UAS control in specific cells or 
regions of tubules. 
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1.3.3 A model for epithelial fluid transport and second messenger signalling 
Classically, insect Malpighian tubules have been used as models of epithelial 
fluid secretion and its neurohormonal control (Maddrell, 1981; Maddrell, 1991; 
Maddrell and O'Donnell, 1992). Malpighian tubules from Drosophila 
melanogaster were demonstrated to be amenable to physiological study, with the 
development of an assay for measurement of fluid secretion (Dow et al, 1994b) 
(Figure 1.5). However, tubules from Drosophila melanogaster are suited not only 
to classical physiology, but also molecular genetic analysis, thus allowing an 
approach termed integrative physiology to be deployed (Dow and Davies, 
2001). Taking this approach, we can address cell function in an organotypic 
context. 
Intracellular second messengers are important modulators of epithelial 
function. An integration of signals leads to overall function and tight control of 
second messenger levels, both within and between cells, is needed. Receptors 
expressed on the plasma membrane are involved in control of second 
messenger levels, by recognising and binding ligands, and then relaying that 
signal through alteration of second messenger levels. Heterologous expression 
of a receptor in a cell line similar to the cell type from which it was isolated 
helps characterise its function, but may not reflect any subtle differences 
apparent in an in vivo multicellular environment. The aim of this project is to 
distinguish the signalling pathways that coordinate fluid transport, using 
ectopic expression of receptor transgenes in tubules that signal via distinct 
second messengers, and to characterise the pharmacology of these receptors in 
a differentiated multicellular environment. 
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Figure 1.5: Measurement of fluid secretion by Drosophila Malpighian tubules 
Malpighian tubl-Iles were dissected from the fly in Schneider's insect culture niedium (Gibco 
BRL) in pairs, by severance Of the Ureter. One tLIl)LIIL' was wrapped around in anchori'lig pill 
whist the other remained in a9 ýd drop Of 1: 1 MiXtUre Of SChneider's: Drosopltila saline, 
positioned with a depression in a paraffin WaX base. Fhlid SeCretiOll is l`IIVlSUrCd under 
mineral oil to prevent evaporation. Secreted fluid forms as a spherical d rop at the ureter, and 
can be removed at intervals with a fine glass rod. The diameter of the drop can lie ineasured 
with an ocular micrometer, allowing volume of secreted fILlid to be L'alCLII, lt('d. 
[Taken from Dow et al, 1994bl. 
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1.3.4 Distinct functions of tubule regions and cell types 
The regions of the tubule have different functions and physiological properties. 
It has been demonstrated that the main segment performs a secretory role, 
whereas the lower segment is involved in fluid reabsorption (O'Donnell and 
Maddrell, 1995), and the initial segment is thought to be involved in calcium 
transport (Dube et al, 2000). Furthermore, the two cell types (principal and 
stellate) of the main segment have been shown to be involved in separate 
functions. It is accepted that the primary active ion pump in Malpighian tubules 
is an apical vacuolar-type H'-ATPase (V-ATPase). The vha55 gene encoding the 
V-ATPase B-subunit was shown to be strongly expressed in principal cells of 
the main segment of tubules by enhancer trap analysis (Davies et al, 1996), 
indicating that the V-ATPase was confined to these cells. The V-ATPase 
maintains a proton gradient across the apical membrane that drives movement 
of alkali cations from cell to lumen through apical sodium/proton (Na'/H") 
and/or potassium/proton (K'/H") exchangers (antiporters). The V-ATPase also 
establishes a favourable electrical gradient for the flow of anions, such as 
chloride (U), from cell to lumen. This in turn establishes an osmotic gradient 
that promotes the movement of water from cell to lumen as a secondary 
consequence of ion transport. Microelectrode measurements of transepithelial 
potentials in tubules showed that stimulation of tubules with cyclic nucleotides 
made the lumen more electropositive through the activation of the apical 
electrogenic V-ATPase in principal cells (O'Donnell et al, 1995). This response 
could also be achieved by treating tubules with the neuropeptide CAP2b 
(cardioacceleratory peptide 2b, a neuropeptide peptide isolated from Manduca 
sexta related to the Drosophila melanogaster capa peptide family), which acts to 
raise intracellular cGMP in principal cells of tubules through activation of a 
nitric oxide synthase (NOS) sensitive soluble guanylate cyclase (O'Donnell et al, 
1998; Davies et al, 1995; Davies et al, 1997). However, changes in extracellular 
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chloride levels did not alter this potential, suggesting that chloride must pass 
through cells by another route (O'Donnell et al, 1996). It was subsequently 
demonstrated by vibrating probe (or self-referencing electrode) analysis (which 
measures tiny disturbances in the electric field around a tissue) that chloride 
movement was confined to a small number of current density hot-spots. These 
hot-spots were consistent with the positions of stellate cells, and could be 
abolished with low-chloride saline or by incubating tubules with chloride 
channel blockers. The chloride permeability of tubules can be raised by the 
insect neuropeptide leucokinin, which has been shown to raise intracellular 
calcium levels rapidly and specifically in stellate cells (O'Donnell et al, 1998; 
Rosay et al, 1997). This is conclusive evidence that anion and cation transport is 
not only functionally separable, but controlled by different cell types of tubules. 
This is summarised in Figure 1.6. 
Much insight has been gained about the signal transduction pathways that 
control fluid transport in tubules; however an approach whereby the actions of 
a single second messenger could be isolated and its downstream effectors 
subsequently analysed may be able to identify points of crosstalk. It is perhaps 
important to define what is meant by crosstalk at this point. In a particular cell, 
if signal components from one pathway can influence components of another 
pathway, then crosstalk is said to occur. However the definition can also be 
extended to "cross activation", whereby actions at common targets or actions at 
separate targets ultimately produce an identical action on a single effector. 
In order for a specific second messenger signal transduction pathway to be 
successfully dissected out, receptors and their ligands have to be carefully 
chosen. This study would not be easy using the endogenous neuropeptides at 
our disposal (CAP2b, capa peptides, CRF-like peptide and leucokinin). Although 
the main second messengers activated have been identified, there is no way of 
determining whether these peptides are only being bound by receptors on one 
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particular cell type. There is also ambiguity as to the action of other components 
in these pathways. For example, when CAP2b or a CAPA peptide binds to its 
receptor, there is an initial rise in intracellular free calcium concentration 
([Ca 2+1i) which is necessary for the activation of NOS (Rosay et al, 1997; Davies et 
al, 1997; Kean et al, 2002). Therefore, the activation of soluble guanylate cyclase 
by NO to produce cGMP is much further down the signal cascade than calcium 
(Ca'+). Intracellular Ca' is known to have fundamental roles in control of fluid 
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Figure 1.6: Summary of cell signalling pathways in the cells of the Malpighian tubule 
The neuropeptides CAP2b and members of the CAPA family bind to a receptor on the 
basolateral membrane of principal cells and stimulates a rise in JC'a2+j, (through aG protein- 
coupled receptor). This rise activates DNOS, producing NO, which activates soluble guanylate 
cyclase to produce cGMP. The rise in cGMP results in increased activity of the V-ATPase and 
an increase in fluid transport. Increased V-ATPase activity and the subsequent increase in 
fluid transport can also be achieved when tubules are treated with cAMP. The neuropepticle 
Drosokinin binds to aG protein-coupled receptor on the basolateral membrane of stellate cells 
and stimulates a rise in JCa2+jj exclusively in the stellate cells, which increases chloride shunt 
conductance. This, in turn, increases fluid transport. 
[Taken from Dow and Davies, 20011. 
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1.3.5 Measuring intracellular calcium concentration in Drosophila tubules 
Malpighian tubules are too small to measure intracellular calcium 
concentrations ([Ca"]i) with traditional techniques, such as using ion-specific 
n-dcroelectrodes. Also, as the primary function of this tissue is to actively secrete 
waste, using fluorescent Ca'-sensitive dyes, such as fura-2, is not practical. 
However, the adaption of a technique previously used in cell culture and 
plants, is to transgenically express the Ca'-sensitive luminescent protein 
aequorin (Sheu et al, 1993; Knight et al, 1991; Brini et al, 1995). Aequorin is 
isolated from the jellyfish Aequoria victoria and is a complex of aequorin and the 
substrate coelentrazine. In the presence of Ca", aequorin is rapidly converted to 
apoaequorin, coelentran-dde and CO, (Figure 1.7). This reaction results in the 
emission of blue light, which can be quantified into [Ca'*]i. Therefore, if 
apoaequorin is placed under UAS control, it can be expressed in a cell-specific 
manner using any of the panel of GAL4 driver lines available. Thus, cell-specific 
[Ca"]i can be measured non-invasively, and in real-time, when tubules 
expressing the transgene are incubated with coelentrazine. 
Flies containing a UAS:: aeq transgene have been generated, and have been 
shown to be useful in Malpighian tubule [Ca'*]i measurements and in other 
tissues (Rosay et al, 1997; Rosay et al, 2001). Cell-specific Ca", signals can now be 
resolved in tubules in an organotypic context, probably with less artefact than 
other techniques, and has aided the characterisation of the CAP2b/capa and 
Drosokinin signal transduction pathways discussed previously (Rosay et al, 
1997; Terhzaz et al, 1999; O'Donnell et al, 1998; MacPherson et al, 2001; Kean et 
al, 2002). Expression of transgenic receptors in the same cell type that aequorin 
is expressed in will therefore allow the evaluation of cross-talk between cyclic 
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Figure 1.7. Aequorin expression in the Malpighian tubule. 
Progeny of a cross between flies that express GAL4 in a cell-specific manner and flies 
containing the apoaequorin gene under the control of UAS express the apoaequorin gene in 
a cell-specific manner. The constitution of apoaequorin with coelentrazine, results in the 
slow formation of aequorin, which, in the presence of calcium, rapidly converts back to 
apoaequorin. This results in the emission of blue light, which is quantifiable, allowing 
calcium concentration within the cells to be calculated at any given time. 





1.4 Receptors as tools for specific manipulation of second 
messengers in tubules 
Clearly, it is desirable to be able to manipulate the major second messengers 
(cGMP, cAMP and Ca") in specific cells in tubules, or indeed in any cell type. 
This project investigates the feasibility of performing such manipulation, by 
ectopic expression of receptors under spatial and temporal control. 
1.4.1 Guanylate cyclases 
Guanylate cyclases serve as receptors that produce cGMP in response to ligand 
binding. They fall into three distinct groups; those which are found on the 
plasma membrane, which recognise a variety of different peptides (rGCs); those 
in the cytoplasm, which recognise nitric oxide (sGCs); and vertebrate 
photoreceptor rod outer segment guanylate cyclases (ROS-GC) (Davies, 2000). 
The ROS-GCs differ from rGCs in that they are not regulated by extracellular 
ligands. Instead, they are regulated intracellularly by Ca", via Ca"'-binding 
proteins (Goraczniak et al, 1998; Kumar et al, 1999). 
The rGCs possess a single transmembrane domain, separating the protein in to 
an extracellular ligand binding domain and an intracellular region consisting of 
an intracellular kinase homolgy domain (KHD) and an intracellular cyclase 
catalytic domain (Chinkers et al, 1989). However, it is proposed that a 
homodimer is the rrdnimurn catalytic element of membrane guanylate cyclases. 
The cytoplasmic forms consist of two different subunits (cc and 0), each of 
which contains a cyclase catalytic domain (Garbers and Lowe, 1994). The 
known peptide ligands for the membrane receptors fall into two families: 
natriuretic peptides (atrial natriuretic peptide (ANP), brain natriuretic peptide 
(BNP), and C-type natriuretic peptide (CNP)); or heat-stable 
enterotoxins/guanylins. The membrane guanylate cyclases differ most greatly 
in the N-terminal ligand-binding domain, and are classified according to their 
ligand specificities. 
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1.4.2 cGMP signalling & GC-A as a tool to specifically manipulate cGMP 
We chose to use a rat membrane-bound guanylate cyclase (GC-A) as a tool to 
specifically manipulate intracellular cGMP ([cGMPi]) in vivo. GC-A is a 
membrane form of guanylate cyclase and upon binding the peptide atrial 
natriuretic peptide (ANP) elevates intracellular levels of cGMP directly. ANP 
was discovered by de Bold et al (de Bold et al, 1981; de Bold, 1982) as an 
endogenous natriuretic factor. It is found primarily in atria as a preprohormone 
that is cleaved to a prohormone of 126 an-dno acids (Gardner et al, 1991). The 
carboxy-terminal 28 amino acids represent the circulating form of ANP 
(Thibault et al, 1985; Glembotski et al, 1988). Binding of ANP to renal receptors 
was first reported by Napier et A 1984 using radiolabelled ANP and principally 
induces natriuresis and diuresis in the kidney, as well as induction of smooth 
muscle relaxation and inhibition of aldosterone synthesis from the adrenal 
gland (Drewitt and Garbers, 1994). 
Maximal activation of GC-A by ANP requires the presence of ATP (Foster and 
Garbers, 1998). It has been shown that the kinase homology domain (KHD) 
functions as a regulatory element although it does not have protein kinase 
activity (Chinkers and Garbers, 1989; Potter and Hunter, 1999). The KHD 
conforms to the protein kinase consensus sequence in 30 out of 33 residues and 
the Gly-X-Gly-X-X-Gly consensus sequence of protein kinases is Gly-X-GIY-X-X- 
X-Gly in the rat guanylate cyclase (Chinkers et al, 1989). When the KHD was 
removed by deletion mutagenesis, the resulting ANP receptor retained 
guanylate cyclase activity, but the activity was ANP-independent and its 
stimulation by ANP was markedly reduced (Chinkers and Garbers, 1989). This 
result suggests that binding of ANP to the receptor evokes a conformational 
change in the KHD which allows derepression of guanylate cyclase activity. It 
has subsequently been suggested that dephosphorylation of the receptor 
mediates desensitisation to ANP. Abolishing the six phosphorylation sites by 
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conversion to alanine residues in the KHD results in loss of ability to be 
activated by ANP. This suggests that the receptor is active in its phosphorylated 
state, and dephosphorylation is the regulatory means by which receptor activity 
declines over time (Potter and Hunter, 1999; Potter and Garbers, 1992) (Figure 
1.8). 
It has been demonstrated in GC-A knock-out mice, that disruption of GC-A 
leads to mice with elevated blood pressure, which is not altered by either 
n-dnimal or high salt diet (Lopez et al, 1995). This was not due to reduced ANP 
levels in plasma in response to acute volume expansion, which were similar in 
both wild type and GC-A deficient mice (Kishimoto et al, 1996). However, 
elevated urine, sodium and cGMP output by wild type mice in response to 
volume expansion was not seen in GC-A deficient mice, implying that GC-A is 
essentitial for ANP-induced acute regulation of natriuresis and diuresis. 
It is critical to our approach that the tissue of interest (in this case Malpighian 
tubules) does not respond to the hormone(s) that activate the chosen receptor. 
Tubules have been shown not to respond to ANP (Dow et al, 1994a) and in 
addition there are no ANP-like peptides in the Drosophila genome, determined 
by BLAST search. This suggests that ectopic hs:: GC-A or UAS:: GC-A will have 











Figure 1.8: ANP-induced stimulation of GC-A catalyses formation of cGMP 
GGA is thought to exist as a dimer, or possibly higher-order configurations. An extracellular 
domain binds ANP, resulting in a conformational change that brings the guanylate cyclase 
domains into close contact with each other. This association catalyses formation of cGMP 
from GTP. At least four serine and two threonine residues in the kinase homology domain are 
phosphorylated in the absence of ligand, and dephosphorylation correlates with receptor 
desensitisation. 






1.4.3 G protein-coupled receptors 
G protein-coupled receptors (GPCRs) form a large superfamily with over 1000 
different GPCRs estimated to exist in mammals (>l% of the genome! ), making 
them the most diverse membrane-bound receptors to exist (Strader et al, 1994; 
Gudermann et al, 1995). They are classified into over 100 subfan-dlies, according 
to their sequence homology, ligand structure, and receptor function. A large 
degree of amino acid similarity is seen among members of a particular 
subfamily, but comparisons between subfamilies show considerably less, or no 
similarity. However, all GPCRs have an extracellular an-dno terminus, a central 
core domain constituted of seven transmembrane helices connected by three 
intracellular loops and three extracellular loops, and an intracellular carboxyl 
terminus in common (Dohlman et al, 1991; Baldwin, 1994). In Drosophila, the 
many families are categorised into four larger families on the basis of similarity 
in both topology and sequence: rhodopsin-like; secretin-like; metabotropic 
glutamate-like; and atypical seven transmembrane (7TM) proteins. 
Unsurprisingly there is vast array of ligands for these receptors, ranging from 
hormones, neurotransmitters and growth factors, to odorants and light, and 
mutations in GPCRs have been observed that relate to a similarly wide range of 
disorders and diseases, from infertility to cancer. They are also estimated to be 
the target of more than 30% of the drugs used in clinical medicine. Thus, an 
understanding of GPCR function is an important goal. 
When a GPCR is activated by an extracellular ligand, the receptor relays this 
information by activating the G protein with which it is associated. These G 
proteins are heterotrimers composed of, cc, 0, and y subunits, and are classified 
based upon an-Lino acid similarity of their cc subunits. More than 20 distinct a 
subunits are known, which are subdivided into four fan-dlies: Goc., G%., Gaq, and 
GCC12 (Simon et al, 1991). Five 0 and eleven y subunits have been described 
(Watson et al, 1994; Morishita et al, 1995, Ray et al, 1995), however 0 and y 
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subunits are tightly associated and are usually regarded as one functional unit. 
In the inactive state, Gccsubunits have GDP bound in a high-affinity binding 
pocket for guanine nucleotides, and are associated with the Oy subunit. 
Activated GPCRs catalyse the exchange of GDP for GTP, and the ctsubunit 
becomes dissociated from the Oy subunit. The Gcc subunit had originally been 
regarded as the activator of signalling pathways, whereas the Py subunit played 
a role in anchoring the Gcc subunit to the membrane near the receptor. 
However, both GTP-Gec and Py are signalling molecules, and modulate the 
activity of specific effector systems (Birnbaumer, 1992; Clapharn and Neer, 1993; 
Neer, 1995). The Gcc subunit controls the stimulation or inhibition of cAMP, or 
the release of Ca"' from internal stores. The intrinsic GTPase activity of the GcC 
subunit hydrolyses GTP to GDP, thus rendering it inactive and the GcC subunit 
then reassembles with the Py subunits. In order for this cycling between active 
and inactive states of the G protein, there needs to be receptor desensitisation to 
persistent stimulation. This can occur in numerous ways, from transcriptional 
and translational mechanisms, to the more rapid control of protein levels. The 
control of receptor stimulation at the protein level can involve regulation of the 
rate at which the receptor is internalised and degraded, or by covalent 
modifications and/or association with other regulatory proteins which block 
receptor-G protein association. An established mechanism for GPCR 
desensitisation is by feedback via kinase(s) activated by GPCR stimulation. Both 
cAMP-dependent kinase (cAK, stimulated by cAMP production), and Ca'*- 
dependent kinase (PKC, stimulated by Gccq activation of phospholipase C) 
regulate GPCRs this way (Hausdorff et A 1990; Sibley et al, 1987). 
Phosphorylation causes a conformational change in the receptor, which inhibits 
association with the G protein. This is a non-specific, or heterologous 
mechanism, because elevated cAK or PKC activity, caused by any agonist, will 
potentially phosphorylate any GPCR that has the appropriate phosphorylation 
46 
site. The major agonist-specific, or homologous, mechanism for rapid 
desensitisation of GPCRs involves a two step process. First, the activated 
receptor is phosphorylated by aG protein-coupled receptor kinase (GRK) and 
then the receptor binds P-arrestin protein, which blocks signalling to the G 
protein. This is reported to be an important process in the internalisation of 
GPCRs (for a review see Ferguson et al, 1996). P-arrestin binds with high- 
affinity to clathrin, suggesting that it acts as an adaptor in clathrin-coated 
vesicle-mediated endocytosis of receptor. Rapid desensitisation by 
internalisation of receptors is also rapidly reversible, with dephosphorylation of 
the receptor occuring in endosomes, before being returned to the plasma 
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Figure 1.9: A model for G protein-coupled receptor desensitisation 
A: The activated receptor stimulates production of cAMP or release of Ca2l. 
B: An activated G protein receptor kinase phosphorylates the activated receptor, which 
blocks further stimulation of the G protein. This in turn allows the association of P-arrestin 
and clathrin. 
C: Clathrin assembly results in endocytosis of the receptor, where it can be 
dephosphorylated and recycled or degraded. 
48 
1.4.4 Serotonin (5HT) receptors 
Receptors for serotonin (5-hydroxytryptamine, 5HT) are classified into seven 
different subfan-dlies, all of which are G protein-coupled, with the exception of 
the 5HT3 receptor; this receptor is coupled to the direct activation of ion 
channels. Serotonin is a biogenic amine endogenously synthesised from 
tryptophan through the actions of tryptophan hydroxylase and aromatic L- 
amino acid decarboxylase, as well as being found in a variety of dietary sources, 
and is rapidly metabolised by monoamine oxidase. It is found in three main 
areas of the body; the intestinal wall, blood vessels, and the CNS. Serotonin is 
involved in control of various physiological functions, such as appetite, sleep, 
memory and learning, temperature regulation, mood, sexual and 
hallucinogenic behaviour, cardiovascular function, muscle contraction, 
depression, and endocrine regulation. Drosophila serotonin receptors, however, 
are predominantly expressed in the CNS, and have an important 
developmental role (Colas et al, 1993; Colas et al, 1997, Colas et al, 1999). 
Drosophila tubules are known to be insensitive to 5HT (Julian Dow, personal 
communication), and the 5HT receptor family contains members that modulate 
both cAMP and Ca" signalling pathways. It seemed therefore that these 
receptors would be ideal candidates for manipulation of these second 
messengers in tubules. However, if this is to be successful, it would depend 
critically on the receptor interacting with its cognate G protein complex, which 
in turn requires that these are expressed in the cell-type of interest. This cannot 
be assumed: overexpressed G proteins have been known to show some 
promiscuity with receptors (Offermanns and Simon, 1995; Li et al, 2000; 
Kostenis 2001). Accordingly, this study will go into some detail to demonstrate 
that the receptors used really do act exclusively on the second messenger of 
interest, and exclusively on the intended cell types. These are essential 
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validations of the method, and as will be seen, the transgenic receptors indeed 
behave as desired. 
1.4.5 cAMP signalling & 5HT7D,,,, as a modulator of cAMP 
The manipulation of cAMP was achieved using a Drosophila receptor for 
serotonin, 5HT7Dr,, (Witz et al, 1990; Saudou et al, 1992; see Table 1.1 and review 
by Tierney (2001) for nomenclature). This receptor is aG protein-coupled 
receptor, which upon activation, stimulates adenylate cyclase to catalyse the 
formation of cAMP when expressed in insect cell lines (Obosi et al, 1996) (Figure 
1.10 and Table 1.2). It has been implicated in regulation of circadian rhythms, 
based on the presence of a Gly-Ser repeat in the N-tern-dnal tail of the receptor. 
This motif is an attachment site for glycosaminoglycans found in biological 
clock genes, such as period. 
Serotonin does not physiologically affect Drosophila tubules, however adenylate 
cyclase activity can be raised by the activator forskolin, confirming the presence 
of adenylate cyclase(s) in this tissue, and suggests that the 5HT7Dro is a good 
candidate as a receptor to specifically modulate cAMP. 
The role of cAMP in cells can be diverse, but the simplistic model is that cAMP 
is generated and acts to raise cAK activity, which is its main effector. The 
actions of cAK then depend on the particular cell type and appropriate 
substrates containing the cAK consensus phosphorylation site. 
Phosphodiesterase activity increases in response to elevated cAMP levels, and 
hydrolyses cAMP to 5'-AMP. This is rather more complicated than a simple 
linear pathway that is dampened by degradation of cAMP, and this is largely 
due to differential expression and compartmentalisation of the adenylate 
cyclase and cAMP-dependent phosphodiesterase subtypes in a particular cell. 
Adenylate cyclases belong to a large family encoded by at least nine 
independent genes, with the different subtypes only expressed in distinct 
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Original name Revised name Accession n Reference 
5HT-drol 5HT71ý,, M55533 Witz et al, 1990 
5HT-dto2A 5HT1ADro Z11489 Saudou et al, 1992 
5HT-dro2B 5HT1BDro Z11490 Saudou et al, 1992 
5HT2D,. 5HT2DrO X81835 Colas et A 1995 
Table 1.1- Drosophila 5HT receptor nomenclature 
[Adapted from Tierney, 20011. 
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Receptor Transduction Agonists Antagonists Reference 
5HT7D,,, 





5HTlADr. Decrease 5HT (6) dihydroergocryptine (1) 
cAMP 8-OH-DPAT (8) prazosin(2) 










5HT2D,. ? 5HT (4) ritanserin (1) 
N-acetyl-5HT (6) ketanserin (2) 
a-methyl-5HT (8) pizotifen (3) 
2-methyl-5HT (13) setoperone (5) 
tryptamine (13) spiperone (6) 
1-methyl-5HT (15) cyproheptadine (6) 
quipazine (17) TFMPP (6) 









Saudou et al, 1992 
Saudou et al, 1992 
Colas et A 1995 
Table 1. Z- Pharmacological profile of heterologously expressed Drosophila 5HT receptors 
Table includes all serotonergic ligands tested in rank order of potency (except for 5HT2D,. where 
the 25 most potent compounds are listed). Numbers in parentheses after each compound indicate 
the order of potency of agonists relative to antagonists; equally potent compounds are assigned 
the same number. Abbreviations: 8-OH-DPAT, (±)-S-hydroxy-2-(di-n-dipropylamino) tetralin; 5- 
MeOT, 5-methoxytryptan-Line; TFMPP, N-(-3-trifluoromethylphenyl)piperazine. 
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Figure 1.10: Activation of the 5HT7Dru (; protein-coupled receptor stimulates cAMP 
production 
Binding of 5HT to the 5HT7D, receptor stimulates the heterotrimeric G protein with which it 
is associated to exchange GDP for GTP. This exchange allows the (1,,, subunit to dissociate from 
the Py subunits, and consequently stimulate adenylate cyclase to catalyse the formation of 
cAMP from ATP. The intrinsic GTPase activity of the (x,. subunit hydrolyses GTP to GDP, thus 
allowing it to reassociate with the Py subunits in its inactive state. In the absence of 5HT, 
almost all the Got, is in the inactive GDP-bound form. 
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tissues. In addition to activation by G(x, and inhibition by Geci, the different 
isoforms can be modulated by a variety of other sources: GPy, protein kinases 
(cAK, PKC and calmodulin (CaM) kinase), phosphatases, calcium and 
Ca"/CaM. This allows the integration of different regulatory pathways 
through cross-talk with other signal transduction pathways. Inhibition of 
adenylate cyclase by cAK presents a model whereby desensitisation can be 
achieved by a short negative-feedback loop (Iwami et al, 1995) and has been 
demonstrated in chick hepatocytes (Premont et al, 1992). Interestingly, G 
protein-coupled receptor stimulation amplifies the ligand-induced signal at the 
level of Gcc subunit: there is great excess of Gcc subunit in comparison to both 
receptor and the effector. However, this amplification is not directly transferred 
to adenylate cyclase activity. Work by MacEwan et al (1996) demonstrated that 
the maximal hormonal stimulation of cAMP production could be potentiated 
by raising total levels of adenylate cyclase. Neuroblastoma-glioma NG 108-15 
hybrid cells were transfected with various amounts of adenyate cyclase 2 
isoform (AC2), which is not normally present in these cells, and cAMP 
production was elevated in cells expressing greater levels of AC2, thus 
confirn-dng that adenylate cyclase was the limiting factor in receptor-mediated 
stimulation of cyclase. 
The profile of the cAMP signal can also be due to the phosphodiesterases 
present in a tissue/cell. Phosphodiesterases are a family of enzyme that has 
expanded rapidly in recent years: at present there are at least eleven subfamilies 
of mammalian phosphodiesterase, most of which contain more than one gene 
product. They are grouped according to their regulator and substrate 
specificities and genetically on the basis of sequence homology (Essayan, 2001). 
Regulation of PDEs can occur by Ca"/CaM, cGMP, cAMP, cGK, cAK, insulin, 
leptin and light. The function of phosphodiesterases also varies between 
families: this is determined by both tissue distribution and by which cyclic 
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nucleotide the phosphodiesterase hydrolyses (PDEs 4,7 and 8 hydrolyse cAMP; 
PDEs 5,6 and 9 hydrolyse cGMP; and PDEs 1,2,3,10 and 11 will hydrolyse 
both cAMP and cGMP). The diversity in tissue distribution and regulators of 
PDEs creates great potential for cross-talk between pathways that elevate cGMP 
production and pathways that function via cAMP. Indeed, there appears to be a 
degree of cross-talk already identified in tubules: the addition of cAMP to 
tubules increases V-ATPase activity, as does that of cGMP, indicating that 
regardless of prior events leading to elevated cyclic nucleotide, they have at 
least one downstream effector in common. 
1.4.6 Ca" signalling & 5HTlAD,, as a modulator of [Ca'*Jj 
The manipulation of intracellular Ca"' was achieved using a Drosophila receptor 
for serotonin, 5HTIAD. 0 
(Saudou et al, 1992; see Table 1.1 and review by Tierney 
(2001) for nomenclature). As with the 5HT7Dr. receptor, this is aG protein 
coupled receptor. However, it does not couple to adenylate cyclase activation, 
but instead stimulates production of inositol 1,4,5- trisphosphate (InsP3) via 
coupling to GoCq when expressed in mammalian cell lines (Saudou et al, 1992; 
Table 1.2). InSP3 is generated by the hydrolysis of the lipid precursor 
phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) to diacyl glycerol (DAG) 
and InsP3 by phospholipase C (PLC) upon its activation by Gaq (Figure 1.11). 
InsP3 diffuses through the cytosol and binds to InsP3 receptors (InsP3R) found 
on the membrane of internal stores (such as the endoplasn-dc reticulum). These 
receptors are found as six transmembrane-spanning tetramers that form Ca 2+ 
channels, allowing Ca 2+ to be released from stores into the cytosol, although are 
also sometimes found on the plasma membrane. They have also been 
implicated as mediators of Ca' release from secretory vesicles and the Golgi 
apparatus (Petersen, 1996; Pinton et al, 1998). Three distinct genes (I-III) have so 
far been identified that encode mammalian InsP3 receptors, with two additional 
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isoforms (IV and V) proposed to exist, based on partial sequence information. 
However, alternative splicing generates further heterogeneity amongst these 
isofoms. There does not appear to be such diversity in Drosophila, with only one 
InsP3 receptor gene identified (Yoshikawa et al, 1992). Nevertheless, there is a 
family of evolutionarily related receptors, named ryanodine receptors (RyR), 
found in both mammals and Drosophila that are also involved in release of Ca` 
into the cytosol, which adds further heterogeneity to the mechanisms that can 
influence Ca 2' release. 
Cytosolic Ca` is kept low (-UgM) under resting conditions, but under 
hormonal stimulation it may rise to -1ýtM (Berridge, 1993). This is achieved by 
Ca 2' release from internal stores, which can also mediate Ca", entry from 
extracellular fluid (known as capacitative calcium entry, through store operated 
channels (SOCs)); both have far higher concentrations of Ca 2+ than the cytosol 
(Berridge, 1995). InsP3R and RyR both display calcium-induced calcium release 
(CICR), whereby Ca 2+ released from one receptor can excite its neighbours, thus 
triggering a wave of Ca 2' release throughout the cytoplasm (Berridge 1997; 
Berridge et al, 2000). At rest, InsP3 is actually also capable of sensitizing InsP3R 
to produce Ca" oscillations, known as sparks or puffs (Bootman et al, 2002). 
Because of the high surrounding levels of Ca'+, the cell has to continually pump 
Ca` out of the cytoplasm, using Ca'+-ATPases on the plasma membrane and 
endoplasmic reticulum, maintaining two sources of Ca` to utilise as a signal. 
Cytosolic Ca` is relatively non-diffusable, due to the many high-affinity 
binding capabilities of relatively immobile proteins (Kasai and Petersen, 1994), 
and so a variety of different messages can be achieved from this second 
messenger, simply by the spatial and temporal control of Ca` release. 
Ca" signalling and the Ca` channels present in Drosophila tubules have been 
examined in elegant detail previously (O'Donnell et al, 1996; Rosay et al, 1997, 
Terhzaz et al, 1999; MacPherson et al, 2000; MacPherson et al, 2001; Pollock et al, 
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submitted 2002). As described earlier, CAP2bstimulation of tubules results in a 
principal cell-specific rise in [Ca 2+1i which in turn activates a Ca 2"/CaM- 
sensitive nitric oxide synthase (NOS) (Davies et al, 1997), whereas tubule 
stimulation with Drosophila leukokinin induces a rise in [Ca'+jj only in stellate 
cells. Elevated fluid transport and [Ca 2+ ]i are both dependent on channels that 
allow Ca 2' entry into tubules; these are both abolished in calcium-free medium. 
Furthermore, in the absence of external calcium, tubules treated with the Ca 2+_ 
ATPase inhibitor thapsigargin only display elevated [Ca 2+1 i in stellate cells, 
which suggests that principal cells do not have a thapsigargin-sensitive 
intracellular calcium pool, or that it is too small or labile to be detected (Rosay et 
al, 1997). This implies that the [Ca'+jj rise seen in response to CAP2b is by Ca 2+ 
entry through basolateral membrane Ca 2+ channels. It also suggests that 
different cell subtypes have different Ca 2+-cycling mechanisms. Expression of 
the 5HTIADr,, receptor as a specific modulator of [Ca 2+ ]i adds a new dimension to 
studying Ca 2+ cell specific signalling events, with serotonin creating no 
background activity in tubules. Thus, this approach removes the complication 
of cross-activation that is evident in pre-existing fluid transport mechanisms. 
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Figure 1.11: Activation of the 5HTIAD,. C protein-coupled receptor stimulates Ca2+ release 
from the ER 
Binding of 5HT to the 5HTIADro receptor stimulates the heterotrimeric G protein with which it 
is associated to exchange GDP for GTP. This exchange allows the G(x subunit to dissociate 
from the Py subunits, and consequently activate phospholipase C (PLC). Phospholipase C then 
hydrolyses the lipid precursor phosphatidylinositol 4,5-bisphosphate (PIP2) to give both diacyl 
glycerol (DAG) and inositol (1,4,5)-trisphosphate (InsP3 or 11ý3). The latter then binds to the 
InsP3 receptor (IP3R) to mobilise Ca2l from internal stores (ER). 
The intrinsic GTPase activity of the G(x subunit hydrolyses GTP to GDP, thus allowing it to 
reassociate with the py subunits in its inactive state. In the absence of 5HT, almost all the G". is 
in the inactive GDP-bound form. 
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1.5 Specific aims 
In sun-anary, the aims of this project are to establish the Malpighian tubule as a 
model epithelium within which the in vivo pharmacology of receptors and their 
downstream effectors can be investigated. Ectopic expression of receptors in 
tubules should also provide a method to unambiguously manipulate second 
messengers in an attempt to further our knowledge of how this tissue processes 







2.1 Drosophila melanogaster 
2.1.1 Drosophila stocks 
Listed below are the Drosophila lines utilised in this study and their application. 
Strain Purpose/Use Source/ 
Citation 
Oregon R Control for fluid secretion assays. Control for Standard 
Western analysis. cDNA production. laboratory 
stock. 
Willa Control for fluid secretion assays & cyclic Hazelrigg 
nucleotide assays. Background strain for et al, 1984. 
n-dcroinjection. 
c42 GAL4 enhancer trap line. Expression of GAL4 in S6zen, 1996 
principal cells of main segment in tubules. 
c724 GAL4 enhancer trap line. Expression of GAL4 in S6zen et al, 
stellate cells of main segment in tubules. 1997 
c710 GAL4 enhancer trap line. Expression of GAL4 in S6zen et al, 
stellate cells of main segment in tubules. 1997 
hs:: GC-A P-element insertion of a rat guanylate cyclase Generated 
gene (GC-A) under control of Hsp 70 heat shock for this 
promoter. Used to modulate cGMP levels in study 
tubules. 
I UAS:: GC-A P-element insertion of a rat guanylate cyclase Generated 
gene under control of GAL4 responsive for this 
Upstream Activating Sequence. Used to study 
modulate cGMP levels in tubules. 
hs:: 5HT7Dro P-element insertion of 5HT7D,. receptor under Generated 
control of Hsp 70 heat shock promoter. Used to for this 
modulate cAMP levels in tubules. study 
- UAS:: 5HT7Dro P-element insertion of 5HT7Dr,, receptor under T; enerated 
control of GAL4 responsive Upstream Activating for this 
Sequence. Used to modulate cAMP levels in study 
tubules. 
UAS:: 5HTIADm P-element insertion of 5HTIADr. receptor unde-r Kind gift oT- 
control of GAL4 responsive Upstream Activating Fred6ric 
Sequence. Used to modulate [Ca"Ji in tubules. i Saudou I 
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c42-aeq P-element insertions of aequorin transgene, Rosay et al, 
under control of UAS, and GAL4 enhancer trap 1997 
(c42). Directs expression of aequorin to principal 
cells of tubules, for cell-specific calcium 
measurements. 
c7lO-aeq P-element insertions of aequorin transgene, Rosay et al, 
under control of UAS, and GAL4 enhancer trap 1997 
(010). Directs expression of aequorin to stellate 
cells of tubules, for cell-specific calcium 
measurements. 
hsGAL4-aeq P-element insertions of aequorin transgene, Rosay et al, 
under control of UAS, and GAL4, under control 1997 
of Hsp70 heat shock promoter. Allows global 
expression of aequorin for calcium 
measurements. 
Table 2.1: Drosophila strains used in this study 
2.1.2 Drosophila rearing 
Flies were maintained in standard conditions (Ashburner, 1989) on a 12 h dark: 
12 h light cycle in vials of standard cornmeal/yeast/agar Drosophila medium at 
25'C. If large quantities of flies were required, rearing was in large bottles on 
standard medium. 
2.1.3 Drosophila crossing schemes 
All hs:: transgene, UAS:: transgene and GAL4 lines were homozygosed in a w"18 
background. Lines containing hs:: transgene were used 12-18 h after a 45 min- 
lh heat-shock at 37'C, with no need for further crossing. For expression of a 
transgene under UAS control, UAS:: transgene virgin females were collected 
and crossed with males from the appropriate GAL4 line, or vice versa. Under 
these conditions, all progeny contain one copy of each transgene. 
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2.1.4 Drosophila dissection 
All dissection of tissues were performed on flies anaesthetised on ice in a small 
Petri dish, under a layer of Schneider's revised Drosophila medium (Gibco BRL) 
with two pairs of watchmaker's forceps (Biologie, #55). 
2.2 Fluid Secretion Assays 
This assay was carried out as previously described (Dow et al, 1994b). Adult 
Drosophila tubules were dissected out into Schneider"s revised Drosophila 
medium (Gibco BRQ and pairs of tubules were transferred to a9 111 drop of a 
1: 1 (Schneider's: Drosophila saline) mix (Drosophila saline, 117.5 mM NaCl, 20 
mM KCI, 2 mM CaC'2,8.5MM MgC'2,10.2 mM NaCO3,4.3 mM Na2HP04,8.6 
mM HEPES, pH=6.9, with 20 mM glucose added before use). 
One tubule was drawn from the drop and looped around a pin, ensuring that 
the ureter (from where secretion issues) was out of the drop. 
Every ten min the droplets excreted from the ureter were removed with a fine 
rod and their diameter measured using an eyepiece graticule. 
When agonists were to be added, they were first diluted in 
Schneiders: D rosophila saline, if required, before addition of 1 Al of the 
compound to the bubble. Results were analysed using Excel 5.0 (Microsoft), 
where secretion rate was calculated in nl/n-dn from the volume of fluid secreted 
in 10 n-dn. 
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2.3 Nucleic Acid Isolation 
2.3.1 Plasmid DNA isolation 
Small scale plasmid DNA preparation was performed with the Qiaprep Spin 
Miniprep Kit (Qiagen) following manufacturer's instructions. 
Large scale plasmid DNA preparation was performed with the Qiaprep Spin 
Endotoxin free Maxiprep kit (Qiagen) following manufacturer's instructions. 
2.3.2 Preparation of genomic DNA 
Single fly genomic DNA preparations for utilisation in standard PCR reactions 
were performed according to Gloor and Engels, 1991. Briefly, an anaesthetised 
single fly was placed in a 0.5 ml Eppendorf tube. 50 gl of homogenisation buffer 
(10 mM Tris-HCI (pH 8.3), 1 mM EDTA, 25 mM NaCl, 200 pg/ml proteinase Kj 
was drawn up into the pipette tip and the fly squashed by the tip, without 
expelling the liquid. 
Once the fly was suitably squashed, the liquid was expelled and the reaction 
incubated for 30 min at 370C. The proteinase K was inactivated by heating the 
reaction for 1.5 min at 951C. 1 gl of the reaction was then utilised for PCR. DNA 
from squashed flies could be maintained for several months at -20T. 
Genomic DNA from 30 flies was prepared for inverse PCR reactions (section 
2.10.4). Flies were frozen in liquid nitrogen, then ground in 200 Al 
homogenisation buffer (100 mM Tris-HCl (pH 7-5), 100 mM EDTA, 100 mM 
NaCl, 0.5% (w/v) SDS). A further 200 gl homogenisation buffer was added and 
the ground tissue suspension was incubated for 30 min at 65"C. 800 Al 
LiCl/KAc solution (1 part 5M KAc : 2.5 parts 6M LiCl) was added and the 
homogenate was transferred to ice for 10 min. After this incubation, the 
homogenate was centrifuged at 13 000 rpm for 15 min and 1 ml of the 
supernatant was transferred to a new Eppendorf tube, with care taken to avoid 
transfer of solid tissue. Nucleic acid was precipitated by adding 600 gl 
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isopropanol to the supernatant, which was then vortex mixed and centrifuged 
at 13 000 rpm for 15 min. Supernatant was aspirated, the tube given a pulse 
centrifugation, and remaining supernatant aspirated. The remaining pellet of 
genomic DNA was washed with 70% ethanol and allowed to dry thoroughly 
before resuspending in 150 gl TE buffer. DNA was stored at -20'C. 
2.3.3 Ethanol precipitation of DNA 
When it was necessary to concentrate or clean DNA, ethanol precipitation was 
carried out. 0.1 volume 3M Na acetate, pH 5.3, was added to samples followed 
by 2.5 volumes of 95% ethanol. The precipitation was then allowed to occur on 
ice for at least 1h before DNA was pelleted by centrifugaton for 30 min at 15 
000 rpm. The pelleted DNA was washed in 70% ethanol twice and resuspended 
in an appropriate volume of distilled water or TE buffer (Sambrook et al, 1989). 
2.3.4 Quantification of nucleic acids 
Nucleic acid concentrations were estimated by spectrophotometry at 260 nm 
and 280 nm, where an OD of 1 at 260 nrn corresponds to 50 pg/ml of double- 
stranded DNA and 40 pg/ml of single-stranded DNA and RNA. Readings were 
zeroed with the solution in which the samples had been diluted. The ratio of 
A260/280 provided an estimation of nucleic acid purity. Values between 1.8 and 
2.0 indicated pure preparations (Sambrook et al, 1989). 
Where concentrations of DNA were extremely small, the quantity of DNA was 
estimated by dropping 1 gl onto a 1% agarose (w/v in H20) plate containing 
0.5 pLg/ml ethidium bromide (EtBr), allowing it to dry and comparing its 
intensity to that of a series of known DNA standards (6,12,25,50,100 and 200 
ng) under UV illun-dnation at 254 run on a transillun-dnator. 
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2.4 Restriction Digests and Electrophoresis 
2.4.1 Restriction digests 
DNAs were restricted in single strength REactO buffer appropriate to the 
restriction enzyme being used (all Gibco BRL). Where digests involving two 
enzymes with non-compatible buffers were necessary, a single digest was 
performed for 1h at 37*C in the buffer of lower salt strength and then the 
enzyme was heat inactivated at 65'C for 10 n-dn. At this point, an appropriate 
amount of salt solution was added to adjust to the correct conditions for the 
second enzyme, if possible. Otherwise, the singly digested DNA was purified 
by ethanol precipitation and resuspended in the appropriate single strength 
buffer, before commencing with the second restriction digest for 1h at 37C. 
Typical amounts of DNA in a restriction digest were 1 ptg of plasmid DNA and 
5 gg of genon-dc DNA. 
2.4.2 Agarose gel electrophoresis of DNA 
DNAs were separated in 1% agarose in 1x TBE (90 mM Tris, 90 mM boric acid 
(pH 8.3), 2 mM EDTA) containing 0.1 pg/ml EtBr, as described in Sambrook et 
al, 1989, using 1x TBE as the electrophoresis buffer. Sizes were compared to a1 
kb ladder (Gibco BRQ. Prior to loading 3 jil of loading dye (0.25% (w/v) 
bromophenol blue, 0.25% (w/v) xylene cyanol, 30% (v/v) glycerol in water) 
was added to the samples. 
2.5 Gel extraction of DNA 
DNAs were extracted from agarose gels using the QIAquick Gel Extraction kit 
(Qiagen) following the protocol provided. 
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2.6 Polyacrylarnide gel electrophoresis for DNA sequencing 
Denaturing polyacrylamide gel electrophoresis was used to separate the 
products of sequencing reactions (section 2.12.1). Sequencing gels were 
composed of 6% (w/v) acrylamide/bis (acrylamide: N, N'- 
methylenebisacrylamide, 19: 1), 7M urea in 1x TBE (provided as a complete 
solution by Anachem). Gels were polymerised via the addition of 1 ml 10% 
(w/v in H, O) APS (ammonium persulphate) and 50 pI TEMED in a Bio-Rad 
sequencing apparatus. Gels were allowed to set for at least half an hour before 
use and pre-run to reach the desired temperature (50'C). The samples to be 
electrophoresed were denatured for 5 min at 90'C and snap-chilled on ice 
before loading. Gels were run for two to four hs (in 1x TBE) at 50'C depending 
on the size of DNA to be resolved before drying down onto Whatman 3MM 
paper under vacuum. 
2.7 Ligation of DNA 
Ligation of DNA was typically performed with a ratio of 3: 1 insert to vector, 
using a maximum of 200 ng DNA in 1x ligation buffer, with 2 Weiss units of T4 
DNA ligase (Gibco BRL). Reactions were left for several h at room temperature. 
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2.8 Transformation into E. coli 
2.8.1 E coli strains 
_Strain 
Genotype 
TOP10 competent cells (F- mcr A, A(mrr-hsd RMS-mcrBC), 0801acZ 
(Invitrogen). AM15, AlacX74, recAl, deo R, araD139, A 
(ara-leu)7697, gaIU, gaIK, rpsL, (StrR), 
endAl, nup G). 
DH5aTM subdoning efficiency (F-W80d1ac ZDM15, A(lacZYA-argF), 
competent cells (Gibco BRL). U169, deo R, recAl, endAl, hsd R17 (rK',, 
mK+), pho A, sup E44, X-, thi-1, gyrA96, rel 
Al). 
Table 2.2: E. coli strains used in this study. 
Chemical transformation of competent cells was performed by adding 10-100 
ng plasmid DNA to a 50 ýLl aliquot of cells on ice and stirring gently with a 
pipette tip. The cells were kept on ice for a further 30 min, then heat shocked by 
transferring to a 42'C water bath for 30 s. Cells were returned to ice for 2 min 
before the addition of 250 pl L-Broth medium and incubation on a flat bed 
shaker for 1h at 37*C. A 200 gI aliquot of cells was then spread on agarose 
plates containing antibiotic (typically 100 gg/mI ampicillin). 
2.8.2 Detection of P-galactosidase using X-gal 
If blue/white selection of colonies from plasn-dds containing the 1acZ gene was 
required, plates were spread with 20 pl 40mg/ml X-gal and allowed to dry 
thoroughly, prior to spreading of cells. 
2.8.3 Storage of bacterial cultures 
0.5 ml of bacterial culture was added to 1 n-d of a 2% peptone, 40% glycerol 
solution (in H20) before being frozen under liquid nitrogen. Frozen stocks were 
stored at -70'C. 
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2.9 Oligonucleotide synthesis 
Oligonucleotides were synthesised by the Gibco BRL custom primer service 
and by MWG. These were resuspended in TE buffer to a concentration of 100 
gM. All primers were stored at -20'C. A list of all primers used in this is 
provided in Appendix 1. Primer concentrations were determined by UV 
spectrophotometry if required. 
2.10 Polymerase Chain Reaction 
2.10.1 Standard PCR 
Standard PCR protocols were used for amplification of DNAs. Amounts of 
template DNA varied, with 0.5 gg genon-dc template DNA used per reaction 
and 0.1 gg or less of plasmid template. For reactions using Boehringer 
Mannheim Taq polymerase, dNTPs (Boehringer Mannheim) were added at 
0.125 mM each to single strength PCR buffer, left and right primers at a 
concentration of 0.5 gM with 1u of Taq polymerase. When Applied Biosystems 
Reddy Load Mix Taq was used, only template and primers at the same 
concentrations as above were added to the pre-aliquoted n-dx. 
Cycling was performed in thin walled PCR tubes in a Hybaid OmnE, Hybaid 
PCR Sprint machine, or Hybaid Gradient PCR machine. 
Cycling procedures were typically: 
94'C for 1-2 min to ensure denaturation of template. 
20-30 cycles of : 
Denature at 94*C, 30 sec 
Anneal at 48-60*C, 30 sec 
Extend at 72C, 1 n-dn 
then a final 2 n-dn extension step of 72'C. 
Annealing temperatures depended on the primers used. 
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2.10.2 High Fidelity PCR 
When error free cloning of an open reading frame was required, a proof- 
reading DNA polymerase was used for PCR. The polymerase of choice was 
either Pfu (Promega) or a combination of Taq and Pwo (Roche). 
Cycling procedures were typically: 
94'C for 4-5 min to ensure denaturation of temPlate. 
10 cycles of : 
Denature at 94*C, 15 sec 
Anneal at 55-68*C, 30 sec 
Extend at 68'C or 72'C, 1 n-dn per kilobase DNA 
Followed by 15-20 cycles of : 
Denature at 94'C, 15 sec 
Anneal at 55-68'C, 30 sec 
Extend at 68'C or 72'C, 1 n-dn per kilobase DNA + an additional 5 
sec per cycle 
Then a final 10 n-dn extension step at 72*C. 
Annealing temperatures depended on the primers used, and extension 
temperature depended on the proof-reading enzyme used. 
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2.10.3 Reverse transcriptase PCR 
Reverse transcriptase PCR was performed as previously described (Dow et al, 
1994a). PolyA+ RNA was obtained using the magnetic Dynabeads mRNA 
DIRECT kit (DynalO) according to manufacturers instructions. Heads (5) or 
tubules (80), were used in the extraction. Tissues were ground in Treff tubes 
with matching homogeniser. 
Once the mRNA was extracted a reverse transcriptase reaction was set up. 
This reaction contained; 
0.2 mM of each dNTP 
40 u RNAsin (Promega) 
10 mM dithiotheitol (DTT) 
1x first strand buffer, 
and H20in a volume of 18 gl. 
2 ptl SuperscriptTM II RNase H- Reverse Transcriptase (Gibco BRL) was then 
added to start the reaction. 
Reactions were incubated at 42'C for >30 min, with occasional tapping to 
resuspend the beads. The beads were then collected using the Dynal MPC 
magnet, washed and suspended in 20 gl TE buffer, the suspension being stored 
at -20'C. 1 pLI of the Dynabead solution was sufficient template for a standard 
PCR reaction. 
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2.10.4 Characterisation of P-element insertion sites by inverse PCR 
Inverse PCR is a method for mapping a P-element insertion within the genome 
of Drosophila (Dalby et al, 1995). 
Using outward facing primers corresponding to sequence at either the 5' or the 
3' end of the P-element, adjacent genomic DNA can be amplified (see figure 
2.1). Template is generated by digestion of the P-element and genomic DNA 
with a restriction enzyme that cuts genomic DNA roughly every kilobase, and 
cuts the P-element just downstream (5' end) or upstream (3' end) of the primer 
sites. The digested DNA was then ligated and used in a PCR reaction with 
appropriate primers. 
sau 3A1 S3U3A1 
t d- 
# UAS rb 











Figure 2.1 Schematic representation of inverse PCR 
Genomic DNA was prepared by the 30 fly method described in section 2.3.2. 
10 gI genomic DNA, roughly equivalent of two flies, was restriction digested 
with 10 units of Sau3AI or Mspl in the presence of 100 tig/ml RNase A. Digests 
were incubated for 2.5 h at 370C. The restriction enzyme was then heat 
inactivated for 20 min at 650C. Ligation of digested genomic DNA was 
performed as described in (section 2.7). The ligated DNA was then ethanol 
precipitated, the pellet was washed in 70% ethanol and dried, before 
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resuspension in 150 gl TE buffer (DNA concentration of approximately 1/150 th 
of a fly per pl). PCR of ligated genomic DNA was performed as in section 
2.10.1. 
2.11 Cloning of PCR products 
PCR products were cloned using the Invitrogen TOPO TA cloning kit into 
pCR@2.1 TOPO vector according to manufacturers instructions and 
transformed into TOP10 competent cells. When PCR fragments generated by 
Pfu DNA polymerase were used, addition of overhanging adenine residues was 
necessary before being added to the reaction. This was achieved by incubating 
the PCR fragment in 1X PCR buffer (Roche) with dATP (0.025 mM) and 1 unit 
Taq polymerase for 10 min at 72"C. The PCR fragment was then ethanol 
precipitated and resuspended in an appropriate volume of distilled water. 
Ligations were performed by addition of 1-3 jil of PCR reaction and 1 pl salt 
solution to 1 jil pCR@2.1 TOPO vector and leaving at room temperature for 5 
min. 
pCR(D2.1 transformations were accomplished by adding 2 pl ligation reaction to 
TOP10 competent cells. The cells were left on ice for 30 min then heat shocked 
at 42*C for 30 s. The cells were put back on ice for 2 min before adding 250 gl 
SOC medium then transformations were shaken on their side for 30 min at 
37C. 
100 gl of the transformation was spread onto L-agar plates containing 100 
gg/ml ampicillin and incubated overnight at 37'C. These plates contained X- 
gal. White transformants were removed as single colonies and were inoculated 
overnight (with shaking) at 37C in 5 ml L-broth containing 100 pg/n-d 
ampicillin. 
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2.12 DNA Sequencing 
2.12.1 Manual 
Double-stranded DNA sequencing was carried out using the T7 Sequenase 
version 2.0 DNA sequencing kit (Amersham) or the T7 Sequenase quick 
denature plasmid sequencing kit (Amersham) using the methods described by 
the manufacturer. Both employ the dideoxy chain termination method of DNA 
sequencing using "S-ec-dATP (ICN). 
2.12.2 Automated 
A single stranded PCR was performed with template and primers supplied at 1 
pg and 3.2 pmol respectively, with a PCR mix containing fluorescently labelled 
dideoxynucleotides. Samples were run on an agarose gel with the nucleotides 
being detected on an ABI automated DNA sequencer. Automated sequencing 
procedures and materials were carried out by the Glasgow University 
Molecular Biology Support Unit. Analysis was carried out with the Applied 
Biosystems automated sequence analysis programme (Autoassembler 2.0). 
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2.13 Germline Transformation of Drosophila 
2.13.1 Embryo collection and preparation 
500 flies (w .... ) between 3 and 7 days old were set up in an egg collection cage 
the night before embryos were required. The following day, egg collection 
plates with a thick spot of yeast paste were placed on the cage and changed 
frequently until sufficient eggs were produced for injection (> 30) in a 20-25 n-dn 
period. The eggs were transferred to a slide and dechorionated with fine 
forceps under a light microscope and lined up on the edge of a slide which had 
a thin layer of glue (Scotch tape dissolved in heptane) along the edge. The 
embryos were placed with the posterior pole facing outwards, dehydrated for 1 
min and covered with 10S halocarbon oil (Sigma). 
2.13.2 Glass micropipette preparation 
Glass micropipettes were pulled on a Campden Instruments moving-coil 
microelectrode puller, model 753, from borosilicate glass capillary tubes with 
internal filament (Clark Genetic Instruments) of dimensions 1.0 mm (O. D. ) x 
0.78 mm. (I. D. ), with the puller settings on, 
pre-pull heating time 30 
initial pull force 5 
main pull force 25 
main pull delay 8 
heater control 320 
The micropipette was held vertically, a1 gl aliquot of DNA was dispensed at 
the top and allowed to reach the needle tip by capillary action. When ready to 
inject the sealed tip was broken back by a slight tap on the edge of the slide. 
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2.13.3 Microinjection 
The embryos were injected with a mixture of pP[UASTI (Brand and Perrimon, 
1993) or pPJCaSpeR. hs/actJ (Thummel et al, 1988) containing the sequence of 
interest (400 ng) and the helper plasmid pPIA2-3) (100 ng), which had been 
diluted in injection buffer (0.1 mM Na2HP04,0.1 mM NaH2PO4I5 mM KCI, pH 
7.8). Embryos were injected with this solution using an Eppendorf 
Micromanipulator InjectMan connected to an Eppendorf Femtojet" pressure 
modulator. Embryos were viewed under a Zeiss inverted stage microscope. 
2.13.4 Post-injection care 
Slides containing injected embryos were placed on a fresh grape-juice agar 
plate. The embryos were left to recover for 1-7 d at 18"C and any hatched larvae 
transferred to standard food. Surviving adults were mated individually back to 
the host strain and the progeny scored for eye colour transformation. 
Transformants were crossed again to the host strain and transformed progeny 
of this cross were mated to siblings. Selection against flies with white eyes 
through generations allowed, in most cases, homozygous lines to be generated 
for the P-element insertion. 
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2.14 Cyclic AMP assay 
This protocol is an adaption of the Biotrak cAMP ["I] assay system 
(Amersham), as previously described in Davies et al, 1995. The assay is based on 
the competition between unlabelled cAMP and a fixed quantity of "I-labelled 
cAMP for a limited number of sites on a cAMP-specific antibody. With fixed 
amounts of antibody and radiolabelled cAMP, the amount of radiolabelled 
cAMP bound by the antibody will be inversely proportional to the 
concentration of non-radiolabelled cAMP contained in the tissue homogenate. 
The antibody bound cAMP is then reacted with a second antibody which is 
bound to magnetizable polymer particles. Separation of the antibody bound 
fraction is achieved by centrifugation and aspiration of the supernatant. 
Measurement of the radioactivity in the pellet enables the amount of 
radiolabelled cAMP in the bound fraction to be calculated. The amount of 
unlabelled cAMP in the sample is then determined by interpolation from a 
standard curve. 
2.14.1 Preparation of samples 
Tubules were dissected in Schneider's medium (Gibco BRL). Ten pairs were 
transferred to 2 ml collection tubes containing 100gl Schneider's medium. 
Samples were prepared in triplicate and incubated for 20 min with the non- 
specific phospho dies terase inhibitor IBMX (lxlO-' M) and, if necessary, the 
appropriate antagonist. When required, agonist was added at varied 
concentrations after 10 min. All reactions were quenched with 70% ice cold 
ethanol after 20 n-dn and transferred to ice. The tubules were then homogenised 
for 1 n-dn using a Polytron homogeniser (Kinematica), and vacuum dried for 
several hours. Dried samples were stored at -70T until required. 
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2.14.2 Resuspension of samples 
Samples were resuspended in 500 pLI assay buffer (0-05 M sodium acetate, pH 
5.8 containing sodium azide). 
2.14.3 Cyclic AMP assay procedure 
Serial dilutions of a cAMP standard (32 pmol/ml) were prepared, in duplicate, 
ranging from 25-1600 fmol to generate a standard curve against which samples 
of unknown cAMP content could be compared. Duplicate zero standard tubes 
were prepared containing assay buffer only. For use in the assay, 100 At 
aliquots were taken from all standard and unknown tubes and dispensed into 
appropriately labelled reaction tubes. Into all tubes 100 At of [`I] cAMP was 
added, followed by 100 At of antiserum. A tube containing only 100 At of ['11] 
cAMP was prepared as a measure of the total amount of radioactivity available 
per reaction. This tube was labelled "total count" (TC). 
The tubes were then thoroughly vortex mixed, wrapped in lead and incubated 
for 3 hs at VC. After incubation, 500 At of second antibody reagent was added 
to all tubes, except the total count tube, vortex mixed immediately, and 
incubated for 10 min at room temperature. The antibody bound fraction was 
separated by centrifugation for 10 min at 13 000 rpm. The supernatant was 
carefully aspirated and tubes were placed in a gamma scintillation counter for 1 
min. 
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2.14.4 Calculation of cAMP content 
The average counts per min (cpm) were calculated for the duplicate standards 
and zero standards. The percent of the total count ["I] cAMP bound to second 
antibody in the zero standard (BO) was calculated as an indicator of antibody 
efficacy using the following equation: 
Bo cpm 
%/Bo / TC = 
TC cpm 
The percent bound [III] cAMP for each standard and sample was calculated 
using the following equation: 
(Standard or sample cpm) 
%B/BO = 
BO cpm. 
Standard curves were generated by plotting the percent B/130 as a function of 
the log cAMP concentration. B/Bo was plotted on the y-axis against the fmol 
standard per tube on the x-axis. The fmol per tube value for samples could then 
be read directly from the graph. Figure 2.2 shows a typical standard curve 
generated in this assay. This value was then divided by the number of tubules 
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Figure 2.2: A typical standard curve generated for a cAMP assay 
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2.15 Cyclic GMP assay 
The general principles of this assay are the same as those for the cyclic AMP 
assay and have been described previously in Dow et al 1994a. The assay is 
based on the competition of radiolabelled cGMP with endogenous tissue cGMP 
for a limited number of sites on a cGMP-specific antibody. With fixed amounts 
of antibody and radioactive ligand, the amount of radioactive ligand bound by 
the antibody will be inversely proportional to the concentration of added non- 
radioactive ligand. However, cGMP in samples and standards was acetylated at 
the 2'0 position by acetic anhydride. TO substituted cyclic nucleotides have 
greater affinity for the antibody than parent cyclic nucleotides because the 
antibody is made to a protein conjugate coupled at the TO position, thus 
making the assay more sensitive (Harper and Brooker, 1975). This is necessary, 
as intracellular cGMP levels are greater than 10 fold lower than intracellular 
cAMP levels in tubules (Davies et al, 1995). 
2.15.1 Preparation of samples 
Samples were prepared as in the cAMP assay, but with an initial incubation in 
the cGMP-specific phosphodiesterase inhibitor zaprinast (1 x 10' M) rather than 
with IBMX. 
2.15.2 Resuspension of samples 
Samples were resuspended in 500 gl assay buffer (0.05 M sodium acetate, pH 
5.8 containing sodium azide). 
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2.15.3 Cyclic GMP assay procedure 
Serial dilutions of a cGMP standard (2.56 pmol/ml) were prepared, in 
duplicate, ranging from 2-128 fmol. Duplicate zero standard tubes were 
prepared containing 500 pl assay buffer only. An acetylation reagent was 
prepared by mixing 1 volume of acetic anhydride with 2 volumes acetic 
anhydride in a glass vessel. 25 pl of acetylation reagent was added to all tubes 
containing standards and unknowns and 100 pl aliquots were transferred to 
appropriately labelled reaction tubes. 100 pl of antiserum was then added to all 
tubes and were vortex mixed immediately. Tubes were covered and incubated 
at room temperature for 1h before addition of 100 jil of [`I] cGMP. A 100 gl 
aliquot of ["I] cGMP was also added to an empty "total count" tube. Tubes 
were vortex n-dxed again, wrapped in lead and incubated for a further 18 h at 
40C. 
The following day 500 pl of second antibody bound to beads was added to all 
tubes, except the total count tube. Tubes were vortex mixed and incubated at 
room temperature for 10 min before separation of the antibody bound fraction 
by centrifugation (13 000 rpm for 10 min). The supernatant was then decanted 
and radioactivity present in each tube was determined by counting for 60 s in a 
gamma scintillation counter. 
2.15.4 Calculation of cGMP content 
Calculation of cGMP content in samples was determined in exactly the same 
manner as with the cAMP assay. An example of a typical standard curve 








fmol / tube 
Figure 2.3: A typical standard curve generated in a cGMP assay 
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2.16 Western Blot analyses 
For Western analyses, tissues were homogenised in 130 pI of Tris-lysis buffer 
(2% SDS, 70 mM Tris PH 6-8) +1 pl protease inhibitor cocktail (Calbiochem, 500 
gM AEBSF, 500 gM EDTA, 1 gM E-64,1 pM leupeptin and 1 mg/ml Aprotinin) 
and centrifuged to remove debris. 
The protein concentration of each sample was measured using the Lowry 
protein assay. To each 25 pl of unknown or standard protein sample 100 PI of 
Folin & Ciocalteu's phenol reagent (Sigma) and, 1 ml of solution X (10 Al 1% 
CuSO,, 10 gI 2% K'Na' tartate, 1ml 10% Na2CO3 in 0.1 M NaOH) was added. 
Absorbance of each sample was then measured at 750 nM with a 
spectrophotometer and unknown sample concentrations estimated through 
comparison with known 1-10 mg/ml BSA standards. The samples were then 
electrophoresed on a 3-8 % Tris-acetate gel with 5 pl loading buffer (60 % 
glycerol, 12.5 % P-mercaptoethanol, 1% bromoPhenol blue) for 60 min at 100 V 
in running buffer (see Appendix 4). A nitrocellulose membrane was cut to the 
size of the gel and soaked for 10 min in H20, then 10 min in transfer buffer. The 
blot for transfer was prepared according to kit instructions (NuPage 
Electrophoresis system, NOVEX), and the proteins were transferred from gel to 
membrane by electric current (45 min at 190 V). 
Transfer of proteins was affirmed by staining the membrane with Ponceau dye. 
The membrane was then washed twice in distilled water, before being blocked 
in 5% dehydrated milk powder, 0.1 % Tween in 1X PBS, for 1-2 h. The 
membrane was hybridised with the appropriate primary antibody diluted in 
5% dehydrated milk powder, 0.1 % Tween in 1X PBS overnight. After two 30 
min washes in 1X PBS, the membrane was hybridised with the secondary 
antibody diluted in 1X PBS. 
84 
2.17 Immunocytochemistry 
This protocol is the same as described in MacPherson et al, 2001. Slides were 
washed with water and dried with ethanol, before a wax circle was drawn on 
using a wax pen (Vector). Slides were treated with 100 pl 0.1 mg/ml poly-L- 
lysine solution (Sigma) for 30 min, then washed with tap water and left to air 
dry. Tubules were dissected in Schneider's Drosophila medium and stuck onto 
slides in 1X PBS solution. Tubules were fixed with 4% paraformaldehyde in 1X 
PBS for 30 min, then washed 5-7 times in 1X PBS before permeabilisation with 
0.2% (v/v) Triton X-100 in PBS for 30 min. Permeabilisation solution was 
changed every ten min, after which the tubules were blocked for 3h in PAT 
(PBS containing 0.5% (w/v) Sigma cold fraction V bovine serum albumin and 
0.2% (v/v) Triton X-100). Samples were then hybridised overnight in a 
humidity chamber with the primary antibody diluted in PAT. The following 
day, slides were washed four times in PAT over a period of 2 h. They were then 
blocked with PAT containing 2% (v/v) normal goat serum (Scottish Antibody 
Production Unit (SAPU)) for a further 4 h. The samples were next incubated 
overnight with the secondary antibody diluted in PAT with 2% normal goat 
serum in a humidity chamber. The slides were then washed four times over a 
period of 2h in PAT and twice for 10 min in PBS before being mounted in 
Vectashield mounting medium (Vector). Slides were examined under UV light 
with a conventional light n-dcroscope (Zeiss). 
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2.18 Antibodies 
Antibody Raised V or Epitope Use Specificity Dilution 
in 20 
R1214 Rabbit I' Glu-Arg- Inununocytochernistry N/A 1: 7000 
anti-GC-A Gly-Cys-Ser- Western blot N/A 1: 250 
(Kind gift, Th-Arg-Gly 
David 
Garbers) 
Anti-cGMP Rabbit P 2'-O-succinyl Immunocytochernistry cGMP: 100% 1: 7000 
polyclonal cGMP-BSA No cross 
antiserum reaction to 
(Chen-dcon other 
Int. Inc. nucleotides at 
AB303) concentrations 
to 1 mm 
Anti-cAMP Rabbit 10 2'-O-succinyl Immunocytochen-dstry cAMP: 100% 1: 200 
polyclonal cAMP-BSA ATP: --5 0.01% 
antiserum cGMP: 0.1% 




Anti- Donke 2* Rabbit IgG Irrununocytochernistry N/A 1: 250 
rabbit- 
fluorescein 
Table 2.3: Antibodies used in this study 
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2.19 Cyclic GMP-dependent kinase assay 
This protocol has been adapted from the SignaTECTI cyclic AMP-dependent 
protein kinase assay system (Promega) (M. MacPherson, unpublished) and is 
similar to that described in Osborne et A 1997. The method involves measuring 
the transfer of "P-labelled phosphate to a peptide substrate that is captured on 
phosphocellulose filter via weak electrostatic interactions. However, in the 
presence of multiple kinases in a tissue extract, the "P-labelled 
pep tides /proteins bound to the phosphocellulose filter may reflect kinase 
activity other than that due to cGMP-dependent protein kinases (cGKs). To 
increase the specificity of the cGK assay the heptapeptide glasstide (RKRSRAE, 
Calbiochem), a specific substrate for cGK, was used in the reaction (Hall et al, 
1999). The inclusion of PKA inhibitor (Sigma) in the reaction also helped 
minimize background phosphorylation. 
2.19.1 Sample preparation 
Approximately 800 tubules were dissected and placed in 200 Al buffer (20 mM 
Tris, 150 mM sucrose, 2 mM EDTA, 100 mM NaCl, 50 mM f3, mercaptoethanol, 2 
ptg/ml leupeptin, 5 gg/ml aprotinin, 1 gg/ml PMSF). Appropriate samples 
were treated with agonist for 10 min before being homogenised and centrifuged 
for 5 min at 13 000 rpm. A Lowry protein assay was then conducted to 
detern'dne the protein concentration of samples, and samples were diluted to 
equivalent concentrations. Approximately 200 ng protein was used for each 
experimental condition. 
Two reaction n-dxes were prepared with and without addition of cGMP (20 mM 
Tris, 20 mM MgAc, 100 gM zaprinast, 100 pg/n-d glasstide (RKRSRAE), 200 pM 
ATP, 2 gl [y_32p] ATP (10 gCi/pl), 1 nM PKA inhibitor, +/- 100 jil cGMP (10 
ptM) in 1 ml). 
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40 pl reaction buffer was added to 5 gl protein sample. For each protein 
preparation, separate conditions with and without cGMP were set up using the 
two different reaction mixes. Reactions were incubated for 30 min at 30 *C, after 
which 25 gl of each sample was spotted onto individual squares of P81 paper 
(Whatman). These squares of paper are referred to as reaction samples. Several 
samples were chosen randomly and 5 gl aliquo. ts spotted onto individual 
squares of P81 paper, allowed to dry and set aside. These samples 
(representative of 1/9 th of total count) are necessary to determine the specific 
activity of the radiolabelled ATP. 
The reaction squares were washed 3 times for 5 min in 75 mM phosphoric acid, 
then washed once for 15-20 sec in ethanol and allowed to dry. All squares of 
paper, including the specific activity samples were then transferred to 
scintillation vials and covered with 3 n-d scintillation fluid. Radioactive counts 
from were measured in a scintillation counter for 60 sec. 
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2.19.2 Calculation of kinase activity 
Specific activity of [y-"PIATP was calculated using the following equation: 
Specific activity = 
(Total reaction vol/5) x Average activity of 591 total count squares 
Total conc AfP used in reaction 
Units of specific activity = cpm/pmol ATP 
Protein kinase enzyme activity was calculated using the following equation: 
(cpm. of reaction sample - cpm of blank sample) 
vol sample on filter x time x amt protein in sample x specific activity 
Units of enzyme activity = pmol ATP/n-dn/gg protein. 
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2.20 Phosphodiesterase Assay 
The radioactive assay of cyclic nucleotide phosphodiesterase activity was first 
described by Thompson and Appleman (Thompson and Appleman, 1971; 
Thompson et al, 1974). The protocol for measurement of PDE activity in 
Drosophila Malpighian tubules was developed by Kate Broderick (manuscript in 
preparation) and assays were performed in the laboratory of Prof. N. Pyne, 
University of Strathclyde. Use of radioactive tracers (tritiated cAMP or cGMP) 
allows enzyme activity to be measured at subsaturating levels of substrate. 
Measurement of enzyme activity involves quantification of reaction product 
formed. A second incubation step converts the product of the first incubation 
(5'-nucleotide monophosphate) to 5'-nucleotide, which is catalysed by 5'- 
nucleosidase present in snake venom. This allows the reaction product to be 
more effectively separated from the unreacted substrate. 
The two incubation steps can be represented thus: 
(i) 3', 5'[8-'HI-cyclic NMP -ý 5'[8-'HI-NMP 
(ii) 5'[8_3 Hj-NMP -4 [8-HI-nucleoside 
Step (i) is catalysed by cyclic NMP (cNMP) phosphodiesterase; Step (ii) 
catalysed by 5'-nucleotidase; NMP = nucleotide monophosphate. 
Separation uses Dowex-1 -chloride anion exchange resin which selectively binds 
cyclic nucleotide. Quantification is by liquid scintillation counting of the 
isolated product (tritiated 5'-nucleotide). 
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2.20.1 Preparaton of samples 
200 tubules (80-120 gg of protein) were dissected into 150 Al of PDE buffer and 
agonist added to appropriate samples for 10 min before being homogenised. 50 
gl of 'H cGMP working stock (0.185 kBq/gl in 1 gM cGMP, 10 mM Tris, 5 mM 
MgC'2, pH7.4. ) was added to a 50 pil aliquot of each sample. Blank samples were 
prepared containing 50 gl of PBS and 50 jil of working stock 'H cGMP. Positive 
controls were made by preparing samples with 50 pl TOPO TOP10 cell lysates 
transformed with pcDNA3.1-PDE5Al and 50 jil of working stock 'H cGMP. 
The same procedure was followed for cAMP-dependent phosphodiesterase 
assays, but with '-H cAMP in place of 3-H cGMP and TOP10 cell lysates 
transformed with pcDNA3.1-PDE4 as a positive control. 
2.20.2 Assay procedure 
The samples were incubated at 30'C for 10 min and then boiled for 2 min to 
stop the reaction. The samples were cooled on ice and 25 ptl of 1 mg/ml snake 
venom added and incubated for 10 min. 400 pl of re-suspended Dowex-1- 
chloride (Sigma) was then added and the mix was vortex mixed every 5 min for 
15 min. The samples were centrifuged for 2 min at 12 000 rpm. 150 111 of the 
supernatant was then removed and added to 2 ml scintillation fluid. The 
samples were counted in a scintillation counter for 60 s. 
2.20.3 Calculation of PDE activity 
Enzyme activity was calculated using the following equation: 
cpm of sample x total assay vol x nucleoside binding factor x pmol cNMP 
Total cpm x assay vol measured x incubation time x protein conc 
Units are in pmol/n-dn/mg protein. 
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2.21 [Ca"Ii measurements in aequorin expressing tubules. 
The method for measurement of [Ca"Ji in aequorin expressing tubules is 
described in Rosay et al, 1997, and is as follows. For reconstitution of 
intracellular aequorin, 50 tubules from 3-7 day old adults were dissected in 
Schneider's medium and placed in 160 gl of Schneider"s medium with 
coelentrazine, to a final concentration of 2.5 gM. Samples were then incubated 
for 3h in darkness. Bioluminescence recordings were carried out using an 
LB9507 luminometer (Berthold Wallac). Samples were 'mock' injected with 20 
pil of Schneider's before injection with 20 gl of appropriate agonist at 10 X the 
desired concentration. At the end of each recording tubules were disrupted in 
350 gl lysis solution (1% (v/v) Triton X-100,100 mM CaCl2,, causing discharge 
of the remaining aequorin, thus allowing an estimation of the total amount of 
aequorin in the sample by integration of total counts. Calcium concentrations 
for each time point in an experiment were calculated by backward integration, 








A rat receptor guanylate cyclase gene (GC-A) was chosen as a tool to 
specifically modulate cGMP in tubules. This receptor met two prerequisites: 
firstly, the receptor directly activates cGMP production upon activation, and 
secondly, the ligand to this receptor, ANP, does not elicit a response in wild- 
type tubules. 
A 3.1 kb open reading frame was subcloned into the P-element vectors 
pPjCaSpeRhs/actj and pPjUAST) to allow temporal and spatial control of 
expression of the gene, respectively. The insertion of the construct into the 
genome of individual lines of flies was confirmed by PCR and the locus 
identified by inverse PCR. Transcription of the gene was detected in tubules by 
reverse transcriptase PCR. Western blots revealed a protein product of 180 kDa, 
consistent with other findings (Paul et al, 1989; Koller et al, 1992) and 
immunocytochemical studies localised the protein to the basolateral membrane 
of tubules. 
Fluid secretion was elevated in tubules expressing GC-A throughout tubules, or 
in a cell-specific manner, in response to ANP. This response was dose- 
dependent, and transgenic tubules treated with very high concentrations (>1 
mM) ANP showed an attenuation of fluid secretion. The GC-A specific 
antagonist anantin attenuated the response seen in transgenic tubules to ANP. 
Intracellular cGMP content was measured by radioimmunoassay in transgenic 
tubules, and shown to be elevated in response to ANP in a dose dependent 
manner. This could be attenuated with anantin, consistent with fluid secretion 
data. Using an antibody to cGMP, production of the second messenger was 
detected immunocytochernically in tubules that were challenged with ANP, 
whereas background levels were shown to be very low. 
The specificity of cGMP as a downstream effector of GC-A activation was 
determined by measuring intracellular cAMP levels in ANP-stimulated tubules. 
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No significant change in intracellular cAMP levels between stimulated and 
unstimulated samples were observed by radioimmunoassay, suggesting that 
GC-A acts specifically to generate cGMP. 
The possibility of elevation of intracellular cGMP affecting Ca"' levels as a result 
of cross-talk was investigated by aequorin bioluminescence assay. A biphasic 
elevation of intracellular Ca"' was observed when GC-A was expressed in 
principal cells, suggesting that there is a degree of cross-talk between the cGMP 
pathway and Ca"' signalling. However, no effect on Ca" levels was seen when 
GC-A was expressed in stellate cells only, which suggests a differential 
response to cGMP in different cell types. 
Tubules have previously been shown to express two cGMP-dependent kinases 
(cGK), namely dgl and dg2 (Dow et al, 1994a) and the activity of these kinases is 
likely to alter as a consequence of intracellular cGMP production. Cyclic GMP- 
dependent kinase activity was therefore assayed in tubules expressing GC-A in 
a cell-specific manner in the presence and absence of ANP. In order to 
determine ANP-induced changes in kinase activity, as opposed to absolute 
kinase activity, tubule samples were prepared in assay buffer lacking cGMP. 
This ensured that kinase activity measured was due directly to endogenous 
intracellular cGMP generated by GC-A. Kinase activity was elevated upon 
incubation with ANP in tubules expressing GC-A cell-specifically in either 
principal or stellate cells. 
Interestingly, when the assay was carried out in assay buffer containing 10 PM 
cGMP, there was not a consistent absolute kinase activity amongst all samples; 
samples treated with ANP had a potentiated kinase activity. 
In most signalling systems, there is the requirement for a negative feedback 
loop to allow a signal to be dampened, or turned off. The only known 
enzymatic reaction for the degradation of cyclic nucleotide is its conversion to 
5'-nucleoside by cyclic nucleotide phosphodiesterases. Therefore, activity of 
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cGMP- and cAMP-dependent phosphodiesterases in GC-A transgenic tubules 
was assayed, both in the presence and absence of ANP. There was a marked 
increase in cGMP-dependent phosphodiesterase activity in ANP-stimulated 
tubules, indicating a negative feedback mechanism. Interestingly, there was a 
slight decrease in cAMP-dependent phosphodiesterase activity in response to 
ANP, although cAMP levels remained unaltered. This might potentiate a cAMP 
signal only when adenylate cyclase activity is elevated. 
Finally, the use of GC-A as a generic tool for manipulating cGMP in any tissue 
was illustrated by the elevation of intracellular levels of cGMP in brains taken 
from heat-shocked hs:: GC-A flies, in the presence of ANP. 
These results directly demonstrate that cGMP is a primary modulator of fluid 
transport in Malpighian tubules and that activation of GC-A by ANP leads to 
both elevated cGMP-dependent kinase and phosp ho dies terase activity. 
Furthermore, there is evidence for either cross-talk between cGMP- and cAMP- 
dependent phospho dies terases or elevation of a dual specificity 
phosphodiesterase by cGMP. In principal cells, the direct elevation of cGMP in 
response to ANP, leads to an elevation of intracellular Ca" levels. This link to 
Ca" signalling is not present in stellate cells, which unravels differential cellular 
responses to elevated intracellular cGMP. 
This work demonstrates that ectopic expression of GC-A in Drosophila can 
therefore be used as a tool for manipulating intracellular cGMP in vivo. 
96 
3.2 Introduction 
There are a number of putative roles for intracellular cGMP. It has been 
implicated in direct ion channel activation, and several cGMP dependent 
protein kinases and phosphodiesterases have been identified. Overall, cGMP 
can influence cell function through protein phosphorylation or mechanisms not 
directly related to phosphorylation. It controls diverse physiological responses, 
such as vascular smooth muscle relaxation and neutrophil activation, as well as 
having an essential role in normal kidney function (Lopez et al, 1995; Dubois et 
al, 2000). It has also been suggested that cGMP pools generated at the plasma 
membrane by membrane guanylate cycIases have a role in control of 
intracellular Ca" levels (Zolle et al, 2000). 
Fluid transport by Malpighian tubules has been shown to be controlled, in part, 
by elevation of cGMP via activation of a soluble guanylate cyclase (Dow et al, 
1994a; Davies et al, 1995). However, the distinct role of cGMP may be difficult to 
infer when levels are elevated by activation of the endogenous receptor for the 
neuropeptide CAP2b (Davies et al, 1995). This receptor activates cGMP/NO 
signalling via a calcium/calmodulin dependent nitric oxide synthase (dNOS); 
this process is also dependent on calcium influx to the tubule (Rosay et al, 1997; 
MacPherson et al, 2001; MacPherson et al, in preparation). There is therefore 
likely to be a bifurcation of signals when Ca 21 levels are altered by this receptor, 
upstream of guanylate cyclase activation. An approach whereby the role of 
cGMP can be studied without the complications created by use of an 
endogenous peptide is therefore required. To achieve this, a gene encoding a 
guanylate cyclase that, upon activation, directly stimulates cGMP was 
ectopically expressed in tubules. The rat GC-A receptor was chosen for this 
study, as tubules have been shown not to respond to its ligand, atrial natriuretic 
peptide (ANP) under normal conditions (Dow et al, 1994a). Unlike GPCRs, this 
receptor directly affects second messenger levels through its guanylate cyclase 
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domain. This system thus does not impose any requirement for the expression 
of cognate G proteins in the host cell. Furthermore, there are no ANP-like 
peptides encoded in the Drosophila genome (data not shown), making GC-A a 
generally useful receptor to study cGMP signalling in this organism. 
3.2.1 Guanylate cyclases 
Guanylate cyclases are a family of enzymes that catalyze the formation of 
cGMP from the purine nucleotide GTP. The family comprises both membrane- 
bound and soluble isoforms that are expressed in many cell types. They are 
regulated by diverse extracellular agonists, including peptide hormones, 
bacterial toxins, and free radicals, as well as intracellular molecules, such as 
calcium and adenine nucleotides. 
Guanylate cyclases are divided into two classes; a soluble haem containing 
heterodimer, and a single-pass transmembrane form, which forms homodimers, 
or even homotetramers (for review, see Lucas et al, 2000). The ligands for the 
soluble guanylate cyclases are NO (Gerzer et al, 1981a; Gerzer et al, 1981b; 
Drewitt and Garbers, 1994; Garbers et al, 1994) and CO (Snyder and Bredt, 1992; 
Friebe et al, 1996), which bind to the prosthetic haern group. The ligands for the 
membrane guanylate cyclases fall into two categories, namely natriuretic 
peptides (NPs) and the heat-stable enterotoxins of E. coli, for which the 
endogenous homologues are guanylin/uroguanylin. In mammals there are at 
least six forms of membrane guanylate cyclase, named GC-A-F (Garbers, 1992), 
and ligands from the natriuretic peptide (NP) family have been identified for 
three (GC-A-C): GC-A is activated by atrial natriuretic peptide (ANP) and brain 
natriuretic peptide (BNP) at physiologic concentrations, but not C-type 
natriuretic peptide (CNP). Conversely, CNP, but not ANP or BNP, activates 
GC-B. In addition, all three natriuretic peptides bind to the natriuretic peptide 
clearance receptor, GC-C, with similar affinities (Maack, 1992). This receptor 
has no guanylate cyclase activity and is thought to regulate concentrations of 
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NP available to bind to GC-A and GC-B (Maack, 1992). However, a signalling 
function for this receptor has also been reported (Anand-Srivastava and 
Trachte, 1993), altering cell function through Gi-2protein-coupled inhibition of 
membrane-bound adenylate cyclase activity (Murthy and Makhlouf, 1999; 
Murthy and Makhlouf, 2000; Yanaka et al, 1998) or activation of phospholipase 
C via the Py-subunits of Gj_j and Gj_2 (Murthy et al, 1999). 
In this study, we chose to use ANP, the ligand with highest affinity for GC-A. 
ANP was originally identified in atrial myocardial extracts as a factor 
promoting natriuresis (de Bold et al, 1981) and contains a 17-amino acid 
disulphide ring with a highly conserved sequence (FGXXXDRIGXXSGL) shared 
amongst all natriuretic peptides. Similarly, anantin, a peptide isolated from a 
strain of Streptomyces coerulescens, consists of 17 amino acids which from a 
peptidic ring, and binds to GC-A (Weber et al, 1991). This peptide does not 
activate the receptor, and acts as a competitive antagonist of GC-A. 
Work described in this chapter aims to look at the direct role of cGMP in 
Drosophila Malpighian tubules using the rat GC-A receptor as a modulator of 
intracellular cGMP levels. 
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3.3 Results 
3.3.1 Cloning of GC-A into P-element vectors pP(CaSpeRhs/act) and 
pPJUASTJ 
A rat particulate guanylate cyclase (GC-A) was provided as a 3.7 kb cDNA with 
the upstream ATGs removed, cloned into the Eco RI site of pBluescript KS+ 
(Chinkers et al, 1989, kind gift of Michael Chinkers, University of Alabama). 
A 3.1 kb fragment containing the open reading frame with engineered 5' BgI Il 
and 3' Not I restriction sites was amplified by PCR, using a combination of Taq 
and Pwo DNA polymerases. The PCR product was subcloned into the TOPO 
TA cloning vector pCR2.1 (Invitrogen) to allow efficient digestion at the 5' and 
3' ends with BgI II and Not I restriction enzymes, respectively. The cloned 
fragment was sequenced before being cloned into the 5' BgI II and 3' Not I 
restriction sites in pPIUAST) (Figure 3.1) and pP(CaSpeRhs/act) (Figure 3.2) 
and then sequenced again to confirm error free directional cloning of the open 
reading frame. Transgenic lines created with these constructs are referred to as 
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Figure 3.1: Cloning of rat GC-A into pPjCaSpeR-hs/actj vector 
A 3.1 kb rat GC-A open reading frame was amplified from a cDNA clone in pB]uescript KS+ 
(kind gift, Michael Chinkers). Primers used (Appendix 1) introduced 5' BgI 11 and 3' Not I to 
the open reading frame to allow for directional cloning into pPICaSpeRhs/act) (Thummel et 
al, 1988). 
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Figure 3.2. Cloning of rat GC-A into pPIUAST) vector 
A 3.1 kb rat GC-A open reading frame was amplified from a cDNA clone in pBluescript KS+ 
(kind gift, Michael Chinkers). Primers used introduced (Appendix 1) 5' BgI 11 and 3' Not I to 
the open reading frame to allow for directional cloning into pPIUAST) (Brand and Perrimon, 
1993). 
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3.3.2 Expression of GC-A in Drosophila melanogaster. 
Transgenic lines were generated by random insertion of the engineered P- 
elements containing the GC-A gene into the fly genome. Insertion of the gene 
was determined by PCR of a 525 bp 5' GC-A fragment from genomic DNA. 
Lines were bred to homozygosity where possible, and kept as separate stocks. 
The chromosomal locations of insertions were determined by aligning 
sequences of inverse PCR products against the Drosophila genome sequence (see 
Appendix 4). 
Conditional expression of GC-A was determined by performing reverse 
transcriptase PCR (RT-PCR) (Figure 3.3) in control and transgenic flies. The 
general method for detecting an mRNA product is to amplify DNA that flanks 
an intron. This makes detection of genomic DNA or immature RNA 
contan-tination obvious, as it produces a larger PCR product than the intronless 
mRNA PCR product. However, when conducting RT-PCR, if a gene does not 
contain any introns (or in this case, expression is of a cDNA open reading 
frame), this method cannot be utilised. Therefore, the best control for genomic 
contandnation is to prepare a sample for PCR that has gone through exactly the 
same procedure for generation of cDNA template as all other samples, with the 
omission of reverse transcriptase enzyme. Any PCR product obtained from 
preparations like this would then represent contamination. An additional 
control PCR was conducted using intron flanking primers for a product known 
to be present in tubules (protein kinase C (PKQ). The absence of genomic 








Figure 3.3: The expression of GGA in transgenic lines 
Reverse-transcription polymerase chain reaction (RT-PCR). 
A: Lane 1: lkb ladder (Gibco BRL). Lane 2: PCR using Drosophila mehillogaster genornic DNA 
from pP(CaSpeRhs:: GC-Al flies as a positive control. Lane 3: cDNA template prepared from non 
heat-shocked pPjCaSpeRhs:: GC-Aj flies. Lane 4: cDNA (no superscript) prepared fron-i heat- 
shocked pPjCaSpeRhs:: GC-Aj flies. Lanes 5&6: cDNAs prepared from heat-shocked 
pPjCaSpeRhs:: GC-Aj flies. Lane 7. PCR using wild-type genomic DNA as a negative control. 
B: Lane 1: ]kb ladder (Gibco BRL). Lane 2: cDNA template prepared from c42/UAS:: GC-A 
tubutes. Lane 3: cDNA template prepared from c724/UAS:. GC-A tubules. Lane 3: cDNA 
template prepared from c7lO/UAS:: GC-A tubules. Lane 5: cDNA template prepared from 
c42/UAS:: GC-A tubLdes, using intron-flanking PKC primers (appendix 1) as a control for 
genomic contamination. Lane 6: PCR using wild-type genornic DNA as a negative control. 
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3.3.3 Western analysis of GC-A transgenic flies. 
Using Western blot analysis, the expression levels of GC-A protein in heat- 
shocked and non heat-shocked hs:: GC-A flies were exan-dned. Protein samples 
from heat-shocked and non heat-shocked hs:: GC-A flies were analysed against 
protein from Ore R flies using an antiserum against the last eight amino acids of 
GC-A (Glu-Arg-Gly-Cys-Ser-Th-Arg-Gly), raised in rabbit (R1214, kind gift of 
David Garbers, University of Texas SouthWestern Medical Centre at Dallas). 
Detection of a 180 kDa band in protein samples from heat-shocked hs:: GC-A 
flies, that was not detectable in other samples, confirmed the presence of GC-A 
in these flies (Figure 3.4). 
3.3.4 Immunocytochemical localisation of GC-A. 
Using the GC-A specific antiserum (R1214) the cellular distribution of GC-A 
protein was examined in tubules from hs:: GC-A flies, and from the progeny of 
crosses between UAS:: GC-A flies and GAL4 enhancer trap lines, in which 
expression of GC-A could be expected to be targetted to specific cell types. 
Results obtained are shown in Figure 3.5 and show that GC-A was localised to 
the basolateral membrane of tubules (Figure 3.5B). In tubules from progeny of 
crosses between UAS:: GC-A flies and c42 flies, localisation was shown to be 
confined to the principal cells of the main segment of tubules, with no apparent 
localisation to stellate cells (Figure 3.5A & B). Similarly, in tubules from 
progeny of a cross between UAS:: GC-A flies and c724 flies, Iocalisation of GC-A 
is confined to stellate cells, with the exclusion of principal cells (Figure 3.5C & 
D). These patterns of GC-A expression are consistent with patterns of GAL4 
expression. 
Tubules from heat-shocked hs:: GC-A flies showed ubiquitous expression of 






Figure 3.4: Western analysis with GC-A specific antibody 
Protein samples were prepared from whole flies as described in Materials and Methods. 
Samples were run on a 4-15'%, Tris-acetate gel. Western blot analysis was carried out as 
described in Materials and Methods, with a 1: 7000 dilution of R1214 rabbit GC-A antiscrL1111 
(kind gift, David Garbers). Anti-rabbit second antibody was also LISVd at a dilution of 1: 7000. 






Fig 3.5: Ailti-GC-A immunocytochemical analysis reveals cell-specific localisation of GC- 
A in transgenic tubules 
TLIbUIC's were prepared as described in Materials and Methods. TLIbLIICS Were iIICLIbJtL'd With 
rabbit R1214 anti-GC-A antiserurn (kind gift, David Garbers, I loward I ILIglICS Medical 
IIIStitUte, Texas) and then With flUoresCein-COlIjUgated anti-rabbit second antibody (SAPU). 
TLIbLIICS were viewed Under UV light. A&B: GC-A is confined to principal cells in the main 
SegInent Of tLIbLIleS from progeny of a cross between c42 GAL-1-driver line and a UAS: -GC-A 
line. A: Expre. "ion of GC-A is CXCILIded from stellate cells (200 x magnification). B: GC-A is 
targetted to the basolateral membrane of principal cells (400 x magnification). C&D: GC-A is 
confined to type 11 (stellate) cells of tLIbLIleS fl-0111 progeny of a cross between c724 GAL4- 
driver line and a UAS:: G('-A line (C: 200 x magnification; D. 400 x magnification). 
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Figure 3.6: Heat-shocked hsGC:: A express GC-A throughout tubules 
Tubules from heat-shocked hsGC-A flies were treated with R1214 anti-GC-A antiserum (Kind 
gift, David Garbers, I loward I ILIghes Medical IIIStitUte, Texas) and fluorescein-conjUgatCd 
secondary antibody. 
GC-A expression was ubiquitOLUS throLIglIOLIt tUbLIJeS (A: 200 x magnification) and targetted to 
the basolateral membrane (B: 400 x magnification). 
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3.3.5 Conditional expression of the GC-A transgene confers tubule sensitivity 
to ANP. 
Flies from the strain pP[CaSpeRhs:: GC-A) which conditionally express GC-A 
under heat-shock (referred to as hs:: GC-A) were heat-shocked at 37T for 45 
min 12-18 h before use. Tubules from these flies were then dissected for both 
fluid secretion assays and cGMP assays. These flies displayed sensitivity to 
ANP, the ligand for GC-A. Fluid secretion rate was measured for 30 n-dn before 
ANP was added, over a range of concentrations, to the bathing solution. The 
fluid secretion rate was measured for a further 30 min. Figure 3.7 shows the 
results of fluid secretion assays on heat-shocked hs:: GC-A flies. Significant 
changes from basal fluid secretion rates were observed in tubules treated with 
2: 10" M ANP, with an estimated mean EC50 of 7.2 xlO-'O A Due to variation in 
the basal fluid secretion rates of Malpighian tubules, the percentage rise in fluid 
secretion rate compared to basal was taken as the most fitting and consistent 
measurement of the efficacy of ANP. This value was calculated as shown 
below: 
Percent change = 
(max. stimulated rate - average basal rate) X 100 
average basal rate 
where max. stimulated rate is the maximum fluid secretion rate recorded post- 
ANP stimulation, and average basal rate is the mean of three measurements 
taken prior to ANP stimulation. 
Figure 3.8 shows typical fluid secretion assays on tubules from flies expressing 
GC-A principal cell-specifically (Figure 3.8A) or stellate cell-specifically (Figure 
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Figure 3.7: Fluid secretion is elevated in hs:: GC-A tubules by ANP in a dose-dependent 
manner 
Tubules from heat-shocked hs:: GC-A were challenged with ANP at 30 min. 
Tubules challenged with ANP showed elevated fluid secretion rates over basal controls at 
physiological levels of ANP. At high ANP concentration (104M), fluid secretion was 
inhibited. Results are expressed as a percentage change from basal secretion rates ± SEM, 
n_>10. 
Secretion rates significantly different from basal are denoted by *. (P<0.05, determined with 
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Figure 3.8: Targetted expression of GC-A transgene confers ANP-stimulated elevation of 
fluid transport 
Basal secreton rates were measured for 30 min before tubules were treated with 1 pM ANP 
(arrow). Secretion rates were measured for a further 30 min. 
A: Tubules from c42/UAS:, GC-A flies. Results shown are mean fluid secretion rate (nl/min) 
A SEM, n=10. 
B: Tubules from c7lO/UAS:: GC-A flies. Results shown are mean fluid secretion rate 
(nl/n-Lin)A SEMn=10. 
Secretion rates significantly different from basal are denoted *. (P<0.05, detennined with 
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Figure 3.8: Targetted expression of GC-A transgene confers ANP-stimulated elevation of 
fluid transport 
Basal secreton rates were measured for 30 rnin before tubules were treated with 1 gM ANP 
(arrow). Secretion rates were measured for a further 30 min. 
A: Tubules from c42/UAS:, GC-A flies. Results shown are mean fluid secretion rate (nl/min) 
± SEMn=10. 
B: Tubules from c7lO/UAS:: GC-A flies. Results shown are mean fluid secretion rate 
(nl/min) ± SEMn=10. 
Secretion rates significantly different from basal are denoted *- (P<0.05, determined with 
Student's Mest on unpaired samples, assuming unequal variances). 
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3.3.6 ANP-stimulated tubules expressing the GC-A transgene elevate 
intracellular cGMP levels. 
Cyclic GMP levels were assayed in tubule samples from heat-shocked hs:: GC-A 
flies in either the absence or the presence of 0.1 gM ANP. These samples were 
compared to cGMP levels in tubule samples from non heat-shocked hs:: GC-A 
flies in either the absence or the presence of 0.1 gM ANP and control samples 
from heat-shocked wild type flies treated with 0.1 gM ANP (Figure 3.9). All 
samples showed similar intracellular levels of cGMP (approximately 1 
fmol/tubule), with the exception of the heat-shocked hs:: GC-A sample which 
had been treated with ANP. This sample contained approximately double the 
cGMP content, indicating that the GC-A receptor had been stimulated to 
generate the second messenger. 
The expression of the GC-A gene was also targetted to specific cell types in the 
tubule, by crossing UAS:: GC-A flies with c42, c724 and c7lO GAL4 enhancer 
trap lines (Figure 3.10). Tubules from progeny of these crosses were sensitive to 
ANP, as reflected by the elevation of intracelluar cGMP. Furthermore, the 
quantity of intracellular cGMP generated was directly proportional to the 
concentration of ANP used in the assay, with a mean EC50 for production of 
cGMP calculated to be 2x 10-'M. 
Tubules with GC-A localised to principal cells gave rise to larger increases in 
cGMP than tubules expressing GC-A stellate cell-specifically, which reflects the 
greater volume and number of principal cells in tubules. Nevertheless, despite 
their smaller size and number (estimated to be 1-2% of total tubule volume), 
stellate cells were still able to produce a surprising amount of cGMP in 
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Figure 3.9: ANP-stimulated cGMP elevation in heat-shocked hs:: GC-A & wild-type 
tubules 
Flies were heat-shocked at 37 for 1 h, 12-18 h prior to use. Tubules were treated with 0.1 tLM 
ANP and the cGMP-specific phosphodiesterase inhibitor Zaprinast (10-6 M) for 10 min, 
and then prepared as described in Materials and Methods. Results are expressed as mean 
cGMP content (fmol /tubule) _t: 
SEM, n--6. cGMP content significantly different from basal 
cGMP content is denoted by *. (P<0.05, determined with Student's t-test on unpaired 
samples, assuming unequal variances). 
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Figure 3.10: cGMP content in transgenic tubules is elevated by ANP in a dose dependent 
manner 
Tubules were incubated with ANP and the cGMEP-specific phosphodiesterase inhibitor Zaprinast 
(10-6 M) for 10 minutes. Control tubules were incubated with Zaprinast only (10-6 M). 
A: Tubules from progeny of a cross with the principal cell-specific GAL4 driver line c42 and a 
UAS: ISC-A line. 
B: Tubules from progeny of a cross with the stellate cell-specific GAL4 driver line c724 and a 
UAS:, GC-A line. 
C: Tubules from progeny of a cross with the stellate cell-specific GAL4 driver line 010 and a 
UAS: -GC-A line. 
Results are expressed as mean cGMP content (fmol/tubule) ± SEM, n>-6. cGMIP content 
significantly different from control sample is denoted by *. (P<0.05, determined with Student's t- 
test on unpaired samples, assuming unequal variances). 
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3.3.7 Anantin inhibits ANP-induced fluid secretion and cGMP production in 
GC-A transgenic tubules 
Tubules transgenic for GC-A share a common pharmacology with COS-7 cells 
transfected with GC-A (Schulz et al, 1989). The ANP-induced effects, on both 
fluid secretion rate and intracellular cGMP levels in tubules, were assayed in 
the presence of the GC-A competitive antagonist, anantin. 
The addition of the competitive inhibitor anantin to GC-A transgenic tubules 
was shown to attenuate the ANP-induced rise in fluid secretion (Figure 3.11A). 
The production of cGMP in tubules co-presented with anantin (at various 
concentrations) and 1 gM ANP was assayed using tubules from the progeny of 
a cross between UAS:: GC-A flies and the principal cell specific GAL4 enhancer 
trap line c42. There was a dose dependent attenuation of cGMP production in 
these samples. On stimulation with 1 gM ANP, both production of cGMP and 
elevation of fluid secretion were almost completely attenuated with 10-' M 
anantin. 
The concentration of anantin needed to cause 50% inhibition of maximal cGMP 
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Figure 3.11: Anantin inhibits ANP-induced cGMP elevation and fluid secretion in GC-A 
transgenic tubules 
A: Tubules from progeny of a cross with c42 (principal cell GAL 4 driver line) and UAS:: GC-A 
were treated with 1 gM ANP, the cGMP-dependent phosphodiesterase inhibitor Zaprinast (10-6 
M) and varying concentrations of the GC-A-specific antagonist anantin for 10 min. Tubules 
were then prepared as described in Materials and Methods. Results are expressed as 
percentages of cGMP content in tubules unchallenged with anantin ± SEM, n=3. Samples 
significantly different from ANP-stimulated control tubules are denoted by *. (P<0.05, 
determined with the Student's t-test on unpaired samples, assun-dng unequal variances). 
B: Tubules challenged with 1 gM ANP at 30 min showed elevated fluid secretion rates (*) over 
non-treated tubules (0). Tubules treated with the GC-A-specific inhibitor anantin (10-5 M) at 
t=O showed an attenuated response to ANP (0). Results shown are mean secretion rate 
(nl/n-dn) ± SEM, n=10. 
Secretion rates significantly different from basal are denoted by *- (P<0.05, determined with the 









3.3.8 Immunocytochemical localisation of cGMP. 
The localisation of cGMP generated in GC-A transgenic tubules was detected 
by immunocytochernistry using antiserum to 2'-O-succinyl cyclic GMP 
conjugated to BSA raised in rabbit (Figure 3.12). Tubules from progeny of 
crosses with UAS:: GC-A and GAL4 lines were treated with Zaprinast (10' M) 
alone or with 1 gM ANP and Zaprinast (10' M) for ten n-dn before being fixed 
with 4% paraformaldehyde. Tubules treated with Zaprinast alone displayed 
very low background levels of fluorescence with the fluorescein-conjugated 
anti-rabbit secondary antibody. Tubules treated with ANP and Zaprinast 
showed high levels of fluorescence in a cell-specific manner, consistent with the 
driver for the transgene. 
In tubules from progeny of a cross between UAS:: GC-A and c42 GAL4 flies, 
cGMP appeared to be localised throughout the principal cells of the main 
segment (Figure 3.12A), but appeared to have strongest localisation in pools at 
the basolateral membrane (Figure 3.12B). This would suggest that the second 
messenger does not diffuse rapidly throughout the cell from its site of 
generation. Stellate cell-specific generation of cGMP was achieved by 
stimulating tubules from the progeny of a UAS:: GC-A cross and GAL4 line c724 
with ANP and Zaprinast (Figure 3.12C). Cyclic GMP was clearly generated 
exclusively in these cells; however, the stellate cells were too small to determine 
subcellular distribution of 'the second messenger. 
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Fig III Anti-cGMP ininiunocytocheinical analysis reveals cell-specific generation of 
cGMP in GC-A transgenic tubules in response to ANP 
Tubules frorn progenv of a cross between GAL4 enhancer trap lines and UAS:. CC-A lines 
were treated with the cGMP-specific phosphodiesterase inhibitor Zaprinast (10' M) and I pM 
ANP for ten minutes before being fixed, as described in Materials and Methods. Tubules 
were incubated with rabbit anti-cGMP antiserUm and then with fluorescein-conjugated anti- 
rabbit second antibody. TLIbLIleS were viewed under UV light. A: Cyclic GMP production is 
confined to principal cells in the main segment Of tLIbLIles from progeny of a cross between 
A2 GAL4-driver line and a UAS:: GC-A line (200 x magnification). B: Cyclic GMP production 
is not elevated in the initial segment of tubules (ni=n1ain segment; i=initial segment) (400 x 
magnification). C: Cyclic GMP procILICtiOn is Confined to t' N'l)V 11 (Stellate) Cells Of tLIbLIIeS from 
progeny of a cross between ('724 GA1.4-driver line and a UAS:: (; C-A line (200 X 
magnification). 
118 
3.3.9 Cyclic AMP levels in GC-A transgenic tubules 
The possibility that intracellular cAMP levels may be altered upon activation of 
GC-A was investigated by assaying levels both with and without ANP 
stimulation in samples from tubules expressing GC-A, and from a wild type 
control (Figure 3.13). All samples contained approximately the same basal 
levels of intracellular cAMP, and there was no significant change in these levels 
upon ANP-induced GC-A activation. This demonstrates that cGMP is the 
specific downstream effector of GC-A, and that its effects on cell function do 
not include modulation of the basal levels of cAMP. 
3.3.10 [Ca'*Jj in ANP-stimulated GC-A transgenic tubules 
In Drosophila, [Ca"]i is conveniently measured using a cell-specific transgenic 
aequorin system. GAL4 drivers are used to direct expression, as described 
elsewhere in this chapter. Flies homozygous for the GAL4 driver and for 
UAS:: aequorin were crossed with flies homozygous for UAS:: GC-A, and 
progeny heterozygous for each transgene were then used to measure [Ca"*]i. 
Intracellular Ca" levels were assayed in tubules from progeny of a cross 
between male UAS:: GC-A flies and female UAS:: apoaequorin; +/+; c42 GAL4 
flies for principal cell-specific measurements and a cross between male 
UAS:: GC-A flies and female UAS:: apoaequorin; +/+; c7lO GAL4 flies for stellate 
cell-specific measurements. Tubules responded to ANP with a rapid elevation 
of [Ca'+], in principal cells followed by a sustained secondary response (Figure 
3.14A). Cross-talk is therefore taking place between cGMP or a cGMP- 
dependent effector and mechanisms dependent on Ca' in principal cells. 
There was no change in [Ca'+Jj in stellate cells, suggesting that no cross-talk 
occurs in these cells (Figure 3.14B). 
ANP did not cause a rise in [Ca+]i in control tubules, that only expressed 
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Figure 3.13: GC-A transgenic tubules do not significantly raise intracellular cAMP levels in 
response to ANP 
Tubules were treated with ANP (IILM) and IBMX (10--5M) for 10 min and prepared as 
described in Materials and Methods. Results are expressed as mean cAMP content 
(fmol/tubule) ± SEM, ný3. Differences between samples ANP-treated samples and control 
samples are not significant (P>0.05, determined with Student's t-test on unpaired samples, 
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Figure 3.14: ANP-induced [Ca2+1i rises in tubules expressing GC-A: representative traces 
Typical traces of changes in [Ca2+1i in tubule cells expressing GC-A when stimulated with 1 gM 
ANP (large arrows). 
A: Caý+ response W ANP in principal cells of aeq; +/+; c42 /GC-A tubules. 
B: Caý+ response to ANP in stellate cells of aeq; +/+; 010 GAL4/GC-A tubules. 
The peaks prior to the main rises in [Ca2+]i are control ("mock") injections of Schneider's 
medium (small arrows). 
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3.3.11 Cell-specific cyclic GMP-dependent kinase activity in GC-A transgenic 
tubules. 
Cyclic GMP-dependent kinase activity was assayed in tubules from progeny of 
crosses between UAS:: GC-A flies and GAL4 enhancer trap lines c42 (principal 
cell-specific) and c724 (stellate cell-specific) in the presence and absence of 
ANP. In order to determine ANP-induced changes in kinase activity, as 
opposed to absolute kinase activity, tubule samples were prepared in assay 
buffer lacking cGMP (Figure 3.15A). This ensured that kinase activity measured 
was directly due to endogenous intracellular cGMP generated by GC-A. 
Tubules were treated with the cGMP-specific phosphodiesterase inhibitor 
Zaprinast and stimulated with 1 pM ANP for 10 min in Schneider's medium 
before being transferred to assay buffer. Tubules expressing GC-A in principal 
cells showed nearly a 20 fold elevation above basal kinase activity when 
challenged with ANP, and tubules expressing GC-A in stellate cells showed a 
doubling in kinase activity above basal when challenged with ANP. 
As a positive control for kinase activity, the assay was also conducted on 
samples that were treated as above, but were transferred to assay buffer 
containing 10 gM cGMP (Figure 3.15B). These samples were intended to 
measure absolute kinase activity. This assay indicated that tubules pre-treated 
with ANP, and therefore having generated elevated cGMP levels before being 
assayed, had greater kinase activity than the maximum achievable rate in 
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Figure 3.15: Cyclic GMP-dependent kinase activity is elevated by ANP in GC-A transgenic 
flies 
A: Tubules from progeny of crosses between CALA driver lines and UAS:: GC-A lines were 
treated with the cGMP-dependent phosphodiesterase inhibitor Zaprinast (10-6 M) +/- I VLM 
ANP for 10 minutes. Tubules were then transferred to assay buffer and prepared as described 
in Materials and Methods. Results are expressed as mean kinase activity (pmol ATP/ min/jLg 
protein). t SEM, n=6. 
B: Tubules were treated as above, then transferred to assay buffer containing 10 ILM cGMP. 
Results are expressed as mean kinase activity (pmol ATP/ min/tLg protein) -!: SEM, n--6. 
Activity significantly greater than basal is denoted *. (P<0.05, determined with Student's t-test 
on unpaired samples, assuming unequal variance). 
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3.3.12 Cell-specific phosphodiesterase activity in GC-A transgenic flies 
Tubules expressing GC-A in a cell-specific manner were treated with ANP for 
10 min, then transferred to PDE buffer. Tubules expressing GC-A in principal 
cells showed an approximate twofold increase in cGMP-hydrolysing 
phosphodiesterase activity, suggesting that the signal achieved by a large rise in 
cGMP in these cells is quickly dampened by activation of phosphodiesterase. 
Tubules expressing GC-A in a stellate cell-specific manner also showed an 
approximate doubling in phosphodiesterase activity upon stimulation with 
ANP (Figure 3.16A). The magnitude of the phosphodiesterase activity in 
c7lO/UAS:: GC-A tubules was equal to that of c42/UAS:: GC-A tubules, even 
though stellate cells are much smaller and fewer in number than principal cells. 
This perhaps suggests that either cGMP is degraded more rapidly in this cell 
type, or that the response elicited through production of cGMP in these cells 
evokes increased phosphodiesterase activity in principal cells. However, there 
was a significantly lower elevation of phosphodiesterase activity in 
c724/UAS:: GC-A tubules than in either c42/UAS:: GC-A or c7lO/UAS:: GC-A 
tubules. This observation is more consistent with the smaller amount of cGMP 
generated in tubules expressing GC-A in stellate cells. 
Activity of cAMP-hydrolysing phosphodiesterase in samples stimulated and 
unstimulated with ANP was also measured. There appeared to be a small 
decrease in activity below basal levels in ANP-stimulated samples, which 
indicates that there was a cAMP-independent mechanism controlling this 
down-regulation, as cAMP levels were shown not to be significantly raised 
upon GC-A activation (Figure 3.13). This suggests that there is an element of 
cross talk between cGMP-hydrolysing and cAMP-hydrolysing 
phosphodiesterases, or that a phosphodiesterase that hydrolyses cAMP has 
been inhibited by cGMP. However, as with the cGMP-hydrolysing 
phosphodiesterase assay, there is an inconsistency between samples expressing 
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GC-A in stellate cells (c7lO/UAS:: GC-A and c724/UAS:: GC-A). Both samples 
have approximately the same basal level of activity, but only c724/UAS:: GC-A 
samples demonstrated significant inhibition of activity. 
3.3.13 GC-A as a generic tool for study of tissue-specific cGMP signalling 
Flies with a P-element insertion containing GC-A can potentially be used for 
studying cGMP signalling in any tissue or cell type throughout the organism. 
This can be achieved either by heat-shocking hs:: GC-A flies, resulting in 
ubiquitous expression of the gene, or by crossing UAS:: GC-A flies with any of 
the huge range of GAL4 lines that are available for targetted expression: 
introduction of ANP to the fly, or a particular tissue, will stimulate the receptor 
to elevate intracellular cGMP levels. This obviously creates great scope for 
studying cGMP in Drosophila, and even behavioural phenotypes could be 
studied if ingestion of ANP was achieved. Figure 3.17 illustrates that this 
method of study can be used generically. Brains (including optic lobes) were 
assayed for cGMP content with and without 1 gM ANP, as in other assays, from 
heat-shocked and non heat-shocked hs:: GC-A flies. Elevated cGMP content was 
only observed in brains from flies that had been treated with both heat-shock 
and ANP. This demonstrates that rat ANP does not normally elicit a response 
in this tissue, and therefore confirms the potential for GC-A to be used as a 









..... ..... ...... ..... 





13 + ANP 60 0 075 
. 
0 0.05- 
41 ; 1- 0 025 
. 
* 
Fig 3.16: Phosphodiesterase activity is altered in GC-A transgenic tubules in response to ANP 
Tubules from the progeny of crosses with GAL4 enhancer trap lines and UAS:. -CC-A lines were 
treated with I tLM ANP for 10 min. Phosphodiesterase activity was assayed as described in 
Materials and Methods. 
A: Samples were assayed for cGM P-dependent phosphod iesterase activity. 
B: Samples were assayed for cAMP-dependent phosphodiesterase activity. 
Results are expressed as mean phosphodiesterase activity (nmol/ min/ IL9) --t: SEM, ný3. 
Activity significantly different to basal is denoted *. (P<0.05, determined with Student's t-test on 
unpaired samples, assuming unequal variance). 
r. 0. ( 
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Figure 3.17: GC-A expression allows specific manipulation of cGMP in Drosophila 
melanogaster brain 
Brains were dissected from pP(CaSpeRhs:: GC-A) flies (five per sample), heat-shocked and non 
heat-shocked. Brains were treated with the cGMP-specific phosphodiesterase inhibitor 
Zaprinast (10-6 M) and a subset treated with 1 gM ANP. Results are expressed as mean cGMP 
content (fmol/brain) ± SEM, n=3. cGMP content significantly different from basal cGMP 
content is denoted by *. (P<0.05, determined with Student's Mest on unpaired samples, 
assuming unequal variances). 
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3.4 Discussion 
A 3.1 kb rat GC-A open reading frame was subcloned into the P-element 
vectors pP[CaSpeRhs/actj and pPjUAST) to allow temporal and spatial control 
of expression of the gene, respectively. Transcription of GC-A was detected in 
tubules by reverse transcriptase PCR and a protein of approximately 180 kDa 
was detected in whole fly protein samples by Western analysis using an 
antibody raised to the last eight amino acids of GC-A. Immunocytochen-dcal 
studies with the same antibody localised the protein to the basolateral 
membrane of tubules. Sorting of proteins to the basolateral membrane in 
polarised epithelia requires cytoplasn-dc tyrosine-based signals or cytoplasmic 
dileucine motifs (Brown and Breton, 2000). Therefore, GC-A n-dght be expected 
to be basolaterally targetted due to the presence of a C-terminal dileucine motif. 
This basolateral targetting is also consistent with the fact that the ligand for GC- 
A, ANP, is released into the bloodstream primarily from cardiornyocytes in 
mammals and would therefore be bound by receptors on the outer surface of 
tissues without the need for internalisation. 
Expression of GC-A throughout tubules conferred ANP sensitivity, and 
elevation of fluid secretion was achieved with low concentrations of ANP, with 
an EC50of 7.2 x1O-'O M (±1.7 x101" M). This value for half-maximal stimulation of 
fluid secretion is far lower than the EC50 calculated for ANP-induced cGMP 
production (1.89 x 10-1 M (±1.052 x lOr'M)). However, at 0.1 mM, ANP inhibited 
fluid secretion, suggesting that high levels of cGMP can inhibit fluid transport. 
This is consistent with the inverted V response to cGMP previously reported 
(Davies et al, 1995), whereby fluid transport rate is elevated by cGMP at low 
concentrations, but at high concentrations cGMP becomes inhibitory. At 
physiological ranges ANP also acted to elevate fluid secretion rate when GC-A 
was expressed in a cell specific manner. Surprisingly, the maximum fluid 
secretion rates measured in tubules expressing GC-A in stellate cells were very 
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similar to those measured in tubules expressing GC-A in principal cells, despite 
stellate cells being smaller and fewer in number. Expression of GC-A in both 
principal cells and. stellate cells (in hs:: GC-A tubules) had an additive effect on 
fluid secretion rate, which implies distinct roles for cGMP in different cell types 
(Figure 3.18). That ubiquitous expression of GC-A results in almost double the 
maximal rates from stimulated c42/GC-A and c710/GC-A tubules is 
interesting; the lower segment of tubules is known to be involved in the process 
of fluid reabsorption (O'Donnell and Maddrell, 1995). Therefore, one might 
expect that expression of GC-A, and subsequent elevation of cGMP in response 
to ANP, would stimulate the lower tubule and elevate reabsorption. One 
explanation as to why an attenuation of the increased activity in the main 
segment is not observed is simply that the lower tubule is not contained within 
the bathing medium in these assays, and therefore GC-A expressed in this 
segment is not exposed to ANP. 
Production of the second messenger cGMP was detected 
immunocytochemically in transgenic tubules that were challenged with ANP, 
whereas background levels were very low; in principal cells cGMP appeared in 
pools at the basolateral membrane. This implies that there is low diffusiblity of 
the cyclic nucleotide, resulting in compartmentalisation. The production of 
cGMP was shown by radioimmunoassay to be dependent on the concentration 
of ANP used, and production could be attenuated by the GC-A receptor 
antagonist anantin. 
The specificity of cGMP as a downstream effector of GC-A activation was 
determined by measuring intracellular cAMP levels in ANP-stimulated tubules. 
No significant changes in intracellular cAMP levels between stimulated and 
unstimulated samples were observed, suggesting that GC-A acts to specifically 
generate cGMP and that there is no cross-talk that leads to changes in resting 
levels of cAMP. 
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Intracellular Ca" levels were measured in both principal cells and stellate cells, 
and tubules expressing GC-A in principal cells responded to ANP with a 
biphasic elevation of [Ca"Ji. This is consistent with the model for CAP2b/CAPA 
signalling in principal cells; the elevation of cGMP is thought to induce Ca 2+ 
entry into principal cells. However, tubules expressing GC-A in stellate cells 
did not display elevation of [Ca 2+]i in response to ANP. This suggests that in 
principal cells cross-talk between cGMP or a cGMP-dependent effector and 
mechanisms dependent on Ca` is taking place, whereas there is no cross-talk of 
this nature in stellate cells. Interestingly, it has been demonstrated that calcium 
channels sensitive to the calcium channel antagonists verapan-dl and nifedipine 
are necessary for cGMP-induced calcium entry to tubules (MacPherson et al, 
2001). It was also demonstrated by RT-PCR that the Drosophila cyclic nucleotide 
gated (CNG) ion channel (cng) is found in Malpighian tubules and must, 
therefore, have a role in fluid transport. Using fluorescent calcium channel 
antagonists, verapamil was demonstrated to bind at high affinity to basolateral 
membranes of main segment principal cells, suggesting that verapamil- 
sensitive calcium channels are not found in stellate cells (MacPherson et al, 
2001). This is consistent with the observation that ANP-induced cGMP rises in 
principal cells induce Ca` entry, but ANP-induced cGMP elevation in stellate 
cells does not affect [Ca'*jj levels. The possibility that there are other types of 
ion channels gated by downstream effectors of cGMP in stellate cells, is 
therefore plausible. For example, the role of cyclic nucleotides in stellate cells 
may be to regulate phosphorylation of chloride channels. Indeed, in the T84 
intestinal epithelial cell line, cGMP accumulation by heat-stable enterotoxin 
increases chloride conductance across the membrane by cross-activation of cAK 
(Forte et al, 1992). However, it has previously been reported that cAMP and 
cGMP alter the activity of the V-ATPase located in principal cells, with only a 
negligible effect on anion conductance (O'Donnell et al, 1996). This evidence 
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would oppose the suggestion that cyclic nucleotides may regulate chloride 
conductance, but it does not address stellate cell-specific intracellular 
generation of cyclic nucleotides; rather, it implies that stellate cells are not 
capable of transporting cGMP across the basolateral plasma membrane. 
Here it was demonstrated in both principal and stellate cells that cGMP- 
dependent kinase activity was elevated in response to ANP-induced elevation 
of [cGMP]i. This suggests the possibility of direct phosphorylation of ion 
channels by cGK or cross-activation of cAK (which is inhibited in the cGK 
assay) leading to increased ion conductance across tubules. 
In most signalling systems, there is the requirement for a negative feedback 
loop to allow a signal to be dampened, or turned off. The only known 
enzymatic reaction for the degradation of cyclic nucleotide is its conversion to 
5'-nucleoside by cyclic nucleotide phosphodiesterases. Therefore, activity of 
cGMP- and cAMP-dependent phosphodiesterases in GC-A transgenic tubules 
was assayed, both in the presence and absence of ANP. Elevation in activity of 
cGMP-hydrolysing phosphodiesterases was found, but conversely a decrease in 
activity of cAMP-hydrolysing phosphodiesterase was observed. This cross-talk 
between phosphodiesterases did not appear to significantly alter the resting 
levels of cAMP, and perhaps would only have impact when adenylate cyclase 
activity was also elevated. Finally, the use of GC-A as a generic tool for 
manipulating cGMP in any tissue of Drosophila was illustrated by assaying 
[cGMP]i in brains taken from hs:: GC-A flies, both heat-shocked and non heat- 
shocked in the presence and absence of ANP. The elevation of [cGMP]i in brains 
demonstrates that this work could be extended to the study of signal cross-talk 
in any tissue or cell type with which there is an accompanying GAL4 driver. 
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Figure 3.18: A model for cell-specific action of cGMP in GC-A transgenic Malpighian tubules 
A: ANP-induced cell-specific generation of cGMP in principal cells elevates fluid secretion via cGMIP- 
dependent kinase (cGK), and elevation of JCa2+J,, to stimulate V-ATPase activity. 
B: ANP-induced cell-specific generation of cGMP in stellate cells elevates fluid secretion via cGMP- 
dependent kinase (cGK), to increase chloride conductance. 









Introduction of a Drosophila serotonin gene (5HT7Dro) into the genome of 
Drosophila by P-element mutagenesis creates a unique in vivo model to study the 
direct role of intracellular adenosine 3', 5'-cyclic monophosphate ([cAMP]i) in 
fluid secretion of Malpighian tubules. Critically, the ligand for 5HT7D, 1 
serotonin (5-hydroxytryptamine, 5HT), does not normally affect [cAMPjj in 
wild-type Drosophila Malpighian tubules. Expression of engineered P-element 
constructs pP[CaSpeR. hs:: 5HT7[, r,, ) and pP[UAS:: 5HT7Dr. 
1, allows temporal and 
spatial control of expression of 5HT7Dr,, respectively, and transcription of the 
gene is demonstrated by reverse transcriptase PCR. Both fluid transport of 
5HT7Dr. and elevated [cAMPjj, determined by ra d ioi mmuno assay.. are 
modulated by 5HT in a dose dependent manner in transgenic Malpighian 
tubules. The effect of 5HT on tubules is attenuated by the 5HTM,, antagonist 
(+)-butaclamol, at the level of cAMP production. Immunocytochernical 
localisation of cAMP suggests 5HT-induced elevation is confined to specific 
cells, as determined by the particular GAL4 driver used to express 
UAS:: 5HT7Dro' Cell-specific cAMP-dependent phosphodiesterase activity is 
increased in GAL4/UAS:: 5HT7Dro treated with 5HT. cGMP-dependent 
phosphodiesterase activity also increases slightly in response to 5HT, even 
though [cGMP]i remains constant, suggesting cross talk between cAMP- and 
cGMP-hydrolysing phosphodiesterases. 
RT-PCR analysis of tubules revealed the presence of transcripts for all 
Drosophila G protein subunits with the exception of G076C, which strengthens 
the probabilty that elevated cAMP is achieved through activation of adenylate 
cyclase by G(x,. 
Finally, the use of 5HT7D.. as a generic tool for manipulating cAMP in any tissue 
was illustrated by assaying intracellular levels of cAMP in brains taken from 
hs:: 5HT7D,,, flies, both heat-shocked and non heat-shocked, in the presence and 
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absence of 5HT. This assay illustrates that these transgenic lines may also be 
used to study the effects of increased intracellular cAMP on learning and 
memory in Drosophila. 
4.2 Introduction 
In the preceding introduction, the role of intracellular cGMP in Malpighian 
tubules was discussed. Cyclic AMP was the first of the 3-5'-nucleotides found 
to occur naturally and activation of cAMP controls diverse phenomena 
including gene transcription, metabolism and memory via several different 
target proteins, including ion channels, cAMP-dependent kinases and 
phospho dies terases. However, its role in Malpighian tubules is less well 
characterised than that of the less abundant cGMP. It has been demonstrated 
that tubules incubated with cAMP have elevated fluid secretion rate (Coast et al, 
1991; Maddrell, 1971; Dow et al, 1994b). In Drosophila, this response is additive 
to that of cGMP (Davies et al, 1995), the response elicited by the neuropeptide 
CAP2b (Davies et al, 1995) and also to the action of the endogenous 
neuropeptide leucokinin, which acts to raise intracellular Ca", (Davies et al, 
1995; O'Donnell et al, 1996; Terzhaz et al, 1999). This suggests that cAMP has a 
distinct signalling role in this epithelium. Furthermore, forskolin, a lipid-soluble 
activator of adenylate cyclase, is a potent agonist for fluid secretion in 
Drosophila (Dow et al, 1994b). This demonstrates that tubules have endogenous 
adenylate cyclase(s) and implies that cAMP is a stimulatory second messenger 
in tubules. It has recently been shown that a corticotropin-releasing factor-like 
(CRF-like) peptide (encoded by the Dh gene) also acts to stimulate fluid 
secretion rate, and that this effect is mediated by cAMP production in only 
principal cells, which stongly implies that the endogenous receptor for CRF-like 
peptide stimulates adenylate cyclase (Cabrero et al, submitted 2002). 
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The activities of adenylate cyclases are controlled dynamically by a variety of 
hormones, neurotransmitters and other regulatory molecules which generally 
activate a heterotrimeric GTP-hydrolysing protein (G protein, which consists of 
an cc, Pand ysubunit), via a seven transmembrane receptor coupled to the G 
protein. These G protein-coupled receptors (GPCRs) belong to a large and 
ancient superfan-dly of integral cell membrane proteins that are involved in a 
diverse array of signal transduction pathways, and approximately 200 genes 
coding for GPCRs have been identified in the Drosophila genome (Brody and 
Cravchik, 2000). Unsurprisingly, there are a number of different G protein 
subunit genes in the Drosophila, genome (8 cc, 5 0, and 2y genes, as determined 
by BDGP Drosophila BLAST and GADFLY searches). In its inactive state, aG 
protein consists of a GDP bound cc subunit associated with a Oy subunit. Upon 
activation, the cc subunit exchanges GDP for GTP and dissociates from the Py 
subunit. The Go:, subunit stimulates adenylate cyclase to catalyse the 
conversion of ATP to cAMP, whereas the G(xi inhibits adenylate cyclase. There 
is growing evidence that many agonists can simultaneously stimulate G 
proteins that activate phospholipase C (PLC) leading to the production of InsP3 
(with subsequent release of Ca"' from internal stores) and modulate adenylate 
cyclase activity. Various receptors, including somatostatin (Murthy et al, 1996), 
(x-2-adrenergic (Dorn et al, 1997) and some opioid receptors (Murthy et al, 1996) 
are reported to be negatively coupled to adenylate cyclase and concurrently 
positively coupled to PLC. However others, such as vasopressin and luteinising 
hormone receptors (Zhu et al, 1994) stimulate both adenylate cyclase and PLC. 
The strength of coupling varies from one receptor type to another and between 
different species. 
As described in the previous chapter, a powerful method to study the role of a 
particular second messenger in the function of Drosophila Malpighian tubules is 
to overexpress a receptor that normally employs a specific second messenger 
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for intracellular signalling. In parallel with activating a specific second 
messenger, the ligand for the receptor must not have any endogenous effects on 
the tissue. Therefore, aG protein-coupled receptor that activates adenylate 
cyclase when stimulated with a ligand that has no endogenous action on 
tubules would be required. 
Serotonin (5-hydroxytryptamine, 5HT) is a biogenic amine neurotransmitter 
found in both vertebrates and invertebrates with a large family of receptors and 
diverse signalling functions, such as control of sleep, appetite, pain perception 
and circadian rhythms. With the exception of mammalian 5HT3 receptors (of 
which there is no Drosophila homologue) which are ligand-gated ion channels, 
all 5HT receptors belong to the superfan-dly of G protein-coupled receptors. It 
has been demonstrated that although serotonin modulates fluid secretion in 
some insects (Morgan and Mordue, 1984; Maddrell et al, 1991), it does not alter 
cell function in Drosophila Malpighian tubules (Julian Dow, personal 
communication). A 5HT receptor positively coupled to adenylate cyclase would 
therefore be ideal for selective modulation of cAMP in particular tubule cell- 
types. 
A Drosophila serotonin receptor was cloned from genon-dc and cDNA libraries 
by Witz et al (1990) using a strategy based on nucleotide sequence homology 
between G protein-coupled receptor genes. It comprises of one long coding 
sequence with no introns, which is not uncommon among genes encoding G- 
protein coupled receptors. This receptor is expressed predominantly in 
Drosophila heads and was found to activate adenylate cyclase in response to 
serotonin when stably introduced into mouse NIH 3T3 cells. At the time, this 
receptor exhibited highest similarity to the human 5HT1A receptor, and being 
the first 5HT receptor to be cloned from Drosophila, was named 5HT-dro. It is 
now apparent that this receptor has highest similarity to mammalian 5HT7 
receptors and has been renamed 5HT7D,,, (Tierney, 2001; Table 1.1) and will be 
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referred to this way herein. This receptor gene (gift, Luc Maroteaux, Universitie 
L. Pasteur de Strasbourg) was subcloned into the P-element vectors 
pPjCaSpeR. hs/actj and pPjUAST) and inserted into the fly genome by P- 
element mutagenesis. Work described in this chapter aims to look at the direct 
role of endogenously produced intracellular cAMP in Drosophila Malpighian 
tubules using the 5HT7Dr. receptor as a modulator of intracellular cAMP levels. 
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4.3 Results 
4.3.1 Cloning of 5HT7Dro into P-element vectors pP(CaSpeRhs/ act) and 
pPjUASTj 
A 1.7 kb 5HT7Dro cDNA clone was used as a template for PCR mutagenesis to 
incorporate 5'EcoRI and 3'NotI restriction sites. The clone was amplified with a 
combination of Taq and Pwo DNA polymerases and subcloned into the TOPO 
TA cloning vector pCR2.1 (Invitrogen). The PCR product was then sequenced 
to verify error-free amplification, before being directionally cloned into the P- 
element vectors pP[CaSpeR. hs/act) and pPjUAST) using the engineered EcoRl 
and Noff restriction sites (Figures 4.1 and 4.2). The clone was then sequenced 
again using a P-element-specific primer, to confirm successful incorporation of 
the open reading frame. Transgenic lines created with these constructs are 
referred to as hs:: 5HT7D,. and UAS:: 5HTýý,, depending on which of the vectors 
was used. 
4.3.2 Expression of 5HT7D.. in Drosophila ittelayipgaster 
Transgenic lines were generated by germline transformation of embryos, as 
described in the preceding chapter, and inverse PCR was performed to identify 
the chromsomal location of the insertions. Reverse transcriptase PCR was also 
performed on tubules from heat-shocked hs:: 5HT7Drc) flies and tubules from 
progeny of crosses between UAS:: 5HT7D.. lines and GAL4 lines (referred to in 
the text as c42/, c71O/ and c724/UAS:: 5HT7, ),,, ). As before, contamination of 
cDNA preparations with genomic DNA was only detectable indirectly by 
performing PCR on tubule preparations that had not been incubated with 
reverse transcriptase enzyme. Figure 4.3 illustrates conditional expression of 
full-length transcripts from various independent lines. 
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Figure 4.1: Cloning of SHT7D,. into pPjCaSpeR-hs/actl vector 
A 1.7 kb Drosophila 5HT7Dr,, open reading frame was amplified from a cDNA clone in 
pBluescript KS+. Primers used (Appendix 1) introduced 5' EcoRl and 3' Not I to the open 
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Figure 4.2. - Cloning of 5HT7D,. into pPIUASTI vector 
A 1.7 kb Drosophila 5HT7D,,, open reading frame was amplified from a cl)NA clone in 
pBluescript KS+. Primers used (Appendix 1) introduced 5' EcoRl and 3' Not I to the open 
reading frame to aflow for directional cloning into pPIUASTI (Brand and Perrimon, 1993). 
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figure 4.3: 'I-Iie expression of 51""7, ),,, "' transgenic 
lines 
cDNA from tubules expressing 5HT,,,,.,, was used as template for RT PCR. L, inv 1: 1 kh DNA 
ladder (Gibco BRL). Lane 2: c7lO/UAS:: 5f IT 71 )ro cDNA as template. Lane 3: (-724/UAS:: 
51IT7, ),, ) cDNA as template. 
Lane 4: c42/UAS:: 5HT71)ro cDNA as template. Lane 5: hs:: 
5' IT71)r(, cDNA from heat-shocked flies as template. No expression of 51 ITý,, $, " W, js (Jete(, 
ted 
with cDNA frorn non heat-shocked hs:: 51 IT, /, ),, ) 
flies as ternplate (not -; hown). No genomic 
products Were detected in an RT-PCR using intron spanning primers, for the gene (not 
shown). This indicated that cDNA samples did not have genonlic contamination, and that 
products detected with primers for 51 IT- -C 'lot generated from genomic DNA. We' 
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4.3.3 Conditional expression of 5HT7Dro in tubules confers 51IT-induced 
elevation of fluid transport. 
Progeny of a cross between the strain pP[UAS:: 5HT7Drc)l and GAL4 line c42 
(referred to as c42/UAS:: 5HT7Dr. ) express 5HT7Dr. in principal cells of the main 
segment of tubules. Similarly, progeny of a cross between the strain 
pPIUAS:: 5HT7Drol and GAL4 lines c724 or 010 (referred to as 
c724/UAS:: 5HT7D,. and c7lO/UAS:: 5HT7Dr,, respectively) express 5HT7Dro in 
stellate cells of tubules. 
Flies from the strain pP[CaSpeRhs:: 5HT7D,,,, l which conditionally express 5HT7D,. 
under heat-shock (referred to as hs:: 5HT7D,. ) were heat-shocked at 37'C for 45 
min 12-18 h before use. Tubules from all the flies above were then dissected for 
both fluid secretion assays and cAMP assays. Fluid secretion rate was 
measured for 30 min before 5HT was added to the bathing solution. The fluid 
secretion rate was measured for a further 30 n-dn. All 5HTm. tubules displayed 
sensitivity to serotonin (5HT). Figure 4AA shows a typical fluid secretion assay 
on c42/UAS:: 5HT7D,. flies and Figure 4.413. shows a typical fluid secretion assay 
on c71O/ and c724/UAS:: 5HT7D,, flies. The maximum rate of fluid secretion 
achieved in heat-shocked hs:: 5HT7Dr,, tubules in response to 5HT is additive to 
those achieved when the 5HT7D,. is expressed in principal or stellate cells only 
(Figure 4.4C). Calculations of fluid secretion rate were made as described in the 
previous chapter. In all tubules expressing the 5HT7DrO receptor, there was a 
significant elevation of fluid secretion rate above basal, which was sustained 
over 30 min. 
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Figure 4A Expression of 5HT7DO transgene confers 5HT-stimulated elevation of fluid 
transport 
Basal secretion rates were measured for 30 min before tubules were treated with IAM 511T. 
Secretion rates were measured for a further 30 min. 
A: Tubules from c42/UAS--5HT7Do flies (13) show elevated fluid secretion rates in response to 
5HT, n=10. Tubules from UAS:: 5HT7Do (0) do not respond to 5HT, n=10. 
B: Tubules from c7lO/UAS:. -5HT7Dro flies (13) show elevated fluid secretion rates in response to 
5HT, n=10. Tubules from UAS:: 5HT7Do (0) do not respond to 5HT, n=10. 
C: Tubules from heat-shocked hs:: 5HT7E),. flies (13) show elevated fluid secretion rates in response 
to 514T, n=10. Tubules from non heat-shocked hs:: 5HT7Dro flies (0) do not respond to 5fff, n=10., 
n=10. 
Data shown are expressed as mean fluid secretion rate (nl/min) ± SEM. 
Secretion rates significantly different from basal are denoted by *. (P<0.05, determined with the 
Student's Mest, on unpaired samples, assun-dng unequal variances). 
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4.3.4 5HT-stimulated tubules expressing the 5HT7Diro transgene elevate 
intracellular cAMP levels. 
Cyclic AMP levels were assayed in tubule samples from heat-shocked 
hs:: 5HT7D,,, flies with either absence or presence of 1 gM 5HT. These samples 
were compared to cAMP levels in tubule samples from non heat-shocked 
hs:: 5HT7Dro flies with either absence or presence of 1 gM 5HT and control 
samples from heat-shocked wild type flies treated with 1 ptM 5HT (Figure 4.5). 
All samples showed similar intracellular levels of cAMP (approximately 250 
fmol/tubule), with the exception of the heat-shocked hs:: 5HT7Drosample which 
had been treated with 5HT. This sample contained 82 ±5 fmol (approximately 
fourfold cAMP content), indicating that the 5HT7Dr. receptor had been 
stimulated and the associated G protein cc subunit had upregulated adenylate 
cyclase activity, a cAMP hydolysing phosphodiesterase activity had been 
downregulated, or that modulation of both these enzymes had resulted in 
elevated [cAMPjj. 
The expression of the 5HT7DrO gene was also targetted to specific cell types in the 
tubule by crossing UAS:: 5HT7Dro flies with c42, c724 and 010 GAL4 enhancer 
trap lines (Figure 4.6). Tubules from progeny of these crosses were sensitive to 
5HT, as reflected by the elevation of intracellular cAMP. Furthermore, the 
quantity of intracellular cAMP generated was directly proportional to the 
concentration of 5HT used in the assay, with a calculated mean EC50 for 
production of cAMP of 2.1 x 10' M (± 0.7 x 10 M), consistent with published 
data (Witz et al, 1990). Tubules with 5HT7D,. localised to principal cells gave rise 
to larger increases in cAMP than tubules expressing 5HT7Dro in stellate cells, 
which reflects the greater volume and number of principal cells in tubules. 
Nevertheless, despite their smaller size and number, stellate cells were still able 
to produce a large amount of cAMP in response to 5HT. Control tubules, 
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Figure 4.5: 5HT stimulates cAMP production in heat-shocked hs:: 5HT7D., but not in wild- 
type tubules 
Flies were heat-shocked at 37'C for I hr 12-18 hours prior to use. Tubules were treated with I 
ILM 5HT and the phosphodiesterase inhibitor IBMX (104M) for 10 min, and then prepared 
as described in Materials and Methods. Results are expressed as mean cAMP content 
(fmol/tubule). t SEM, n=3. cAMP content significantly different from basal cAMP content is 
denoted *. (P<0.05, as determined with Student's t-test on unpaired samples, assuming 
unequal variances). 
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Figure 4.6: cAMP content in UAS--SHT7D. transgenic tubules is elevated by 511T in a dose 
dependent manner 
Tubules were incubated with 5HT and the phosphodiesterase inl-dbitor IBMX (10-4 M) for 10 
minutes. Control samples were prepared in the absence of 5HT. 
A: Tubules from progeny of a cross with the principal cell-specificCAIA driver line c42 and a 
UAS: 5HT7Dr. line, n>-5. 
B: Tubules from progeny of a cross with the stellate cell-specificGAL4 driver line c724 and a 
UAS: 5HT7Dr. line, n=6. 
C: Tubules from progeny of a cross with the stellate cell-specificGAL4 driver line 010 and a 
UAS: 5HT7Dr. line, n>-4. 
Results are expressed as mean cAMP content (fmol/tubule) ± SEM. cAMP content significantly 
different from basal cAMP content is denoted by *. (P<0.05, determined with Student's kest on 
unpaired samples, assun-dng unequal variances). 
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4.3.5 W-butaclarnol inhibits 5HT-induced fluid secretion and cAMP 
production in 5HT7,,,,, transgenic tubules. 
The addition of the competitive inhibitor (+)-butaclamol to heat-shocked 
hs:: 5HT7D,,. transgenic tubules was shown to attenuate the 5HT-induced rise in 
fluid secretion (Figure 4.7A). The production of cAMP in tubules co-presented 
with (+)-butaclamol (at various concentrations) and 1 pM 5HT was assayed 
using tubules from the progeny of a cross between UAS:: 5HT7D,,. flies and the 
principal cell specific GAL4 enhancer trap line c42. There was a dose dependent 
attenuation of cAMP production in these samples, with 2.5 x 10-8 M (± 1x VT8 
M) (+)-butaclamol required to achieve half-maximal inhibition of serotonin 
activity (Fig 4.713). Interestingly, 5HT-induced cAMP production, in tubules 
treated with 10-' M (+)-butaclamol, was attenuated by 75% of control 5HT- 
stimulated transgenic 5HT7Dro tubule cAMP content. This was consistent with 
fluid secretion data, whereby tubules, treated with 1V M (+)-butaclamol, 
showed 5HT-induced elevated fluid secrtion rates that were approximately 25% 


















Figure 4.7: (+)-Butaclamol inhibits SHT-induced fluid secretion and cAMP elevation in 
SHT7D.. transgenic tubules 
A: Heat-shocked hs:: 5HT7Dr. tubules challenged with 1 gM 5HT at 30 min showed elevated 
fluid secretion rates (13) Tubules treated with the 5HT antagonist (+)-butaclamol (10-5 M) at 
t=O showed an attenuated response to 5HT (*). Results shown are mean secretion rate 
(nl/min) ± SEM, n=10. 
Secretion rates significantly different from control, 5HT-treated, rates (13) are denoted by 
(P<0.05, determined with the Student's Mest, on unpaired samples, assuming unequal 
variances). 
B: Tubules from progeny of a cross with c42 (principal cell GAU driver line) and UAS-- 
5HT7DrO were treated with 1pM 5HT, the phosphodiesterase inl-dbitor IBMX (10-4 M) and 
varying concentrations of the 5HT7DO antagonist (+)-butaclamol for 10 minutes. A control 
sample untreated with (+)-butaclamol Tubules were then prepared as described in Materials 
and Methods. Results are expressed as percentages of cAMP content in 51IT-stimulated 
tubules unchallenged with (+)-butaclamol ± SEM, n=3. cAMP content significantly different 
from maximal cAMP content is denoted by *- (P<0.05, determined with Student's Mest on 
unpaired samples, assun-dng unequal variances). 
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4.3.6 Generation of a UAS:: 5HT7Dr. / GFP fusion construct. 
A commercial antibody to the 5HT7Dr,, receptor was not available to study 
localisation of the receptor in tubules, so a fusion construct allowing detection 
of the receptor with green fluorescent protein was made. The 5HT7D,. gene and 
GFP open reading frame were amplified from plasmids using a combination of 
Taq and Pwo polymerases (Figure 4.8 A and B). These PCR fragments were 
amplified with primers which introduced novel restriction sites at the 5' end of 
5HT7Dr. and 3'end of GFP and primers with overlapping sequence (10 bases) at 
the 3' end of 5HT7D,,. and 5' end of GFP. The PCR fragments were then gel 
purified, mixed together and fused in a PCR reaction that did not have 
additional primers. The outcome of this PCR reaction was one product 
consisting of the 5HT7Dr. gene with GFP tagged on to the 3' end (Figure 4.8 Q. 
The PCR fragment was then subcloned into pUAST and sequenced to verify 
successful tagging. The protein product would have GFP fused to the C- 
terminal end of 5HT7D, which would not affect ligand binding or G-protein 
interaction. Due to time constraints this construct was not used to germline 
transform flies, but remains a plausible alternative to antibody generation to 
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G FP by PCR Figure 4.8: Fusion of 5FIT. 
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5' IT7DrO and GFP were amplified from plasmids with primer,; which introtillced lim (, I 
restriction sites at the 5'end of 5HT7,,,, and 3' end of GFP and had bv I() 
bases at the 3' end of 5HT7D,. and 5' end of GFP (A and B) (Appendi\ 1). These RN products 
were gel purified, mixed together and fused bv PCR amplification ill tjl(ý jbs(ýllctý (q I)rilljtýrs, 
%vith the minimum number of PCR cycles. Five, tell mcl twVlltV (Ncle reactions wert, carrivd 
out (C: laries 2,3 and 4 respectively). Tile resultiiig PCR product thus has tlitý (j-p ()pt'll 
reading frame fUsed to the C-terminal of 51177P, (C). The PCR prodLlCt from ljlj(ý %v, jS 
then cloned into pUAST to allow for conditional expression in Drosopliihi. 
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4.3.7 Immunocytochemical localisation of cAMP. 
The localisation of cAMP generated in 5HT7Dr,, transgenic tubules was detected 
by immunocytochernistry using antiserum to 2'-O-succinyl cyclic AMP 
conjugated to BSA raised in rabbit (Figure 4.9 and Figure 4.10). Tubules from 
progeny of crosses with UAS:: 5HT7D, and GAL4 lines were treated with IBMX 
(10' M) alone or with 1 gM 5HT and IBMX (10' M) for ten min before being 
fixed with 4% paraformaldehyde. Tubules treated with IBMX alone displayed 
very low background levels of fluorescence with the fluorescein-conjugated 
anti-rabbit secondary antibody (data not shown). Tubules treated with 5HT and 
IBMX showed high levels of fluorescence in a cell-specific manner. 
In c42/UAS:: 5HT7Dr. tubules, cAMP appeared to be localised throughout the 
principal cells of the main segment (Figure 4.9), but appeared to have strongest 
localisation in pools at the basolateral membrane and nuclei (Figure 4.9). 
Stellate cell-specific generation of cAMP was achieved by stimulating 
c724/UAS:: 5HT7Dro tubules with 5HT and IBMX (Figure 4.10). Cyclic AMP 
localised mainly to these cells, and similar to the c42/UAS:: 5HT7D,,, tubules, 
there appeared to be particularly intense perinuclear fluorescence. 
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Figure 4.9: Anti-cAMP inimunocytochemical analysis reveals cell-specific generation of 
cAMPin c42/UAS:: 5HT7, )ro transgenic tubules in responseto 511T 
Tubules from c42/UAS: 5llT7P, o 
"lles were treated with the phosphodicý(er, iw inhibitol 
IBMX (I(y4M ) and I pM 51 IT for 10 111iJILIk'S before being fixed, as described in Mmerialsand 
Methods. TubUles were incubated with rabbit anti-cAMP antisermn and then with 
flUoresceill-COlIjUgated anti-rabbit second antibody before heing vie%ved mider LA' light. A: 
Cyclic AMP production is confined to prillCil), 11 Cells ill the 111aill St'gIlIVIlt 0I tlll)11101ý (tol) 
half) (100 x magnification). B: Cvclic AMP production fornis pools at the hasolateral 
membrane of principal cells LILIt is 110t CICVItLd in stellate cells Girrow) (200 x magnification). 
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Figure 4.10: Anti-cAMP ininiuriocytochenlical analysis tell-Spetillk gent-latioll ()f 
cAMP in c724/UAS:: 5HT7,,, (, 
transgenic tubules in response to 511 F 
Tubules from c724/UAS:: 5HT7])r,, lines were treated with the phosphodiesterose inhibitor 
IBMX (ja4 M) and 1 4M 5HT for ten minutes before heing fixed, as described in Materials and 
Methods. Tubules were incubated with rabbit anti-cAMP antiscrum and then with 
fluorescein-conjugated anti-rabbit second antillociv before being viewed under UV light. A: 
Cyclic AMP production is confined to stellate CVIIS Of tUbUICS (200 x magnification). 13: 400 x 
magnification of the main segment. Stellate cells have elevated cAMP content aItvr incubation 
with 5HT, which appears throughout die cell. 
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4.3.8 Cyclic GMP levels in SHT7Dro transgenic tubules 
The possibility that intracellular cGMP levels may be altered upon activation of 
5HTMrowas investigated by assaying levels both with and without 5HT 
stimulation in samples from 5HT7Dr,, expressing tubules and from a wild type 
control (Figure 4.11). All samples contained approximately the same basal 
levels of intracellular cGMP, and there was no significant change in these levels 
upon 5HT-induced 5HT7Dr(, activation. This demonstrates that cAMP is the 
specific downstream effector of 5HT7Dw and that the effects on cell function do 
not include generation or inhibition of synthesis of cGMP. 
4.3.9 [Ca"Ji in 5HT-stimulated 5HT7D,, transgenic tubules 
Intracellular Ca" levels were assayed in tubules from progeny of a cross 
between male UAS:: 5HT7D,,, flies and female UAS:: apoaequorin; +/+; c42 flies for 
principal cell-specific measurements and a cross between male UAS:: 5HT7Dro 
flies and female UAS:: apoaequorin; +/+; c7lO flies for stellate cell-specific 
measurements. Tubules responded to 5HT with a rapid elevation of [Ca'*Ii in 
principal cells followed by a sustained secondary response (Figure 4.12A). 
Cross-talk is therefore taking place between cAMP or a cAMP-dependent 
effector and mechanisms dependent on Ca"' in principal cells. 
There was no change in [Ca"]i in stellate cells, suggesting that no cross-talk 
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Figure 4.11 : 5HT7D.. transgenic tubules do not have significantly altered cGMP levels in 
response to 5HT 
Tubules were treated with 5HT (I ILM) and Zaprinast (I tLM) for 10 min and prepared as in 
Materials and Methods. Results are expressed as mean cGMP content (fmol/lubule) ± SEM, 
n=3. Differences between samples 5HT-treated samples and control samples are not significant 
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Figure 4.12: 5HT-induced [Ca2+1i rises in tubules expressing 5HT7DW representative traces 
Typical traces of changes in [Ca2+]i in tubule cells expressing SHT7D... when stimulated with 
WO-8 M 5HT (large arrows). 
A: Ca2+ response ba 5HT in principal cells of aeq, +/+; c42 CAL4/51IT7n,, tubules. 
B: Ca2+ response to 5HT in stellate cells of aeq, +/+; 010 GAL4/51ff, tubules. 7Dro 
The peaks prior to the main rises in [Ca2+]i are caused by control ("mock") injections of 
Schneider's medium (small arrows). 
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4.3.10 Cell-specific phosphodiesterase activity in 5HT7D,. transgenic flies 
Tubules expressing 5HTm,, in a cell-specific manner were treated with 5HT for 
10 min, then transferred to PDE buffer. Tubules expressing 5HTM, in principal 
cells showed an approximate twofold increase in cAMP-hydrolysing 
phosphodiesterase activity, suggesting that the signal achieved by a large rise in 
cAMP in these cells is quickly dampened by elevation of phosphodiesterase 
activity. Tubules expressing 5HT7Dro in stellate cells also showed increased 
cAMP-hydrolysing phophodiesterase activity upon stimulation with 5HT 
(Figure 4.13A). Activity of cGMP-hydrolysing phosphodiesterases in samples, 
both stimulated and untreated with 5HT, was also measured (4.13B). There 
appeared to be increased cGMP-hydrolysing phosphodiesterase activity in 
5HT-stimulated samples, which suggests that there was an element of cross-talk 
between phosphodiesterases to achieve this up-regulation, or that a single 
cAMP-regulated phosphodiesterase has dual substrate specificity. Interestingly, 
in the previous chapter it was shown that upregulation of cGMP-hydrolysing 
phosphodiesterase activity in GC-A transgenic tubules by ANP was concurrent 
with a decrease in cAMP-hydrolysing phosphodiesterase activity (Figure 








........ ... ........ ........ ........ ......... ........ ........ ........ ..... ........ ........ ........ ......... ........ ........ 




Fig 4.13: Phosphodiesterase activity is altered in SHT70,. transgenic flies in response to. qHT 
Tubules from the progeny of crosses with CAL4 enhancer trap lines and UAS:: 5HT71D-n, lines 
were treated with I IAM 5HT for 10 minutes. Phosphodiesterase activity was assayed as 
described in Materials and Methods. 
A: Samples were assayed for cAMP-dependent phosphodiesterase activity. 
B: Samples were assayed for cGMP-dependent phosphodiesterase activity. 
Results are expressed as mean phosphodiesterase activity (nmol/min/lLg) :t SEM, n 3. PDE 
activity significantly different from basal PDE activity is denoted by *. (1'<0.05, determined 
















4.3.11 Expression of G protein subunits in Malpighian tubules 
The 5HT-induced elevation of [cAMP]j in tubules expressing 5HT7D,. implies 
that this G protein-coupled receptor activates aG protein to stimulate adenylate 
cyclase. However, as adenylate cyclase activity was not measured directly, due 
to time constraints, an RT-PCR strategy was adopted to determine which of the 
G protein subunits were expressed in tubules. Confirmation of the expression of 
a Goc, subunit establishes the possibility that adenylate cyclase activity could be 
modulated by this receptor (Figure 4.14A). Interestingly, all the Gcc subunit 
genes found in Drosophila are expressed in tubules, including G%, the Got 
subunit that acts to inhibit adenylate cyclase and GCCq, the subunit that acts to 
stimulate PLC. In fact, although RT-PCR was not carried out for all the splice 
variants of G protein subunits, G076C is the only subunit which does not 
appear to be expressed in tubules (Figure 4.14B). Figure 4.14C illustrates that 
both the Gy subunit genes are expressed. 
160 
Gu 
Lane: Ii11,11 1 () 
Gp c Gy 
Lane: 12345t, 1"Ine: 1 
I- igure 4.14: The expression of G protein subunits in Malpighian tubules 
Reverse transcriptase polymerase chain reaction (RT-PCR) using wild-tvpv tubult, template 
cDNA with intron-flanking primers directed against each Drosophila G protein mbunit. 
A: G protein alpha (G(, ) subunits. 
Lane 1: 1 kb ladder (Gibco BRL). Lane 2: Gct, 60A, product of expected 357 ilp. Lane 
product of expected 554 bp. Lane 4: G(t73B, product of expected 326 lip. Lane 5: GuM, product 
of expected 409 bp. Lane 6: Got (cta), prodLICt of expected 384 bp. Lane 7: Gu,, 47A, product of 
expected 705 bp. Lane 8: GuCG17760, product of expected 104 lip. Lane 9: 1 kb ladder (Gibco 
BRL). Lane 10: G(t49B, product of expected 575 bp. 
B: G protein beta (GO)SUbUnits. 
Lane 1: 1 kb ladder (Gibco BRL). Lane 2: G(16013, prodLICt of expected 277 hp. Lane 3: GjiSF, 
prodLICt of expected 303 bp. Lane 4: GP76C, no product of expected size (233 bp). Lane :;: GIN', 
prodLICt of expected 407 bp. Lane 6: G(313F, product of expected 513 bp. 
C: G protein garnma (Gy) SLIbUnitS. 
Lane 1: 1 kb ladder (Gibco BRL). Lane 2: GyI, prodLICt of expected 252 hp. Lane 3: Gy3OA, 
PrOCILICt of expected 295 bp. 
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4.3.12 [Ca"Ji in cAMP-stimulated 5HT7D,., transgenic tubules 
There is the possibilty that the 5HT7D,,, receptor pron-dscuously associates with a 
G protein from the Gccq family, to influence [Ca"]i in 5HT-stimulated tubules. 
Therefore, [Ca"]i levels in cAMP-stimulated tubules were assayed, to determine 
if cAMP could directly influence Ca"' signalling. 
Intracellular Ca"' levels were assayed in cAMP-stimulated tubules from 
UAS:: apoaequorin; +/+; c42 GAL4 flies, for principal cell-specific measurements 
and UAS:: apoaequorin; +/+; c7lO GAL4 flies, for stellate cell-specific 
measurements. A slow elevation in [Ca"Ji was seen in principal cells, similar to 
that seen in cGMP-stimulated tubules, but no change in stellate cell [Ca'*], 
occurred (Figure 4.15). As stellate cells are known to express GcCq subunit(s) 
(determined by the action of the leucokinin G protein-coupled receptor via G(Xq 
on Ca" signalling (Terhzaz et al, 1999; Radford et al, 2002)), it is likely that the 
5HT-induced Ca"' signal generated in principal cells of c42/5HT7Dro tubules is 
downstream of elevated cAMP, rather than direct Ca' stimulation by Gaq. This 
does not confirm that the 5HT7Dr,, receptor only associates with its cognate Gcc 
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Figure 4.15: cAMP-induced [Ca2+1j rises in tubules expressing SHT7D,. - representative 
traces 
Typical traces of changes in [Ca2+], in tubule cells expressing 5HT7Dr. when stiMulated with 
JXJO-4 M cAMP (large arrows). 
A: Ca2+ response to cAMP in principal cells of c42-aeq tubules. 
B: Ca2+ response to cAMP in stellate cells of c7lO-aeq tubules. 
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4.3.13 5HT-induced elevation of cAMP in heat-shocked hS:: SHT7D. brains. 
Flies with a P-element insertion containing 5HT7D,,, can be used to study cAMP 
signalling in any tissue or cell type throughout the organism. This can be 
achieved either by heat-shocking hs:: 5HT7Drc) flies, resulting in ubiquitous 
expression of the gene, or by crossing UAS:: 5HT7Dr. flies with any of the range 
of GAL4 lines that are available for targetted expression: introduction of 5HT to 
the fly, or a particular tissue, will stimulate the receptor to elevate intracellular 
cAMP levels. However, unlike ectopic expression of GC-A in flies, 
overexpression of 5HT7Dr,, may perturb signalling in tissues that are normally 
affected by serotonin. 
Brains (including optic lobes) were assayed for cAMP content with and without 
1 gM 5HT, as in other assays, from heat-shocked and non heat-shocked 
hs:: 5HT7Droflies. A small rise in cAMP content was observed in brains from 
heat-shocked flies, which suggests that 5HT7Dr. had been stimulated by 
endogenous 5HT. However, the elevation of cAMP could be greatly potentiated 













Figure 4.16: Cyclic AMP in Drosophila brain is elevated by expression of SHT7D,,, and is 
potentiated by treatment with 5HT 
Brains were dissected from pPjCaSpeRhs:: 5HT7Dj flies (five per sample), heat-shocked and non 
heat-shocked. Brains were treated with the phosphodiesterase inhibitor JBMX (10-4 M) , IýLM 
5HT. Results are expressed as mean cAMP content (fmol/brain) :t SEM, ný3. cAMP content 
significantly different from basal cAMP content is denoted by *. (P<0.05, determined with 
Student's t-test on unpaired samples, assuming unequal variances). 
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4.4 Discussion 
A 1.7 kb 5HT7D,,, open reading frame was subcloned into the P-element vectors 
pPjCaSpeRhs/actj and pPJUASTJ to allow temporal and spatial control of 
expression of the gene, respectively. Transcription of the gene was detected in 
tubules by reverse transcriptase PCR. Using an antibody to cAMP, production 
of the second messenger was detected immunocytochernically in transgenic 
tubules that were challenged with 5HT, whereas background levels were very 
low. In both principal cells and stellate cells, cAMP appeared in pools at the 
basolateral membrane and at the nuclear membrane, suggesting 
compartmentalisation of the signal. The production of cAMP was shown by 
radioirnmunoassay to be dependent on the concentration of 5HT used, with a 
mean EC50 of 2xlO-'M, and production could be attenuated by the 5HT receptor 
antagonist (+)-butaclamol with a mean IC50 of 2.5 x 10' M, consistent with 
previously published data (Witz et al, 1990; Obosi et al, 1996). Principal and 
stellate cells of the Malpighian tubules were both capable of producing cAMP at 
physiological ranges of 5HT. 5HT acted to elevate fluid secretion rate either 
when 5HT7Dr. was expressed throughout tubules, or in a cell specific manner. 
The maximal rates of 5HT-induced fluid secretion observed with 
c42/UAS:: 5HT7D,, o and c71O/ or c724/UAS:: 
5HT7])ro tubules appear to be 
additive, as the sum of these rates is approximately equal to the maximal 5HT- 
induced rate observed in heat-shocked hs:: 5HT7Drc) tubules. The specificity of 
cAMP as a downstream effector of 5HT7D,. activation was determined by 
measuring intracellular cGMP levels in 5HT-stimulated tubules. No significant 
changes in intracellular cGMP levels between stimulated and unstimulated 
samples were observed, suggesting that 5HT7Dr. acts to specifically generate 
cAMP. These data show that both principal and stellate cells are capable of 
generating intracellular cAMP and that this leads to elevated fluid secretion 
rates. This is the first demonstration that Malpighian tubules of Drosophila can 
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produce cAMP in response to an extracellular ligand, and furthermore, both 
cell types of the main segment can do so, with physiological consequence. 
[Ca"Ji levels were assayed in tubules expressing 5HT7D,,, cell-specifically. 
Stimulation of tubules expressing 5HT7Dr,, in principal cells with 5HT resulted in 
a biphasic elevation of [Ca"ji, whereas there was no change in tubules 
expressing 5HT7D,,, in stellate cells. This implies that the 5HT7Droreceptor does 
not directly stimulate Ca" release into the cytosol via activation of PLC, as if 
this was the mechanism of elevation of [Ca"ji, it would be seen in both cell 
types- the lack of a calcium signal in stellate cells is not due to absence of PLC 
in stellate cells: the receptor for Drosokinin is aG protein-coupled receptor 
which causes a large PLC-induced rise in [Ca'*], in stellate cells when tubules 
are stimulated with the neuropeptide leucokinin (Rosay et al, 1997, Radford et 
al, 2002; Pollock et al, subn-dtted 2002). The elevation observed in principal cells 
could either be due to downstream cross-talk, which does not take place in 
stellate cells, or that principal cells contain cyclic nucleotide gated channels that 
are not present in stellate cells. 
Activity of cAMP-regulated phosphodiesterase(s) in 5HT7, ),. transgenic tubules 
was assayed, both in the presence and absence of 5HT and modulation of 
cAMP-regulated phosphodiesterase activity confirms a role for PDEs in control 
of fluid secretion. Upregulation of cAMP-dependent phosphodiesterase activity 
in 5HT7, ),,, transgenic tubules led to concurrent increases in cAMP- and cGMP- 
hydrolysing phosphdiesterase activity (Figure 4.14A and B), but no significant 
alterations in intracellular cGMP levels were observed in 5HT-stimulated 
tubules (Figure 4.11). The fact that elevation of cGMP-hydrolysing activity is 
observed, yet cGMP levels remain unperturbed perhaps suggests that the 
phosphodiesterase responsible has dual substrate specificity for cAMP and 
cGMP, but either has a higher specificity for cAMP, or cAMP is preferentially 
hydrolysed simply because it is far more abundant than cGMP. The activation 
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of a separate cGMP-hydrolysing phosphodiesterase is, however, also plausible 
and could be a result of either cross-activation by cAMP, or by cross-talk further 
downstream of the cAMP-mediated pathway. A model for the proposed 
signalling events in 5HT7,,,, transgenic tubules is surnmarised in Figure 4.17. 
RT-PCR analysis revealed the presence of transcripts for all DrosopIlila G protein 
subunits with the exception of G076C, which strengthens the probabilty that 
elevated cAMP is achieved through activation of adenylate cyclase by Gee, A 
Go: j subunit was also detected, which implies that there are endogenous 
basolateral membrane receptors that elicit physiological responses through 
modulation of adenylate cyclase(s). 
Finally, the use of 5HT7D,, as a generic tool for manipulating cAMP in any tissue 
of Drosophila was illustrated by assaying [cAMP]i in brains taken from 
hs:: 5HT7D,. flies, both heat-shocked and non heat-shocked in the presence and 
absence of 5HT. The potentiated elevation of [cAMP]j in brains stimulated with 
5HT demonstrates that this work could be extended to studying the effects on 
learning and memory and circadian rhythms; an exciting prospect, as cAMP is 
already known to have an important role in learning and memory on the basis 
of learning deficits seen in flies with mutations in genes in the cAMP-signalling 
cascade (dunce and rutabaga) (Dudai et al, 1976; Livingstone et al, 1984; Chen et 
al, 1986; Levin et al, 1992). While some brain cells clearly already express 
endogenous 5HT7DrO/ the large elevation of intracellular cAMP content in 
hs:: 5HT7D, o brains, in response to 
5HT (Figure 4.16), suggests that most neurons 
are only responsive in transgenic flies, and so a specific GAL4 driver directing 
5HT7ý, O to particular cell types may 
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Figure 4.17: A model for cell-specific action of cAMP in Malpighian tubules 
A: 5HT-induced cell-specific generation of cAMP in principal cells elevates fluid secretion via cAMP- 
dependent kinase (cAK), and elevation of [Ca 2+1,, to stimulate V-ATPase activity. 
B: 51-ff-induced cell-specific generation of cAMP in stellate cells elevates fluid secretion via cAMP- 
dependent kinase (cAK), to increase chloride conductance. 









Transgenic flies containing the Drosophila serotonin receptor gene 5HTIADro 
under UAS control were a gift from Fr6d6ric Saudou, University L. Pasteur de 
Strasbourg. This receptor has previously been shown to both increase inositol 
phosphate production and inhibit forskolin-stimulated elevation of cAMP in 
mammalian cell culture. Expression of 5HTIADroin Malpighian tubules confers 
sensitivity to 5HT in a dose-dependent manner with an EC50 of approximately 5 
x 10-'M, determined by fluid secretion assay. However, in the presence of the 
5HTIAD,,, antagonist, yohimbine, elevation of fluid secretion is attenuated, but 
not completely inhibited. 
The activation of 5HTIADirowith 5HT was shown to elevate [Ca'*Ii in both 
principal and stellate cells of tubules by aequorin bioluminesence assay. 
However, the different cell types had different profiles of calcium response, 
indicating that the cells were responding in a different manner from one 
another. Interestingly, these calcium responses did not appear to influence 
intracellular levels of the second messengers cAMP and cGMP. 
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5.2 Introduction 
Many cellular functions are controlled by modulation of the intracellular free 
Ca 2+ concentration ([Ca 2+]1), including gene expression, contraction, metabolism 
and secretion. Regulation of numerous functions within the same cell requires 
that both Ca 2+ delivery can span the whole cell and that intracellular 
concentrations of Ca 2+ are tightly controlled. Modulation of [Ca 2+1i cannot 
generally be controlled simply by the influx of Ca` because of its low 
diffusibility in the cytoplasm. Therefore, the endoplasmic reticulurn (ER) acts as 
a Ca 2+ store to deliver Ca 2+ in such a way as to allow compartmentalisation and 
site-specific delivery without compromising cell homeostasis. In fact, high 
[Ca 2+]i over prolonged periods of time can be damaging to cells, and because of 
this cytotoxicity [Ca 2+1i in resting cells is normally held between 20-100 nM. A 
Ca 2+-ATPase continually pumps Ca 2+ from the cytoplasm back into the ER to 
maintain this low intracellular concentration (Berridge, 1997). 
As described earlier, Ca2+ has distinct roles in specific cell types of Drosophila 
Malpighian tubules. Members of the leucokinin fan-dly of neuropeptides elevate 
fluid secretion through stimulation of aG protein-coupled receptor, that acts to 
raise [Ca 2+]i in stellate cells (O'Donnell et al, 1996; Rosay et al, 1997; Radford et al, 
2002). This action has been shown to raise chloride shunt conductance, which 
can be blocked with the calcium chelator BAPTA-AM (O'Donnell et al, 1996). 
Current density hot spots, coincident with stellate cells, were revealed with self- 
referencing probe analysis. These hot spots could be abolished with chloride 
channel blockers or low-chloride saline, suggesting that chloride conductance is 
confined to stellate cells (O'Donnell et al, 1997). Recently, the receptor for 
Drosokinin, named DLKR, has been localised to stellate cells of Malpighian 
tubules, which further supports the model for a stellate cell-specific Ca" signal, 
that elevates stellate cell-specific chloride conductance (Radford et 41,2002). A 
principal cell-specific Ca` signal is also necessary for CAP2b/capa-induced 
172 
elevation of fluid secretion (Rosay et al, 1997, Kean et al, 2002). This Ca` signal 
is necessary to activate a Ca'-dependent NOS, which stimulates production of 
NO. This, in turn, stimulates a soluble guanylate cyclase to produce cGMP, with 
elevation of fluid secretion being the end result (Dow et al, 1994a; Davies et al, 
1995; Davies et al, 1997). However, elevated [cGMP]i has been shown to induce 
a [Ca 2+ Ji rise in principal cells through a process dependent on Ca 2'entry, and 
can be blocked with calcium channel antagonists (MacPherson et al, 2001). The 
action of cyclic nucleotides in principal cells involves stimulation of an apical V- 
ATPase, which drives a proton/alkali metal ion exchanger (antiporter), 
determined by the increase in lumen electropositive potential in response 
cAMP or cGMP (O'Donnell et al, 1997). It has been demonstrated in the 
previous chapters that elevation of cyclic nucleotides induce Ca 2, signals in 
principal cells, but not in stellate cells. This implicates Ca 2* as an important 
modulator of principal cell function, which is distinguishable from its role in 
stellate cells. It is therefore desirable to manipulate Ca` in a cell-specific 
manner, using the same technique deployed to manipulate cGMP and cAMP in 
the previous chapters. Using a receptor that is known to stimulate [Ca 2*]i in 
other systems, it would be possible to elevate Ca*, not just in principal and 
stellate cells of the main segment, but also in regions of the tubule (such as the 
initial segment) that are involved in Ca" transport. 
Transgenic flies containing the Drosophila serotonin receptor gene SHTIAD'o 
under UAS control were a gift from Fr6d6ric Saudou, University of Strasbourg. 
This is aG protein-coupled receptor that has been shown to elevate intracellular 
InsP3 in response to 5HT (Saudou et al, 1992). Expression of this transgene 
under UAS control allows both study the pharmacology of this receptor in vivo 
to be studied and the Ca" signal transduction pathway to be isolated. This 
enables cross-talk with the other second messenger pathways discussed 
previously to be examined. As in the previous chapter, serotonin, the ligand for 
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this receptor, does not normally elicit a response in isolated Malpighian tubules, 
making this receptor a good choice as a modulator of [Ca'*],. 
The 5HTIADr,, receptor was cloned by Saudou et al (1992) and designated 5HT- 
dro2A. Heterologous expression studies of this receptor in mammalian cells 
demonstrated that PLC was activated with concurrent inhibition of adenylate 
cyclase when stimulated with 5HT (Saudou et al, 1992). The 5HT-dro2A 
receptor induced a decrease in the levels of cAMP stimulated by forskolin and 
induced a 1-5- to 2-fold increase in the level of inositol phosphates in response 
to 5HT (Table 1.2). Furthermore, pertussis toxin partially blocked the effect of 
this receptor, indicating that the receptor interacts with a pertussis toxin- 
sensitive G protein. This evidence suggests that Ca' plays a key role in the 
signal transduction of this receptor, and targetted expression of this receptor is 
therefore potentially useful for targetted manipulation of Ca'. As with 5HT7Dr4), 
discussed in the previous chapter, this receptor requires its cognate G protein 
subunits to be expressed in the particular cell to which it is targetted. There is 
good evidence that this is the case: both the receptors for CAP2b and for 
Drosokinin are GPCRs that modulate [Ca 2+ 1j, and there is only one G. gene in 
the Drosophia genome, which has been shown to be expressed in tubules by RT- 
PCR (Figure 4.14). 
It is now apparent, that of mammalian 5HT receptors, 5HT-dro2A shares 
greatest similarity and transduction properties with the human 5HTIAreceptor 
and is regarded as an invertebrate 5HTI-like receptor (Gerhardt et al, 1996). It 
has therefore been renamed 5HTIAD") (and similarly 5HT-dro2B, also cloned by 
Saudou et al, renamed 5HTIBD. ) in an attempt to standardize nomenclature of 
this large family of receptors (Colas et A 1997, Tierney 2001; Table 1.1). 
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5.3 Results 
5.3.1 Targetted expression of SHTIADro in tubules confers 5HT-induced 
elevation of fluid transport. 
Progeny of a cross between the strain pPjUAS:: 5HT1ADroj and GAL4 line c42 
(referred to as c42/UAS:: 5HTIADro)would be expected to express 5HT1ADr" in 
principal cells of the main segment of tubules. Similarly, progeny of a cross 
between the strain pPjUAS:: 5HT1ADrOj and GAL4 lines 024 or 010 (referred to 
as c724/UAS:: 5HTIADro and c7lO/UAS:: 5HTIAD,,, respectively) could be expected 
to express 5HTIAD., in stellate cells of tubules. Tubules were dissected for fluid 
secretion assays and fluid secretion rate was measured for 30 rrdn before 5HT 
was added to the bathing solution. The fluid secretion rate was measured for a 
further 30 min. Calculations of fluid secretion rate were made as described in 
Chapter 3. All tubules expressing 5HTIADr, ) 
displayed sensitivity to serotonin 
(5HT) in a dose-dependent manner. Figure 5.1A shows the dose response of 
c42/UAS:: 5HTIAD., tubules to 5HT, expressed as a percentage rise above basal 
secretion rate. Peak rates of fluid secretion were observed at 10 AM 5HT and 
half-maximal stimulation was achieved between 10'M and 10-'M, consistent 
with the EC50 (2xlO-'M) for the action of this receptor to decrease forskolin- 
stimulated cAMP production in mammalian cells (Saudou et al, 1992). A dose 
response curve was similarly generated using c724/UAS:: 5HT1ADrci tubules 
(Figure 5.113). As with expression of this receptor in principal cells, maximal 
elevation of fluid secretion was achieved with 1-100 AM 5HT and half-maximal 
elevation of fluid secretion was achieved with between 10-'M and l(T 7M 5HT. 
In all tubules expressing the 5HTIADr, receptor, there was a significant elevation 
of fluid secretion rate above basal with concentration of 5HT as low as 10-'M, 
which was sustained beyond 30 min post-stimulation. These results indicate 
that the receptor behaves as expected from previous work in cell lines (Saudou 
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Figure 5.1: Fluid secretion is elevated by SHT in GAL4/UAS.: SIITIAD. tubules in a dose 
dependent manner 
Tubules from GAL4/UAS:: 5HTIADro were challenged with 511T at 30 min. 
A: c42/UAS.. -5HTIADro tubules challenged with 51-IT showed elevated fluid secretion rates over 
basal controls. Results are expressed as a percentage change from basal secretion rates ± SEM, 
n=10. 
B: c724/UAS:: 5HTIADro tubules challenged with 511T showed elevated fluid secretion rates over 
basal controls. Results are expressed as a percentage change from basal secretion rates ± SEM, 
n=10. 
Secretion rates significantly different from basal are denoted by *. (P<0.05, determined with the 
Student's Mest, on unpaired samples, assun-dng unequal variances). 
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5.3.2 Yohimbine inhibits 5HT-induced elevation of fluid secretion in SHTIAD. 
tubules 
Yohimbine is known to be a selective inhibitor of 5HT receptors (see Table 1.2), 
with a K, of 18 gM for the 5HTIADrO receptor (Saudou et al, 1992). Therefore, if the 
transgenic receptor is acting physiologically in Malpighian tubules, the action 
of 5HT should be inhibited by yohimbine. 
Figure 5.2A shows a typical fluid secretion assay on c42/UAS:: 5HTIADrc) flies, 
The response to 5HT can be attenuated when tubules are pretreated with 10 
fold excess of the 5HTIADr(, antagonist yohimbine. 
Figure 5.2B shows a typical fluid secretion assay on c724/UAS:: 5HTIADr(, flies. 
Sin-dlarly, the response to 5HT can be attenuated when tubules are pretreated 
with 10 fold excess of the 5HTIAantagonist yohimbine. 
5.3.3 5HT-stimulated tubules expressing the 511TIAM., transgene elevate 
intracellular Ca" levels. 
As activation of 5HTIADroin mammalian cell culture has been shown to increase 
inositol phosphate production, it would therefore be expected that this would 
result in Ca" release from internal stores, through InsP3 receptors. Flies with 
5HT1ADrounder control of UAS were crossed with flies expressing both GAL4 
and aequorin cell-specifically (c42; aeq and c7lO; aeq) to detern-dne the effect of 
receptor activation on Ca"' release. Indeed, 5HT-stimulated tubules expressing 
5HTIADro in principal cells responded with a sharp initial rise in [Ca'*Ii which 
only lasted approximately 20-30 s (peaking at 160 nM), followed by a smaller, 
more sustained rise, lasting 1-2 min (peaking at 110 nM). However, the [Cal*], 
did not return to basal levels for 10-15 min post-stimulation (Figure 5.3A) This 
response does not mirror that of the CAP20nduced Ca 2* rise, which has been 
shown to involve a principal cell-specific rise in [Ca2*], response (Rosay et al, 
1997; Kean et al, 2002; MacPherson et al, submitted 2002). The amplitude of the 
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initial Ca" peak in c42/UAS:: 5HTlADro tubules is lower than that of tubules 
stimulated with CAP2b. Furthermore, the secondary rise in c42/UAS:: 5HTIADro 
tubules has a different profile: almost 1 min elapses before the rise begins, 
which, again is lower in amplitude than that of the CAP2b-induced secondary 
response. The Ca 2' response seen in c7lO/UAS:: 5HTlAl*, tubules to 5HT (Figure 
5.3B) is also somewhat different from Ca 2+ traces observed in tubules stimulated 
with the endogenous neuropeptide, Drosokinin. The calcium signal generated 
from stimulation with Drosokinin has been shown to be stellate-cell specific 
(Rosay et al, 1997; Terhzaz et al, 1999; Radford et al, 2002) and aG protein- 
coupled receptor has been identified as its receptor (Radford et al, 2002). The 
response to Drosokinin is seen as a large initial rise in [Ca 2+ Ji, followed by an 
immediate secondary rise, resembling two peaks within the space of 
approximately 20 s. However, when tubules express the 5HTIAD,,, in stellate 
cells, the calcium response to 5HT is seen as an initial rise in [Ca'+], which peaks 
at 120 nM and lasts approximately 40-50 s, before a smaller secondary rise in 
[Ca 2+]i lasting for more than 5 min (Figure 5.313). A prolonged secondary rise in 
stellate cell [Ca 2+ji has not previously been described, suggesting that the 
calcium signal generated by activation of this receptor is not the same as the 
signal generated by the leucokinin receptor. 
Interestingly, when the 5HTIAD,, receptor was expressed ubiquitously 
throughout tubules by heat-shock (from a cross between UAS:: 5HTIAD. C, and 
aeq; hsGAL4 flies), the initial calcium peak reaches 350 nM, which is 
substantially more than the sum of the c42/5HTIAD,,,, and c7lO/5HTIADrc, initial 
peaks. (Figure 5.4) The initial rise is of approximately the same duration as the 
c7lO/5HTIADropeak, followed by the secondary peak observed in c42/5HTIAD,. 
tubules (peaking at 125 nM; slightly larger than the c42/5HTIAD,, ) peak). There is 
also a sustained elevation of [Ca'+1j which was seen in both c42/5HTIADroand 
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Figure 5.2: SHT-induced stimulation of fluid secretion in tubules expressing 5HTIAD,,. can 
be inhibited by the 5HT1ADro antagonist yohimbine 
A: Tubules expressing 5HTIADro in principal cells (c42/UAS.: 5HTIADr, ) challenged with I AM 
5HT at 30 min (arrow) showed elevated fluid secretion rates (0) over non-treated tubules (*). 
Tubules treated with the 5HTIADrO antagonist yohimbine (10-5 M) at t=O showed an attenuated 
response to 5HT (0). Results are expressed as mean fluid secretion rate (nl/n-Lin) ± SEM, n=10. 
B: Tubules expressing 5HTIADrO in stellate cells (c724/UAS. -. 51IT1AD,. ) challenged with 1 AM 
5HT at 30 n-dn (arrow) showed elevated fluid secretion rates (0) over non-treated tubules (*). 
Tubules treated with the 5HTIADrO antagonist yohimbine, (10-5 M) at t=O showed an attenuated 
response to 5HT (0). Results are expressed as mean fluid secretion rate (rd/min) ± SEM, n=10. 
Secretion rates significantly different from basal are denoted by *. (NO-05, determined with the 

















Figure 5.3: SHT-induced [Ca2+1, rises in tubules expressing SHTIADro cell-Specifically: 
representative traces 
Typical traces of changes in [Ca2+], in tubule cells expressing 5HTIýDO when stimulated with 
JXJO-8 M 5HT (large arrow). 
A: aeq, +/+; c42 GAL4/5HT1ADro' Inset: typical Ca2+ trace of CAP2b-induced Ca2+ rise in 
princial cells (taken from MacPherson et al, submitted 2002). 
B: aeq, +/+; 010 GAL4/5HTlADro* Inset: typical Ca2+ trace of Drosokh-dn-induced Ca2+ rise in 
stellate cells (taken from Radford et al, 2002). 
Peaks prior to the main rise in [Ca2+]i are caused by control ("mock") injections of Schneider's 
medium (small arrow). 
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Figure 5A SHT-induced [Ca2+1i rises in tubules expressing SHTIADro ubiquitously: 
representative trace 
Typical trace of changes in [Ca2+1, in tubule cells expressing 511TIAD ubiquitously (fly line: 
aeq, hsGAL4/+; 5HTIADro/+) when stimulated with WO, M 5HT (large arrow). 
The peak prior to the main rise in [Ca2+], is caused by a control ("mock") injection of 
Schneider's medium (small arrow). 
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5.3.4 5HT does not alter cyclic nucleotide levels in SHTIAD.. transgenic tubules 
The possibility that intracellular cGMP levels may be altered as a result of cross- 
talk upon activation of 5HTIADrowas investigated by assaying levels both with 
and without 5HT stimulation in samples from tubules expressing 5HTIADrO and 
from a wild type control (Figure 5.5). All samples contained approximately the 
same basal levels of intracellular cGMP, and there was no significant change in 
these levels upon 5HT-induced 5HTIADr. activation. 
Similarly, cAMP levels in c42/UAS:: 5HTIAD,,, and c7lO/UAS:: 5HTIADro tubules 
were assayed with and without stimulation of SHTIAD., with 5HT (Figure 5.6). 
Again, there was no significant alteration of cAMP levels in the presence of 
5HT, suggesting that this calcium signal does not contribute to a cAMP- 
generating pathway. However, Saudou et al (1992) reported that forskolin- 
activated adenylate cyclase activity was inhibited by 5HTIADrO activation. No 
decrease in basal levels of cAMP were observed in 5HT-stimulated tubules. 
This leads to one of two possibilities: the 5HTIADrý receptor couples with aG 
protein that leads to PLC activation, but not to adenylate cyclase inhibition in 
Drosophila epithelial cells; or more simply, under these conditions there is very 
little adenylate cyclase activity, and inhibition of this enzyme can only be 
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Figure 5.5: 5HTIAD. transgenic tubules do not have significantly altered cGMP levels in 
response to 5HT 
Tubules were treated with 5HT (1 IAM) and Zaprinast (I tLM) for 10 min and prepared as 
described in Materials and Methods. Results are expressed as mean cGMP content 
(fmol /tubule) ýt SEM, n=3. Differences between 5HT-treated samples and control samples are 












Figure 5.6: SHTIADro transgenic tubules do not have significantly altered cAMP levels in 
response to 5HT 
Tubules were treated with 5FIT (I IAM) and IBMX (10-4 M) for 10 min and prepared as 
described in Materials and Methods. Results are expressed as mean cAMP content 
(fmol/ tubule) j- SEM, ný3. Differences between 5HT-treated samples and control samples are 




Flies expressing 5HTIADroin a cell-specific manner responded to 5HT in a dose 
dependent manner in fluid secretion assays. The pharmacological profile of this 
receptor was similar whether specifically expressed in either principal cells or 
stellate cells. However, the profile of the [Ca"j, increase by receptor stimulation 
was different in these two cell types, which suggests that there is differential 
processing of this signal. When flies expressed the 5HTIAD,,, ) receptor and 
aequorin ubiquitously (using hs:: GAL4 as the driver for UAS:: 5HTIAD,,, and 
UAS:: aequorin), the calcium response to 5HT stimulation was considerably 
larger than those of principal- and stellate cell-specific assays, indicating that 
these signals would have an additive response in a fluid secretion assay. 
However, with ubiquitous expression of 5HT1ADrO in heat-shocked hs:: 5HTIADro 
tubules, [Ca"]i would be elevated in other regions of the tubule (for example, 
the initial segment). Further experiments would be required to determine the 
effects of ubiquitous Ca" modulation on fluid secretion. 
No variation in intracellular cGMP levels resulted from stimulation of 5HTIADro 
tubules with 5HT, suggesting that there is not cross-talk between these two 
signalling pathways, when [Ca'*jj levels are elevated in tubules by this method. 
This is surprising, as it has been demonstrated that tubules treated with the 
neuropeptide CAP2bdisplay an initial rise in [Ca 2+]i in principal cells, which 
ultimately leads to generation of cGMP by a soluble guanylate cyclase. Indeed a 
Ca 2+ signal, and Ca 2+ entry, has been shown to be essential in CAP2b signalling 
(Rosay et al, 1997). However, the calcium signal generated by activation of 
5HT1ADro in principal cells is slightly different from that induced by CAP2b: the 
initial 5HT-induced rise in [Ca'+jj in c42/UAS:: 5HTIADI, tubules is smaller than 
the CAP2b-induced initial [Ca'+Ji rise observed in c42; aeq tubules. The secondary 
rises in [Ca 2+ ]i are also different: although both responses involve prolonged 
elevation of [Ca'+jj over several minutes, the 5HT-induced secondary response 
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only occurs approximately 1 min after the initial [Ca"Ji rise, whereas the CAP2. - 
induced [Ca"Ji rise follows immediately after the initial rise. These results may 
outline the importance of spatio-temporal Ca 2+ signalling in Malpighian 
tubules. A further possibility is that there is an association of a regulatory 
protein(s) to the receptor for CAP2b, which does not associate with the 5HTIAD. 
receptor, meaning the Ca 2+ signal is differentially recognised. 
Interestingly, there was no reduction in basal levels of cAMP in tubules 
expressing 5HTIADrowhen stimulated with 5HT. However, the work by Saudou 
et al demonstrated that forskolin-stimulated cAMP levels were reduced when 
cells expressing 5HTIADrowere stimulated with 5HT, concluding that the G 
protein that associates with 5HTIADroinhibited adenylate cyclase activity. This 
leads to one of two possibilities: the 5HTIAIýro receptor couples with aG protein 
that leads to PLC activation, but not to adenylate cyclase inhibition in Drosophila 
epithelial cells; or more simply, under these conditions there is very little 
adenylate cyclase activity, and inhibition of this enzyme can only be unmasked 
when it is activated by forskolin. A similar experiment to that of Saudou et al 
would need to be performed to determine which of these possibilities is correct. 
A model for the Ca" signalling mechanisms induced by stimulation of the 
5HTIADro iSillustrated in Figure 5.7. 
Ca" signalling is extremely important, and expression of the 5HTIADro transgene 
can potentially be utilised to modulate PLC-activated Ca' release in any cell- 
type, with only tissue sensitivity to 5HT being a limitation. In the context of 
Malpighian tubules, cell-specific 5HTIADro expression may prove to be useful to 
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Figure 5.7. A model for cell-specific action of Ca2+ in 5HTIAD.. transgenic Malpighian tubules 
A: 5HT-induced principal cell-specific generation of lnsl? ý., induces Ca2+ release from the ER. This, in 
turn, stimulates Ca2+ entry which elevates fluid secretion, possibly by stimulation of V-ATPase 
activity. 
B: 5HT-induced stellate cell-specific generation of lnslý, induces Ca2' release from the ER. This, in 











This work has aimed to further our knowledge of how the Malpighian tubule of 
Drosophila integrates cell-specific signal cascades to result in overall control and 
modulation of function. Furthermore, it has established that Drosophila is a good 
model organism for in vivo heterologous receptor pharmacology, which has the 
advantage over cell culture in that receptors are expressed in a differentiated, 
multicellular environment. This allows subtleties to be detected that may not be 
seen in the bland, de-differentiated background of cell lines. Obviously, the 
closer the cellular context from which a receptor has been taken, the more 
relevant the information about that receptor becomes, and if the cells 
themselves have not been removed from their natural context, there is further 
enhancement of relevance. 
As discussed at the end of chapters 3,4 and 5, there is a great amount of 
complexity to the signal transduction pathways known to control fluid 
transport in Malpighian tubules. Even for such a morphologically simple tissue, 
the cross-talk, cross-activation and overall integration of signals is not easy to 
unravel. This work has built a platform for further dissection of signalling 
events by allowing activation of cGMP, cAMP and Ca' to be isolated from one 
another. 
Many of the signalling events which contribute to fluid transport of the tubule 
have previously been characterised (Davies et al, 1995; Davies et al, 1997; Rosay 
et al, 1997; Davies, 2000; MacPherson et al, 2001). This was discussed in chapter 
1 and is surnmarised in Figure 1.6. We now have a better understanding of 
what effectors and negative regulators are modulated in response to second 
messenger stimulation, summarised in Figure 6.1. A brief recapitulation of 
results from this work with additional comments is given below. 
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6.1.1 GC-A and cGMP signalling. 
Transgenic tubules expressed the rat guanylate cyclase receptor GC-A on the 
basolateral membrane, as visualised by fluorescence microscopy. Tubules were 
sensitive to the GC-A ligand ANP, and responded in a dose-dependent manner. 
Fluid secretion of tubules was elevated by ANP, and an EC50 value of 5x 10' M 
was calculated from fluid secretion data. However, at high concentration of 
ANP (0.1 mM) fluid secretion was attenuated. This "inverted U" profile is 
similar to that observed when tubules are treated with exogenous cGMP 
(Davies et al, 1995). Other workers have shown that CAP2b or cGMP are 
inhibitory in other species (Quinlan et al, 1997, Wiehart et al, 2002; Eigenheer et 
al, 2002), which suggests that cGMP acts as an anti-diuretic at high 
concentrations. 
Tubules expressing GC-A under heat-shock control showed higher maximal 
rates of fluid secretion in response to ANP than tubules expressing GC-A in 
only one cell-type of the tubule main segment, implying that there was an 
additive effect of second messenger generation in both cell types. This data 
reveals a role for cGMP in stellate cells that is distinct from its function in 
principal cells. The levels of cGMP generated in response to ANP were directly 
proportional and a similar EC50 for ANP was calculated from cGMP data. Both 
fluid secretion and the subsequent generation of cGMP can be attenuated with 
the peptide inhibitor anantin, with an 'C50 Of 5X10-7 M. 
Immunocytochernistry indicated that the cGMP generated by GC-A in response 
to ANP was localised to pools at the basolateral membrane, which suggests that 
there is a low diffusibilty of cGMP and that there is perhaps 
compartmentalisation of effectors. It may also suggest that localisation of cGMP 
at the basolateral membrane elicits a different response to the cGMP signal 
generated by a soluble guanylate cyclase. This could be achieved by tight 
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signalling complexes, which might include cGMP-dependent kinases or 
phosphodiesterases in order to achieve tight coordination of the signal. 
Indeed, a major effector of cGMP, the cGMP-dependent kinase (cGK) was 
shown to be upregulated in response to ANP in GC-A transgenic tubules, 
expressing GC-A in either principal cells or stellate cells. Elevated kinase 
activity could potentially lead to phosphorylation of a huge range of substrates 
that would be able to contribute to stimulation of fluid secretion. It has 
previously been shown that tubules incubated with exogenous cGMP or with 
CAP2b have increased V-ATPase activity (O'Donnell et al, 1996). This 
demonstrates that cGMP, or one of its effectors, acts to increase V-ATPase 
activity, suggesting this may be a target for phosphorylation by cGK. 
Phosphodiesterase (PDE) activity in tubules expressing GC-A was examined, 
and it was found that tubules had elevated cGMP-dependent PDE activity in 
response to ANP. This indicates that there is a simple negative feedback loop 
which dampens the cGMP signal. In contrast, cAMP-hydrolysing 
phosphodiesterase activity was shown to decrease below basal activity. This 
suggests an element of cross-talk between cGMP and cAMP signal transduction 
pathways in tubules to downregulate cAMP hydrolysis. A plausible 
explanation is that a cAMP-hydrolysing PDE is inhibited by cGMP, as is the 
case with the mammalian PDE3 family. There was no significant elevation of 
cAMP levels in these tubules, however, which implies that the decrease in 
cAMP-dependent PDE activity would only be seen to affect tubules that had 
concurrent elevated adenylate cyclase activity, or that a cGMP-inhibited PDE 
has dual hydrolysing specificity for cGMP and cAMP. Tubules have been 
shown to express at least four distinct PDEs by RT-PCR, but none of these 
appear to be an orthologue of mammalian PDE3 by sequence similarity 
(Jonathan Day, personal communication). This does not rule out the possibilty 
that a cAMP-hydrolysing PDE is negatively regulated by a component of the 
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cGMP signalling cascade in a less direct manner. Indeed, tubules express a 
cAMP-hydrolysing PDE that is homologous to mammalian PDE8, which has 
unknown regulators. 
The effect of cell-specific production of cGMP as a modulator of Ca"' signalling 
was assayed. Tubules expressing GC-A in principal cells showed a biphasic 
elevation of [Ca"']j, which is indicative of a calcium-induced calcium rise. 
Interestingly, ANP has been shown to stimulate L-type Ca' channel current in 
other systems (Barrett et al, 1991). These channels have also been shown to be 
important in regulation of fluid transport in Malpighian tubules (MacPherson et 
al, 2001). Furthermore, these channels have been localised to principal cells of 
tubules, and may explain why tubules expressing GC-A only in stellate cells do 
not respond to ANP with changes in [Ca'*Ii. Therefore, it is likely that cGMP 
provides different mechanisms of action in different cell types of tubules, and 
opens the question of what its role may be in control of stellate cell function. 
Cyclic nucleotide-gated ion channels have been shown to be expressed in 
Malpighian tubules (MacPherson et A 2001), but are likely only to be present in 
principal cells. These ion channels are relatively non-selective, but have high 
conductance for Ca", and may contribute to the rise in [Ca"'j, that is seen in 
principal cells. Similarly, if these channels were present in stellate cells, an 
ANP-induced cGMP rise would likely cause an influx of Ca', which has been 
shown not to occur. A possible role for cGMP in stellate cells could be 
regulation of Cl- channels. This would, however be indirect, as the general 
classes of Cl- channel are those activated by (i) intracellular cAMP, (ii) cell 
swelling, (iii) hyperpolarization and (iv) intracellular Ca". Malpighian tubules 
have been shown to increase fluid secretion by elevated Cl- conductance in 
response to stimulation of aG protein-coupled receptor that is coupled to PLC- 
activated release of Ca' through InsP3 receptor channels in the ER. However, 
chloride channels may also be opened by cAMP, through phosphorylation of 
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the channel by cAK. Therefore, if cGMP or a cGMP-activated kinase could 
cross-activate cAK, chloride conductance may be increased. Both cAK assays 
and microelectrode measurements in tubules would need to be conducted in 
order to test this possibilty. It should be noted that it has previously been 
demonstrated that cyclic nucleotides elicit only a negligible effect on anion 
conductance (O'Donnell et al, 1996). This did not address stellate cell-specific 
increases in cyclic nucleotide levels, but only the effect that incubuation with 
exogenous cyclic nucleotides had on transepithelial potential, and therefore 
may not have unmasked this possible control of anion conductance. Cyclic 
nucleotides may only be transported into principal cells and, therefore, the 
ability to manipulate cyclic nucleotides in stellate cells is generating new 
results. This is accordingly the first demonstration that cGMP plays a role in 
stellate cells. 
6.1.2 5HT7D,,,, and cAMP signaffing. 
Expression of 5HT7Dro in tubules confers 5HT-stimulated elevation of fluid 
secretion, when expressed in either a principal cell- or stellate-cell specific 
manner. Production of cAMP is directly proportional to the concentration of 
5HT used to stimulate tubules, with an EC50 of approximately 5x 10' M. This 
can be attenuated by the 5HTMr. antagonist (+)-butaclamol, which has a 
calculated IC50 of approximately 2 ýM 
This is the first demonstration that an extracellular ligand can stimulate aG 
protein-coupled receptor to signal via cAMP in Drosophila Malpighian tubules. 
As with cGMP, it has previously been demonstrated that exogenous cAMP 
does elevate fluid secretion through an increase in V-ATPase activity but has a 
negligible effect on anion conductance (O'Donnell et al, 1996). The same 
argument applies as it did for the role of cGMP in stellate cells: there are 
perhaps only cyclic nucleotide transporters on the basolateral membrane of 
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principal cells, and therefore the role of cyclic nucleotides in stellate cells 
remained unmasked. There are a number of important proteins that may be 
regulated by cAMP and cAMP-dependent kinase in tubules. Of course, the V- 
ATPase is already implicated as a major candidate for control by cAMP in 
Drosphila tubules (Coast et al, 2001). It has also been suggested that cAMP may 
stimulate a basolateral Na'/K'-ATPase directly, as addition of the Na"/K*- 
ATPase inhibitor ouabain to cAMP-stimulated tubules reduces fluid secretion 
rate slightly (Linton and O'Donnell, 1999). However, these are principal cell- 
specific modulations, and it is apparent from fluid secretion assays that cAMP 
produced specifically in stellate cells also acts to elevate fluid secretion rate. 
The role of stellate cells is proposed to be mainly for the passage of water and 
Cl-, as determined firstly by the simple architecture of these cells. More 
conclusively, however, is that both the receptor for Drosokinin and the 
subsequent elevated chloride conductance in response to activation of the 
receptor by Drosokinin are localised to the stellate cells (O'Donnell et al, 1998; 
Radford et al, 2002). This suggests chloride channels are good candidates for 
regulation by cAMP or cAK: tubule chloride channels have been shown to be 
activated by Ca" in response to Drosokinin (O'Donnell et al, 1998), but there are 
perhaps other chloride channels present, regulated in a different manner, which 
remain to be characterised. Additional routes for chloride flux have been 
proposed, which include K*/Cl- cotransport across the baslolateral membrane 
of principal cells (Linton and O'Donnell, 1999) and via a sodium-dependent Cl' 
/HC03- exchanger, also expressed on the basolateral membrane of tubules 
(Sciortino et al, 2001); regulation of these transporters may involve cAMP either 
directly or indirectly. 
A second possible role for cAMP in stellate cells would be in the recruitment of 
water channels (aquaporins, AQP) to the apical and/or basolateral plasma 
membranes to increase tubule permeability. The elevation of cAMP by the 
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hormone vasopressin, with subsequent phosphorylation of marnmalian AQP2, 
is necessary to recruit AQP2 from intracellular vesicles to apical membranes of 
renal collecting duct epithelial cells (Sabolic et al, 1992; Sabolic et al, 1995; 
Kuwahara et al, 1995; Nielsen et al, 1997). Interestingly, nitric oxide and ANP 
can both stimulate mammalian AQP2 insertion into membranes, which implies 
that this aquaporin can be regulated by cGMP as well as by cAMP (Bouley et al, 
2000). It has also been shown that another aquaporin, AQP1, which was 
originally thought to be constitutively expressed on the apical and basolateral 
membranes of proximal tubules and thin descending limbs of Henle, is also 
regulated by arginine vasopressin (Yool et al, 1996; Patil et al, 1997, Han and 
Patil, 2000). Malpighian tubules have been shown to express six water 
transporters by RT-PCR (Lesley Cunliffe, personal communication), and are 
therefore possibly regulated by cyclic nucleotides or cyclic nucleotide 
dependent kinases. This would be an interesting idea to investigate in future, 
and using GC-A and 5HT7D,, transgenic tubules would be ideal for doing so. 
Phosphodiesterase activity is modulated in 5HT7,,,, tubules in response to 5HT, 
which highlights the importance of this enzyme in regulation of cyclic 
nucleotide signalling. The levels of intracellular cGMP are perhaps decreased 
very slightly in 5HT7D,,, tubules in response to 5HT, but not significantly. The 
increase in cAMP results in a significant elevation of cAMP-hydrolysing 
phosphodiesterase activity. Similarly, the slight decrease of cGMP below basal 
levels in response to 5HT corresponded to significantly elevated cGMP- 
hydrolysing phosphodiesterase activity. As discussed earlier, tubules express at 
least four different PDEs; two of which are likely to be cAMP-hydrolysing 
PDEs. These PDEs are dunce and a homologue to mammalian PDE8A, which 
specifically hydrolyses cAMP. However, there is also a PDE expressed in 
tubules homologous to PDE11A that is possibly a dual-hydrolysing PDE 
(Broderick et al, in preparation). Therefore, there is the possibility that the 
195 
elevation of cAMP- and cGMP-hydrolysing PDE activity is by this single PDE, 
which can be activated by elevation of [cAMPI,. The regulators of these 
Drosophila PDEs are yet to be elucidated, and yet another possibility is that the 
cGMP-hydrolysing PDE found in tubules (homologous to mammalian PDE 6, 
which is regulated by light) is regulated by cAMP or cAK. 
Kinase activity dependent on cAMP was not assayed due to time constraints, 
but is a major effector of cAMP in most cellular systems and is likely to be 
important in any signal transduction pathway that cAMP is involved. in. 
[Ca"Ji levels were assayed in tubules expressing 5HT7Dro cell-specifically. 
Stimulation of tubules expressing 5HT7Droin principal cells with 5HT resulted in 
a biphasic elevation of [Ca"]i, whereas there was no change in tubules 
expressing 5HT7Do in stellate cells. This implies that the 5HT7D, 0 receptor 
does 
not directly stimulate Ca" release into the cytosol via activation of PLC, as if 
this was the mechanism of elevation of [Ca'*],, it would be seen in both cell 
types. The elevation observed in principal cells could either be due to 
downstream cross-talk, which does not take place in stellate cells, or that 
principal cells contain cyclic nucleotide gated channels that are not present in 
stellate cells. 
RT-PCR analysis of G proteins was performed to determine which of the cc, 
and y subunits were expressed in tubules. Unsurprisingly, fragments for all but 
one of the subunit genes were consistently amplified, which suggests there is 
great diversity in the signals received and transduced by tubules. This includes 
those that both stimulate and inhibit adenylate cyclase, and those which result 
in the mobilisation. of Ca" from internal ER stores, as the relevant Ga subunits 
were detected. Of course, this experiment does not demonstrate that every cell 
in the tubule expresses every G protein, but is at least consistent with the results 
in this thesis. 
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6.1.3 5HTIAD,,, and Ca2" signalling. 
Flies expressing 5HTIAD,, ) 
in a cell-specific manner responded to 5HT in a dose- 
dependent manner in fluid secretion assays. The pharmacological profile of this 
receptor was similar when specifically expressed in either principal cells or 
stellate cells. The calcium response to 5HT stimulation was considerably larger 
when 51-ITlADro was expressed ubiquitously than the response of principal- and 
stellate cell-specific calcium responses, indicating that these signals may have 
an additive response. However, it would be very interesting to determine the 
effects of modulating [Ca2'jj levels in other regions of the tubule, for example 
initial or lower segments, using the appropriate GAL4 driver. 
No variation in intracellular cGMP levels resulted from stimulation of 5HTIADro 
tubules with 5HT, suggesting that there is not cross-talk between these two 
signalling pathways, when [Ca 2,1i levels are elevated in tubules by this method. 
This highlights the need for very specific signals to trigger specific responses: 
the Ca 2+ signal generated in principal cells did not eventually lead to elevated 
cGMP levels, as it does in CAP2b-stimulated tubules, and implies that these Ca 2* 
signals are differentially recognised. 
Interestingly, there was no reduction in basal levels of cAMP in tubules 
expressing 5HTIAD,,,, when stimulated with 5HT. However, this receptor has 
previously been demonstrated to inhibit adenylate cyclase activity. This leads to 
one of two possibilities: the 5HTIAD,. receptor couples with aG protein that 
leads to PLC activation, but not to adenylate cyclase inhibition in Drosophila 
epithelial cells; or more simply, under these conditions there is very little 
adenylate cyclase activity, and inhibition of this enzyme can only be unmasked 
when it is activated by forskolin. 
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6.2 Future work 
At the end of chapters 3 and 4, cyclic nucleotide assays were conducted on 
brains from flies expressing GC-A and 5HT7D,,, respectively. These assays aimed 
to illustrate that the scope of this project is not restricted to Malpighian tubules, 
or indeed epithelia. In chapter 3, GC-A was expressed in brains by heat-shock, 
and this conferred sensitivity to ANP, with concurrent elevation of [cGMP]i in 
stimulated samples. Similarly, in chapter 4, the 5HT7D,,, receptor was expressed 
in brain, and this resulted in a slight elevation of 5HT above wild type control 
levels. This elevation could be potentiated with the addition of 5HT to samples. 
These transgenic lines are therefore suitable to study second messenger 
signalling in isolated tissues, and perhaps even to determine behavioural 
phenotypes in the living animal. There are, of course, limitations: ectopic 
expression of a receptor requires that the cells of interest do not normally 
respond to the cognate ligand. In the case of the 5HT7D,. receptor, it would need 
to be established that the cell in which it is expressed does not normally 
respond to serotonin. This is not an issue for ectopic expression of GC-A, as 
Drosophila does not produce endogenous ANP, or any related peptide. 
However, this does present an additional limitation. The biochemistry and 
physiology of an isolated tissue expressing the transgenic receptor can be 
examined if the tissue is bathed in the appropriate ligand, but this is not useful 
if, for example, behavioural phenotypes were of interest. This could perhaps be 
overcome, either by injection of hormone/peptide into the haemolymph of live 
animals, or more ambitiously, by ectopic expression of the gene for the 
hormone/Peptide in neurosecretory cells. Hormone delivery could then be 




Here, it has been demonstrated that transgenic receptors integrate effectively 
with endogenous machinery, and behave broadly as expected. This technique 
has also given some interesting insights to Malpighian tubule regulation. For 
example, intracellular modulation of cyclic nucleotides in stellate cells affects 
fluid secretion of tubules, presumably by controlling the permeability of these 
cells to water and/or chloride. 
In conclusion, integrative physiology has combined genetics/ transgenics with 
classical physiology, to create a powerful system for in vivo characterisation of 
receptors, and also for transgenic manipulation of cGMP, cAMP and Ca'* in 
almost any cells of choice. 
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Figure 6.1: Summary of proposed intracellular signalling and crosstalk in Malpighian 
tubules 
Elevation of intracellular cAMP (jcAMPjj) in principal cells by activation of 5HT7,,,, with 5HT 
elevates fluid secretion, presumably by increasing V-ATPase activity (and possibly also through 
activation of basolateral ouabain-sensitive Na+/ K+ -ATPase activity). A rise in intracellular Ca24 is also seen, indicating that cyclic nucleotide-gated channels (CNG) are activated. Cyclic AMP- 
and cGMP-hydrolysing phosphodiesterase (PDE) activity is elevated in response to activation 
of 5HT7[,,, and completes a negative feedback loop. 
Similarly, elevation of intracellular cGMP (IcGMPI, ) in principal cells by activation of G. C-A 
with ANP elevates fluid secretion, increasing V-ATPase activity and inducing a rise in 
intracellular Ca2+. There is also elevation of cGMP-dependent kinase (cGK) activity in response 
to ANP, implicating this enzyme in control of fluid secretion. ANII stimulation evokes 
modulations in PDE activity, increasing the rate of hydrolysis of cGMP in a negative feedback 
loop, but conversely decreases the rate of hydrolysis of cA MP. 
Elevation of intracellular Ca2+ (ICa2+1, ) in principal cells by activation of 5HTIM), with 5HT 
elevates fluid secretion via a calcium-induced calcium rise, which does not impinge on cyclic 
nucleotide signalling. 
Elevation of [cAMPjj and [cGMP]j in stellate cells by activation of 5HT7D,,, and GCA 
respectively, elevate fluid secretion rate with no downstream activation of a Ca2' -signal, 
suggesting that CNGs are not found in this cell type. As there are no V-ATPases in stellate cells, 
this reveals a separate function for cyclic nucleotides in this cell type. This could be control of 
chloride channel activity, or an increase in permeability via aquaporin recruitment to the 
plasma membrane. PDE activity is elevated in response to 5HT7D,,, activation. 
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Appendix 1 
Primers used in this thesis 
Primer name Sequence 
5HT-drol-Eco Forward 5-GGA ATT CGA AAG ACT GCT CAT GGC TTT A-3' 
5HT-drol-Not Reverse 5-GAA TGC GGC CGC TCG TGG ATG GCC TAG AGA AA-3' 
GC-A-Bgl Forward 5'-AGA TCT ATG CCG GGC TCCCGA CGC GT-3' 
GC-A-Not Reverse 5'-GCG GCC GCT CAG CCT CGA GTG CTA CAT C-3' 
GC-A 5'Reverse 5-CTC CCA GCC CAG CCG TCG ATG CAG CG-3' 
5HT/GFP Forward 5-GGG GCG AGC GAG AGC TIT CTC ATG GTG ACC AAG GGC-3' 
5HT-GFP Reverse 5-TCC TCG CCC TTG CTC ACC ATG AGA AAG CTC TCC CTC-3' 
GFP-Not-Reverse 5'-GCG GCC GCC TTG TAC AGC TCG TCC ATG-3' 
Gs-alpha60A-F 5'-CGG CAA ATC AAC CAT AGT CAA CC-3' 
Gs-alpha60A-R 5'-ATT GTG CTC ACT CGG TCC AGG AAG-3' 
Gi-alpha65A-F 5'-CGT GTG Trr GTG TGT GTG TGC TTG-3' 
Gi-alpha65A-R 5'-AGA GGC GTG TGT GAA GAA CTG G-T 
Galpha73B-F 5'-GGG CAA GAC GAC CAT CAT CAA G-T 
Galpha73B-R 5'-ATT TCG CAC TAT CCA GCA GGG G-3' 
Galpha 2B-F 5'-GCA TCG GAA TCG GAA TCC ATA G-3' 
Galpha 2B-R 5'-CAC GCA CTA AGC ACA AAA CGG-3' 
cta-F 5'-CAA TGT CAT CAC GAA CGG CG-3' 
cta-R 5'-TIT CCA GAT TCC CCA GCA CC-3' 
Goalpha 47A-F 5-CAA CCC ACC GCC TTT TIT TC-3' 
Goalpha 47A-R 5'-TTA TGA CCG CCA CTG TCT GTG C-3' 
CG17760 -Galpha-F 5'-GGC TTG TGA GGA AAG GCG TAT C-3' 
CG17760 -Galpha-R 5'-CCA AAA ATC CCA GGA CCA ATA GC-3' 
Galpha49B-F 5'-CCT CGG ATA GCG GAG TTA GTT TAG C-3' 
Galpha49B-R 5'-AAC GAT GCC AGT GGT CTT GAC G-T 
Gbeta60B-F 5'-GAT GGC TTA GAA ACT GTG TGG TCG-3' 
Gbeta6OB-R 5'-TAC TGG CAG ATG CGG AAG GTC TTG-3' 
Gbeta 8F-F 5'-CGA TGA GAT TCG TGG AGA CCT C-3' 
Gbeta 8F-R 5'- GCA AAC AGG CGG CAT TTA CC-3' 
Gbeta 76C-F 5-ATG AAC CGC CCC AGA AGA ACA C-3' 
Gbeta 76C-R 5'-TTA GAG CCA CAG ACG CAC TTG CTG-3' 
Gbeta 5-F 5'-CAA GCG TCA CAT CAT CTC CTC G-3' 
Gbeta 5-R 5'-AGG TGT TGC CCG TTT CGT TG-3' 
Gbeta 13F-F 5'-GCA AAC ACA GGA CGA CGA CTA TG-3' 
Gbeta 13F-R 5'-CGT TCT TrA GGG ACT CGG CTT C-3' 
Ggaffunal-F 5'-GTT TAG CAA GAT GGA TTA GGA CGC-3' 
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Ggan-tmal-R 5'-GAG M GTG Trr CTG GTT TCG GAC-3' 
Ggamrna30A-F 5'-AAA TGC CCT CAA CAT CAT CAG C-3' 
Ggarruna30A-R 5'-TTA GCC AAA GGA CGA ACA GGA G-3' 
Sp 3 5'-GAG TAC GCA AAG CTT TAA CTA TGT-3' 
Splac 2 5'-GAA TTC ACT GGC CGT CGT 71"r ACA A-3' 
Spep I 5'-GAC ACT CAG AAT ACT ATT C-3' 
P Lac 4 5'-ACT GTG CGT TAG GTC CTG TTC A17 GTT-3' 
P Lac 1 5'-CAC CCA AGG CTC TGC TCC! CAC AAT-3' 
Plw 3-1 5'-TGT CGG CGT CAT CAA CTC C-3' 
Pry 1 5'-CCT TAG CAT GTC CGT GGG GTT TGA AT-3' 
Pry 2 5'-CCT GCC GAC GGG ACC ACC TrA TGT TAT T-3' 
pUAST Forward 5-GAA ATC TGC CAA GAA GT-3' 
M13 (-20) Forward 5-GTA AAA CGA CGG CCA G-3' 
M13 Reverse 5-CAG GAA ACA GCT ATG AC-3' 
77 5'-GTA ATA CCA CTC ACT ATA GGG C-3' 
T3 5'-AAT TAACCC TCA CTA AAG GG-3' 
PKC53e-F 5'-AGA CCA CAA AGA CTT TCT GCG G-3' 
PKC53e-R 5'-GGC TrA AAT GGC GGT GCA C-3' 
vha55-F 5-AAT TCT CGA AAT TTG CAG TGC AC-3' 
vha55-R 5'-GAA TTG GGG GTC CCT TGT CGA TG-3' 
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Appendix 2 
Drosophila and E coli media 
Drosophila media 
Standard growth medium (per litre of water) 
10 g agar 
15 g sucrose 
30 g glucose 
35 g dried yeast 
15 g maize meal 
10 g wheat germ 
30 g treacle 
10 g soya flour 
Egg collection medium (per litre of water) 
15 g Bacto-agar 
26 g sucrose 
52 g glucose 
10 g dried yeast 
100 n-d grape juice 
Escherichia coli growth media 
L-broth (per litre of water) 
10 g bacto-tryptone 
5g yeast extract 
10 g NaCl 
L-agar (per litre of water) 
10 g bacto-tryptone 
5g yeast extract 
10 g NaCl 
15 g Bacto-agar 
SOC broth 2% tryp tone 
0.5% yeast extract 
10 mM NaCI 
2.5 mM KCI 
10 rnM MgC12 
10 MM MgSO4 
20 mM glucose 
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Appendix 3 
Inverse PCR was performed with various transgenic fly lines. PCR products 
were sequenced and aligned against the Drosophila genome, to determine the 
chromosomal localisation of the P element insertions. A table summarising 
these locations, and the corresponding Drosophila BLAST searches are below. 
Transgenic line Chromosomal localisation 
c42 10OC-100D 
hs:: 5HT7D,. 2R 58E-59A 
UAS: 5HT7D,. 3R 85B 
hs:: GC-A ? 
UAS:, GC-A 3L 
PfGAL4lc42 chromosomal location 
&CO08310 : Brosophila mtlanogaster, chromosome 3R, region IOOC-100D, P&C clone 
BACR16C04, oomplete sequence. Last updated 22-HAR-2001 
Length - 159,528 
hinus Strand RSPs: 
Score - 3025 (459.9 bits), Expect . 5.9o-130, P. 3.9@-130 
Identities - 615/625 (98%), positives . 613/625 (98%), StrarA - t1inus I Plus 
Query: 710 TTCTTGCTCTCGCOCTG&KTr7TOAAA&TTTCCNCAAGTTAAAkTTAAATGAAAXAAM 651 
Sbjct: 145694 TTCTTGCTCTCGCGCTC, %MGTOAAAATTTCC&CAAC-TTAAAATTAA&TOAAAAAAM 145733 
Query: 650 CAAAGGAAGCkGXC&AkTAGCOAkTkGTAATTTCOGTTTAACAkCTSCOGOC&GTOCAC 591 
Sbjot: 145754 CAAAGGAAGC&GGCGAAkTAGCGAATkaTk&TTTCGOTTTAACAACTGCOGGC&GT anvmsm 
Query: 590 TASTAACCCTTThAkTGTGkTGAAkGAGTCGkGkAACT&TTGGTOTTTCCA&CG#ATAAO 531 
Sbjot: 145814 TAOTA&CCCTTTAAATGTC-kTGAAAGArAGCAGMACTATTGGTC-TTTCCAACG#ATAAG a0aij 
Query: 530 TTTAAACTTCTAATATAAACTGAATAABGTOCTTATJLATrYTTT&TTTA&CkTACkTATACO 471 
Sbjct: 145874 TTTMACTTCTA&TACMACTCAkTAAGGTGCTTATAATGTTTkTTTAACkTACkTkTkG 145-144 
Query: 470 TG&Tkr7TTTCkGAAC-AkCkTAJLkTTCAAACTTAAA&TAMT&COTACAAATkTOTAATC 411 
Sbjot: 145934 TrATAGTTTCAC, %AG, 6ACKTAMTTCAAACTTAAA&TACAAT&CDTACAAATATC7TAAT, 6%4774 
Query: 410 rzTkT&CAAAACAOTGACGAGGkGCGAAAATGGAACDCTGTkTAOTAATTTAGG&CCTTOT 351 
Sbjct: 145994 GT&TACAAAACAGTGACCXGGAOCC4AAATOGAAGOCTGTATAGTAATTTKGGACCTTOT 146053 
Query: 350 &TkTacGATkTCTGcGkTkTiLATCCCCCCAACCGAkGAATCCOCTCTOTCTCOCTC()CTC 291 
Sbjot: 146054 ATATOCO&TATCTGCG&TkTAATCCCCCCAACCC4AC4ATCCOCTCTC-TCTCOCTCOCTC 446163 
Query: 290 kMkTkTCCGTCTCCTTTTAAkGGCGTkCACGTkCCCAAAGCCQMGTAA&GCAG&GM 231 
Sbjot: 146114 ASTATATCCGTCTCCTTTTAAACGMACACOTACCCAAAGGGGOTGTAAAXAGACvCW 146173 
Query: 230 &TGTGTCCGTGTCCCCTGTkAAGTGJLTCTCTCCGCJLGGCAkCCGCCC&CCCCTkAAACkT 171 
Sbjot: 146174 &TGTGTCCCTOTCCCCTGTAAAGTGATCTCTCCOCAGOCAACCOCCCkCCCCTAWCAT 146233 
Query: 170 CCGCTCTT&TCAGGCGC&GTGTOCC-TOCr7TGTkTGTGTOCeCCTOGGGAGGGM&rGAO III 
Sbjot: 146234 CCOCTCTTATCABGCGCAGTGTOCOTOCOTOT&TOTGTOCOCCTOOGWOOOOTGT A%DA74 
Query: 110 TSWACASCMUTCATTGAAGGOC 86 
Sbjot: 146294 TGAG-CAGCGG-KTGTCGGCKC4. GC 146316 
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Pfhs:: 5H r,, 
l chromosomal location 
&CO08330 : Drosophila molanogastor, chromosome 2R, region 5SE-59k, D&C cloro 
BACRIMOS, complete sequence. Last up4stod 10-MAX-2001 
Length. 169,534 
tfinus Strand HS? s: 
Sooro . 2895 (439.9 bits), Expeot - 1.3*-123, P-1.3*-123 
Identities - 599/617 (97%), Positives . 599/617 (971t), Strand - Maus / Plus 
Query: 865 TO&GAAr. NT-KC, %JýATAAGO-GCAGJLATkTCCGCAAAGCTCCTAATTTTKTGAC&ThkCT 909 
Sbjct: 17704 TC, %S&-GCTGKGASATAAGrYTGCAG#AT&TCCGCAAABCTCCTAATTTTATGACATA&a 17762 
Query: 807 TAAGWTGACGTCTTTACGAG-CGGCTCAAACCAkTTCCAATAAATCCCCCAG&COCAT 749 
Sbjot: 17763 TAAGGGCTGJLCGTCTTTACGAGACWCTCAABCCA"TCCAATAAATCCCC-AG&CGCAT 1792L 
Query: 748 AA&CO-4WTAGTOC-TOCOAASCACTATOCkTkTOCOTAOCkCGGCCkTTCGCAGC&CT 691 
Sbjot: 17822 AAKCGTGGCTAGTOCCTrCGAAGCACTATOC&TATGCGTAOCACOOCCATTCGCAOCACA 1789t 
Query: 690 GCACAkTAATGOCKTAATAkChAOCAATTkTCGTTATAATASOCACCATTCCOOCCACOC 631 
Sbjct: 17882 GCACAATAATGGCATAATAkCAAGC&ATT&TCGTTATAATAGOCACCkTTCCOGCTACGC 17941 
Query: 630 CCGA&AACATAJLCCr. TTACGTTCCTCACGCCCACWGGTCCOOGTGTCOTGOCAGACGC 571 
Sbjct: 17942 CGO&GAACkTA&CCOTT&COTTCCTCACOCCCACWCOOTCCGGMOTCOTOKAOAOCW 19001 
Query: 570 A"TCG&TCTGAAG()CACATCCCkTCGAGAAGThCATCGMCOT&CAAKCAACGGACG 511 
Sbjct: 18002 AA&TCGATCTCAASKAC&TCCCATCGAGAAGTACATCC"GACOTACAAGCCAACOGACO 1906L 
Query: 510 &C&GGTAGGTkCC&CTAACAAAGCTAGAACTCAkTCCGCCGGOCCkaTOACTOTCCAAA 451 
Sbjot: 18062 &C&CGTAGGTACCKCTAACAAADCTAGAACTCAATCCGCCGOOCCACTTG&CTGTCCAAA 19121 
Query: 430 TGACGCGCAkkoCkC&CTCkCTTkCCkTTCAGTTOACGOGahkAkGOGKCTTTGAGO" 391 
Sbjct: 18122 TMCOGr. CAAA3CILCACTCJLCTTACCATTCkOTTGGCOOOCTAAAABGG#. CTTTWO" 19191 
Query: 390 CCGACC<, GTTCCG. %CTGC&CGGCCAAAAGCkTTWCJLCATTTTGTTAACOGGAASOCTT 331 
Sbjct: 18182 CCOACOGGTTCCO&CTOCACWCCAAA&CCkTTWC&CATTTTGTTMCBGO"GGM 18241 
Query: 330 CkTTAr, &TTC&TTAGATTC&TTAATAATGTkTkThATTJLCATGCTGILTTAGTTGGCTAZT 271 
Sbjct: 18242 C&TTK"TTCkTTASATTCkTTAATAATGTkT&TA&TTACATOCTGATTACITTOOCTPCT 18301 
Query: 270 TAACTGTTTNTAA&TT& 254 
Sbjot: 18302 TAAJLTGTTTCTAAATTA 19318 
PfUAS:: 5HT7D,,, l chromosomal location 
AC009512 : Drosophila molanagastor, chroacsomo 3R, rogrion 653-652, BAC clone, 
BACROIF13, ccýplate sequence. Last updated 06-SEP-2001 
Length . 167,467 
Plus Strand HSPs: 
Scoro - 2809 (427.4 bits), Expect m 3.9*-120, Pm3.9o-120 Identities . 570/579 (98%). positives . 570/579 (98%), Strand . Plus / Plus 
Query: t CGATTG"ThTTG, %MCCCGCGGTGCGTTTCTCCTCTCOCAOCCAATCATCGNTTTCOOC 60 
Sbjct: 35828 CO&TTehAT&TTGA"CCCGCGWOCGTTTCTCCTCTCOCAOCCO&TCATCOCTTTCOO-C 35007 
Query: 61 GCGACTCTTTTTTCCTAOTGCCCkTGCACGGCOOC&TCTOG&CACTOTCOCATTGATCTGC 120 
Sbjct: 35880 OCa&CTCTGTTTTCCTOGTGCCCAT(KACGGCGGC&TCTGG"ACTOTOCATTGATCTOC 35947 
Query: 121 CCKTTCAOCAWTGCAGGAACTGCGGCGCAACCCCAAG"CCCACGCGGTGCTCCTCCOT too 
Sbjot: 35948 CC&TTCABCAOCT(KAGGAACTGCGGCGC"CCCCAKOTTCCC, %CGCGOTGCTCCTCCOT 36007 
Query: lot STGTAAACT&CCTGGCCGGCTCAATG"AAACOCACGAi)GCGAGGAGC#. GCGCAACG. %Cg 240 
Sbjot: 36008 GTGT&AACTkCCTOOCCGGCTCAATGGAAAACOCACGAGOCGAGGABCAWGCAACOACT 36067 
Query: 241 GGCAGCACAGTGAGTCAC&GGTCACTCTOCAWCGCATCTG&GTACGTATTCAGOWAO 300 
Sbjct: 36068 GOCAOC&CADTU#. OTC. %CAGGTCACTCTOCAOCCOC&TCTO&OTACOIT&TTCAOGOOCAO 36127 
Query: 30L CCOOTTTOTTAKTCCCkSTCCCALGATCCAChTCCGCTCT, %CTAACTTTCTOGOOOAAATC 360 
Sbjot: 36128 CCOOTTTGTTA&TCCC&OTCCCAOATCCACATCCO-CTCTACTAACTTTCTOGOOGAAAITI 36187 
Query: 361 TCCCGTKTTT&TTGTOTACACTTTTTGCCTTCCTkCTTAOMTTCTTTTA&TACAAAAC 420 
SbjQt: 36189 TCCCOT&TTT&TT(n(nJ6C. %CTTTTTOCCTTCCTACTTA&MTTCTTTT&ATACAAAAC 36247 
Query: 421 ATTKTTTT&TGTACGCkCTTAOCACTAATTGTG, %TTGTAAACTT&CAMCTT. %CAGAGAA 400 
Sbjct: 36248 ATT&TTTTATGTKCGCkCTTAGCACTAATTC4r"TTGTAAACTTACAGACTTACAGAGAA 36307 
Query: 481 TTTTOOTAGAAAACAaCAAACAAGTAOCAThAATkTOTABOTTCGAGGTKTAAoACAgTT 540 
Sbjct: 36308 TTTTC)DTkOA&AACAWAAACAAGTAGCATAAAT&TGT&GMCGAOGTATkoo"AeTT 36367 
Query: 541 G&ATOOT("TTAATGCGT(ýITOGOOTTOOTT-, %ADTAC)CC 578 
Sbjct: 36368 G"TOGTOTTTAKT(K(YrGTGG&-TTOOTTTAAWAOCC 26405 
205 
Pfhs:: GC-Al chromosomal location 
>gbIt159315IDRORUDPEB Drosophila melanogaster rudimentary gene with 3' P element 
insertion site. 
Length . 964 
Minus Strand HSPs: 
Score - 650 (103.6 bits), Expect - 7.99-24, P-7.9*-24 
Identities - 134/138 (97%), Positives - 134/138 (97%), Strand - ftinus / Plus 
Query: 183 CTTAGACCATGATGAAATAAC&TAAGGTGGTCCCGTCGGCAAGAGACATCCACTTAACGT 124 
Sbjct: 224 CTTCC-CCATG&TGAAATAACATAAGGTGGTCCCGTCGOCAAGAGACATCCACTTA&CGT 282 
Query: 123 ATGCTTGCA&TAAGTGCGAGTGAAAGGJkATAGT&TTNTGAj3TGTCGTATTGAGTCTGGGT 64 
Sbjct: 283 ATKTTGCAATAAGTGCGADT&AAAGGAATAGTATTCTGAGTC-TCGT&TTGAGTCTGAGT 342 
Query: 63 GAGACAGCGATATG&TTG 46 
Sbjct:, 343 GAGACACCGATATr7ATTG 360 
PfUAS:: GC-Al chromosomal location 
M010036 : Drosophila melanogaster 3L BAC RP98-7K2O (Roswell Park Cancer 
Institute Drosophila BAC Library) complete sequence. Last updated 
27-DEC-2001 
Length - 190,365 
Minus Strand HSPs: 
Score - 2041 (312.3 bits), Expect - 1.7e-85, P. 1.7*-85 
Identities . 427/449 (95%), Positives - 427/449 (95%), Strand w Hinus i Plus 
Query: 446 CACCCAACGCTCTOCTC-CCA-CAATTATAAAT&CCACCAGAAATTATAATGCkCAGAGT 389 
11 111 1111 11 111 IfIIIIIIIIII 11 
Sbjct: 5824 CCC&CAACGCTCAGATGTCCA&CAATTATAAATAACAACAGAAATTATAATGCACAGAGT 5883 
Query: 388 CTTCAAATCGAATCGAA&TGAAAACOC&A-CGAAC<4AATGCAACAATTGCAGC<, GCCTC 330 
Sbjct: 5884 CTTCAA&TCGA&TCGAAATGAAAACGCAAACGAAC-GAAATGCAACA&TTOCAGOGOCCTC 5943 
Query: 329 CGATTTCGACTTCAACTTTGAATTTCGACTCW&TTTGA&TCGCGGCTTCGAAGAGCAAA 270 
Sbjct: 5944 CGATTTCCAATTCAACTTTG"TTTGGACTCGOATTTGAATCGCGC7CTTCGA&CAKAAA 6003 
Query: 269 TTOCATAATTATTGCTACAAATGAAGCTGAGAAAGTGGT&CCGTTTGA&TCGTG&TAAAG 210 
Sbjot: 6004 TTGCATAATTATTGCTACAAATGAAGCTGAGAAAGTGGTACCGTTTGAATCr-TGATAAAG 6063 
Query: 209 CG&TA&TTTTCCCCCTCACCOCCCAACSCAAAC4. GCCAATC-AAAATC-CATTTC&CTTTTC 150 
Sbjot: 6064 CGATAATTTTCCCCCTCACCGCCCAACGCAAAGAC-CCAATGAAAATGCATTTC&CTTTTC 6123 
Query: 149 AGGTTAACAAACAAAACA&TGCCGACTGTGTT&TTATGAAATCTCGACkr7TCACAATNNN 90 
Sbjct: 6124 ACGTTAACAAACAAA&CAATOCCGACTGTOTTATTATGAAATCTCGACAGTCACAikTAAA 6183 
Query: 89 NNNMNGCGAAAACAACCGAAATCGCCC&CGCGAAAkTAC7CTkTAA&TTCAAAG&TGCA 30 
Sbjct: 6184 AAAAAA-GGGAAAACAACCGAAATCOCCC&CC7CC4A"TAGCTATAAATTCAAAGATGCA 6242 
Query: 29 AAAAGATGCAATTTTTTGTTGCCAATATT I 
Sbjct: 6243 AAAAGATOCAATTTTTTGTTGCCAATATT 6271 
206 
Appendix 4 
Solutions for use in Western blotting 
Running buffer 
1M Glycine 
1M Tris base 
10 % SDS 
Transfer buffer 
1M Glycine 
1M Tris base 
20 % methanol 
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